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T cell types and functions  
T lymphocytes are part of the adaptive 
immune system and play a vital role in the 
orchestration of an immune response and 
the clearance of pathogens and aberrant 
cells from the body. T lymphocytes distin-
guish themselves from other immune cells 
through the expression of the T cell recep-
tor (TCR). This receptor recognizes 
antigens presented by major histocompat-
ibility complex (MHC) class II molecules on 
professional antigen-presenting cells 
(APCs) or MHC class I expressed by all nu-
cleated cells. Each naïve T cell has a unique 
TCR due to somatic recombination of 
genes encoding the chains that constitute 
the receptor during cell differentiation [1-
3]. This provides each cell with a receptor 
specific for a unique peptide repertoire 
enabling a great diversity of antigens to be 
recognized.  
Once a T cell is confronted with an antigen 
that engages its TCR and costimulating sig-
nals such as interleukin 2 (IL2) are present, 
the T cell will become activated or primed. 
Activation results in cell proliferation in 
order to ensure an adequate number of 
specialized cells to deal with the current 
threat [4, 5]. The role the activated T cell 
and its progeny play in the subsequent 
immune response depends on its type. The 
research described in this thesis focuses on 
signal transduction in helper T cells (Th 
cells). 
Th cells were named after their main func-
tion, the stimulation of other immune cells 
by means of cytokine secretion. Th cells are 
classified by their expression of the glyco-
protein cluster of differentiation 4 (CD4) 
and respond to peptides in complex with 
MHC class II molecules. Naïve Th cells can 
therefore only be activated by professional 
APCs such as dendritic cells (DCs), macro-
phages and B lymphocytes. When 
activated, Th cells produce IL2 and start to 
proliferate due to a combination of 
autocrine signaling and exogenic IL2 stimu-
lation by for example, DCs. Additionally, 
upon activation Th cells will differentiate 
into effector T cells. Traditionally, two sub-
classes of effector T cells, i.e. Th1 and Th2 
effector cells (or Th1 and Th2 helper cells), 
were thought to exist, but other types 
have been added over time [6, 7]. 
Th1 effector cells secrete interferon γ 
(IFNγ) and tumor necrosis factor α (TNFα) 
to activate macrophages, cytotoxic T lym-
phocytes (CTLs) and, to a certain extent, 
immunoglobulin G (IgG)-producing B lym-
phocytes. On the other hand, Th2 effector 
cells express IL4, IL5, IL10 and IL13 and will 
activate IgE-producing B cells and, with 
their help, eosinophils, mast cells and ba-
sophils. Th1 cells therefore assist in the 
phagocytosis of pathogens and combating 
intracellular microbes and viruses, while 
Th2 cells focus on the destruction of extra-
cellular pathogens and their removal from 
the body [6, 7]. 
Less abundant subclasses of effector cells 
have been described since the discovery of 
Th1 and Th2 cells, most of them named af-
ter the interleukins they secrete. Th17 
cells, for example, are active at epithelial 
and mucosal barriers and recruit neutro-
phils [8]. These are the most clearly 
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defined subset, but others have been iden-
tified of which the exact relevance and 
function have not yet been fully deter-
mined [6]. 
Not all CD4
+
 T lymphocytes differentiate 
into Th cells. Regulatory T cells (Treg cells) 
have receptor expression patterns similar 
to Th cells but have an opposing function. 
Treg cells suppress the activation of lym-
phocytes in areas where no pathogens are 
present or after an infection has been 
cleared. Thereby, these cells keep the im-
mune response locally restricted and 
prevent overreactions [9]. According to 
current understanding, Treg cells have four 
basic mechanisms by which they can sup-
press immune responses. 1) By secreting 
inhibitory cytokines such as TGFβ, IL10 and 
IL35, Treg cells can suppress the function as 
well as the development of other lympho-
cytes; 2) They mediate cytolysis of other 
lymphocytes through perforin and 
granzymes; 3) Treg cells are thought to 
cause metabolic disruption of effector cells 
through adenosine and cyclic AMP and by 
depriving them of IL2. 4) Finally, Treg cells 
have been implicated to modulate DC 
maturation and function through which 
they indirectly suppress Th cell activation 
[10]. 
The appropriate activation of Th cells and 
other lymphocytes is crucial for a normal 
immune response. Small disturbances in T 
cell activation and regulation can therefore 
have fatal effects.  
 
 
Immunodeficiency and malfunctioning T 
cells 
T cells, together with other cells of the 
immune system, form a highly intercon-
nected network. If only one of these parts 
is defective the entire system is at risk of 
malfunctioning [11]. This is indeed the case 
in immunodeficiencies, autoimmune dis-
eases, allergies and also cancer [12-15].  
Patients suffering from severe combined 
immunodeficiency (SCID), for example, 
have no functional T lymphocytes. This 
leads to improper B cell activation fol-
lowed by an almost complete impairment 
of the adaptive immune system [16]. Con-
sequently, without hematopoietic stem 
cell transplantation these patients have 
very poor life expectancies [17].  
Acquired immunodeficiency syndrome 
(AIDS) is a well-known example of a non-
hereditary immunodeficiency. The syn-
drome is caused by the human immuno-
deficiency virus that infects, next to others, 
CD4
+
 Th cells. As with other T cell deficien-
cies the eventual depletion of the Th cell 
pool leaves the patient unable to fend off 
infections with bacteria, viruses, fungi or 
parasites [18-20].  
Autoimmunity is on the other end of the 
spectrum. In autoimmune diseases, the 
immune system fails to maintain tolerance 
towards self-antigens and launches an at-
tack against cells and tissues of its host. In 
diabetes mellitus type 1, for example, vari-
ous components of the immune system, 
among which CTLs and Th cells, target pan-
creatic β cells leading to a loss of 
endogenous insulin production [21, 22].  
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Finally, in immune responses against can-
cer cells, activated Treg cells can be 
detrimental. Tumor-resident Treg cells sup-
press other lymphocytes to mount an im-
mune response [23, 24]. Here, suppression 
of Treg function enhances tumor-directed 
immunity [25].  
In adaptive immunity, the exact coordina-
tion of T cell activation plays a crucial role 
in order to prevent pathologies as de-
scribed above. In order to understand T 
cell activation, early steps in the activation 
process need to be studied. Understanding 
of these mechanisms may ultimately lead 
to means to specifically modify a deregu-
lated immune response. 
 
Antigen recognition and TCR signal trans-
duction 
For the development of substances that 
can either stimulate, inhibit or modulate 
the function of a specific T cell subset in an 
immune-related disorder, it is important to 
understand how these lymphocytes trans-
late external signals into functional 
responses. To explore these concepts this 
thesis focuses on Th cell models unless ex-
plicitly mentioned otherwise. 
T cell signaling is initiated once a T cell en-
counters an APC presenting the cognate 
antigen through its MHC complex [26]. For 
the full activation of a naïve T cell, 
coreceptors such as CD4 and CD28 also 
need to be engaged. If these additional re-
quirements are not met, the stimulated 
naïve T cell will become permanently 
anergic [27-29]. The stimulation of 
coreceptors such as CD28 serves as a con-
firmation that a T cell is truly being acti-
vated by a professional APC in a patho-
pathological context. After initial activation 
CD28 costimulation is no longer required. 
As a consequence of TCR engagement, 
immunoreceptor tyrosine-based activation 
motifs (ITAMs) in the CD3 complex and the 
ζ chains (both part of the TCR complex) be-
come phosphorylated by the SRC family 
kinases FYN and in particular leukocyte C-
terminal SRC kinase (LCK; Figure 1). The ty-
rosine kinase ζ chain-associated protein 
kinase 70kDa (ZAP70) binds to the 
phosphotyrosines of the ζ chain ITAMS 
through its tandem SRC homology 2 (SH2) 
domains [30]. This brings ZAP70 in the im-
mediate proximity of LCK and FYN, which 
leads to ZAP70 phosphorylation and acti-
vation. ZAP70 subsequently phos-
phorylates tyrosines on the trans-
membrane scaffold protein linker for acti-
vation of T cells (LAT). LAT is the central 
gateway in the network to downstream 
signaling events. It establishes multiple in-
teractions with adaptors and effectors 
through interactions with SH2 domains 
within these proteins [31, 32].  
The key down-stream effector enzyme 
phospholipase C γ1 (PLCγ1) binds LAT 
through an SH2 domain [33-36]. Upon ac-
tivation through its recruitment to the 
membrane and phosphorylation by IL2-
inducible T cell kinase (ITK) [37, 38], PLCγ1 
hydrolyzes phosphatidylinositol-4,5-bis-
phosphate (PIP2) into the second messen-
gers inositol-1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG). IP3 then causes the 
release of calcium from the endoplasmic
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Figure 1. Signaling cascade for the activation of CD4
+
 Th cells. Upon peptide-MHC class II recognition 
by the TCR and CD4, the ζ chains and CD3 (depicted as its γ, δ & ε chains) are phosphorylated by LCK 
creating docking sites for the kinase ZAP70. Subsequent phosphorylation events by LCK and ZAP70 
initiate a signaling cascade involving several adaptors, kinases and guanine nucleotide exchange fac-
tors (GEFs) that leads to the activation of the lymphocyte, provided sufficient costimulatory signals, 
are provided. Protein-protein interactions in the system that have been inhibited by synthetic pep-
tides are marked with a star (see subheading ‘Modulation of signal transduction with synthetic 
peptides inside the cell’ for more information). Abbreviations: T cell receptor (TCR) complex, cluster 
of differentiation 4 (CD4) & 28 (CD28), programmed cell death 1 (PD1), cytotoxic T lymphocyte anti-
gen 4 (CTLA4), leukocyte C-terminal SRC kinase (LCK), ζ chain-associated protein kinase 70kDa 
(ZAP70), linker for activation of T cells (LAT), growth factor receptor-bound protein 2 (GRB2), son of 
sevenless homolog 1 (SOS1), GRB2-related adaptor downstream of SHC (GADS), SH2 domain-
containing leukocyte protein of 76 kDa (SLP76), IL2-inducible T cell kinase (ITK), phospholipase C γ1 
(PLCγ1), non-catalytic region of tyrosine kinase adaptor protein (NCK), Wiskott–Aldrich syndrome 
protein (WASP), phosphatidylinositol-4,5-bisphosphate 3 kinase (PI3K), hematopoietic progenitor ki-
nase 1 (HPK1), adhesion and degranulation promoting adaptor protein (ADAP), caspase recruitment 
domain membrane-associated guanylate kinase protein 1 (CARMA1), SRC kinase-associated 
phosphoprotein 55 (SKAP55), RAS-related C3 botulinum toxin substrate 1 (RAC1), cell division cycle 
42 (CDC42), phosphatidylinositol-4,5-bisphosphate (PIP2), phsphatidylinositol-3,4,5-trisphosphate 
(PIP3), diacylglycerol (DAG), inositol-1,4,5-triphosphate (IP3), IP3 receptor (IP3R), protein kinase A 
(PKA), B (PKB) & Cθ (PKCθ), RAS guanyl-releasing proteins (RASGRP), phosphoinositide-dependent 
kinase 1 (PDK1), mammalian target of rapamycin complex 2 (mTORC2), protein phosphatase type 2A 
(PP2A), SH2 domain-containing PTP 1 (SHP1) & 2 (SHP2), C-terminal SRC kinase (CSK), extracellular 
signal-regulated kinase (ERK), cJUN N-terminal kinase 1 (JNK1) & 2 (JNK2), nuclear factor κB (NFκB), 
factor of activated T cells (NFAT), and activator protein 1 (AP1). 
 
 
reticulum, which results in the activation 
of the transcription factor nuclear factor of 
activated T cells (NFAT) [39]. DAG initiates 
mitogen-activated protein kinase (MAPK) 
signaling by recruiting RAS guanyl-
releasing proteins (RASGRPs) and protein 
kinase C θ (PKCθ) to the membrane [40, 
41]. MAPK signaling in turn leads to the ac-
tivation of the transcription factors ELK1 
and signal transducer and activator of 
transcription 3 (STAT3) [42, 43] and the 
regulation of LCK. In addition, PKCθ phos-
phorylates caspase recruitment domain 
membrane-associated guanylate kinase 
protein 1 (CARMA1), which, after a series 
of other interactions, regulates the nuclear 
import of nuclear factor κB (NFκB) [44]. 
The GADS-SLP76 complex binds LAT 
through the SH2 domain of GRB2-related 
adaptor downstream of SHC (GADS) fol-
lowed by the phosphorylation of SH2 
domain-containing leukocyte protein of 76 
kDa (SLP76) by ZAP70 [45, 46]. Phosphory-
lated SLP76 itself is an important adaptor 
protein with three N-terminal phospho-
tyrosines, a proline-rich domain and a C-
terminal SH2 domain through which it 
binds to many interaction partners. For ex-
ample, the interaction of PLCγ1, ITK and 
SLP76 is required for the stabilization and 
function of PLCγ1 [47]. Furthermore, SLP76 
binds hematopoietic progenitor kinase 1 
(HPK1) which is another regulator of both 
NFκB and c-Jun N-terminal kinases (JNKs) 
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[48-51]. Finally, SLP76 is involved in the 
regulation of cell adhesion through its in-
teractions with adhesion and degranu-
lation promoting adaptor protein (ADAP) 
and VAV1 and regulates cytoskeletal reor-
ganization by recruiting non-catalytic 
region of tyrosine kinase adaptor protein 
(NCK) and facilitating the activation of RAS-
related C3 botulinum toxin substrate 1 
(RAC1) through VAV1 [52, 53]. 
The adaptor protein growth factor recep-
tor-bound protein 2 (GRB2) is capable of 
binding the same phosphotyrosines on LAT 
as its family member GADS [33, 36, 54]. 
GRB2 mediates the recruitment of son of 
sevenless homolog 1 (SOS1) which, like 
RASGRP, is a guanine nucleotide exchange 
factor (GEF) for RAS and contributes to 
MAPK signaling [55]. GRB2 also binds the 
negative regulator cCBL [56], which is im-
plicated in the attenuation of TCR signaling 
as a ubiquitin ligase for CD3, the ζ chains, 
ZAP70, LAT, PLCγ1, VAV, PKCθ and phos-
phatidylinositol-4,5-bisphosphate 3 kinase 
(PI3K) [57-60].  
Like protein tyrosine kinases (PTKs), also 
many protein tyrosine phosphatases (PTPs) 
function as regulators of TCR signaling 
[61]. SH2 domain-containing PTP 1 (SHP1) 
is a negative regulator and is activated by 
LCK [62, 63]. It has been shown to 
dephosphorylate key signaling proteins in-
cluding LCK [64] and ZAP70 [65]. SHP2 on 
the other hand is generally regarded as a 
positive regulator of T cell signaling 
through a positive effect on extracellular 
signal-regulated kinase (ERK) phosphoryla-
tion [61, 66], but the inhibitory receptors 
cytotoxic T lymphocyte antigen 4 (CTLA4) 
and programmed cell death 1 (PD1) are 
implicated to propagate their signal 
through SHP2 as well [67-70].  
Coreceptors play an important role in T cell 
signaling as they determine the functional 
outcome of the signaling cascade. Both 
stimulatory (e.g. CD28) and inhibitory (e.g. 
CTLA4 and PD1) receptors are known and 
these coreceptors qualitatively modify the 
TCR signal. The defining coreceptor of Th 
cells, CD4, appears to augment TCR signal-
ing merely in a quantitative manner and 
has been shown to enhance T cell respon-
siveness in two ways. By binding the same 
MHC class II molecule as the TCR, CD4 sta-
bilizes this interaction. Additionally, CD4 
recruits LCK the to plasmamembrane and 
thereby to its substrates [71, 72].  
CD28 is generally considered to provide 
the most important costimulatory signal 
for initial T cell activation [29]. The interac-
tion of CD28 with CD80 or CD86 on an APC 
induces binding of PI3K to the intracellular 
tail of the coreceptor [73]. PI3K converts 
PIP2 into phosphatidylinositol-3,4,5-
trisphosphate (PIP3) which forms a dock-
ing site for the pleckstrin homology (PH) 
domain of protein kinase B (PKB/AKT) [74]. 
PKB is a serine/threonine protein kinase 
with a wide range of substrates. Its phos-
phorylation by mammalian target of 
rapamycin complex 2 (mTORC2) and phos-
phoinositide-dependent kinase 1 (PDK1) 
initiates multiple pathways that lead to the 
activation of downstream targets such as 
NFκB, inhibitor of NFκB (IκB), B-cell lym-
phoma-extra large (BCL-XL) and mTOR [75-
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77]. mTORC2 is a complex of six different 
proteins and its regulation is poorly under-
stood [78, 79]. The phosphorylation of 
PDK1 is required for its activity but the 
proteins responsible for its phosphoryla-
tion are unknown [80].  Furthermore, 
the phosphorylation of PKB requires the 
binding of PDK1 to PIP3 [81, 82]. Interac-
tions of CD28 with GRB2 [83, 84], GADS 
[85], VAV1 [86], ITK [87] and PKCθ [88] 
have also been implicated in the activation 
of NFκB and NFAT, but an exact pathway 
has not yet been elucidated [89].  
Next to the proteins mentioned above, 
which may be considered as key players of 
the signaling cascade based on the body of 
data obtained, many more proteins are in-
volved in the signaling evoked by the TCR 
and coreceptors. Deregulation of the ex-
pression of any of these proteins can have 
a major impact on T cell function. Fur-
thermore, as described above, many 
proteins execute their function by forming 
complexes with more than one protein. It 
is therefore of great importance to analyze 
protein complex formation and the role of 
these complexes in the integration and 
propagation of a signal to fully understand 
the processes involved in T cell activation. 
 
Scaffold proteins, multivalency and com-
plex formation 
As discussed above, T cell signal transduc-
tion is dependent on the simultaneous 
interaction of a multitude of proteins via a 
modular array of signaling domains. The 
multivalent nature of scaffold and adaptor 
proteins, arising from the presence of mul-
tiple binding sites, plays a central role in 
the formation of signaling complexes. LAT 
for example has five tyrosines that can be-
come phosphorylated of which four have 
been shown to be involved in interactions 
with other proteins [32]. Distinct signaling 
proteins share common interaction do-
mains which in turn possess overlapping 
binding specificities. As a consequence, the 
question arises as to which degree signal-
ing complexes possess one defined 
composition of signaling molecules.  
The C-terminal SH2 domain of SLP76 for 
example will bind only one of its two 
known interaction partners, HPK1 or 
ADAP, at the same time [48, 90]. Similarly, 
for the three N-terminal tyrosines of SLP76 
that have been shown to undergo phos-
phorylation, four binding partners are 
known (ITK, VAV1, NCK and the p85 subu-
nit of PI3K) [46]. The fact that multiple 
interaction partners exist for certain signal-
ing domains shows the possible variety in 
the composition of signaling complexes. 
GRB2 and GADS each have a single SH2 
domain with which they can bind to three 
available phosphotyrosines on LAT. Never-
theless, the mutation of any one of these 
tyrosines reduces the binding affinity of 
GRB2 and GADS to LAT [33, 36]. In fact, 
both proteins appear to require at least 
two tyrosines for association with LAT. 
Taken together, these data indicate that 
these proteins do not bind individually but 
through multivalent interactions as part of 
larger complexes. 
Indeed most of the interactions of protein 
domains and binding motifs are not strong 
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enough to sustain stable molecular associ-
ations. Through the avidity of multiple 
interactions, however, stable complexes 
can be formed. A paradigmatic example 
for this type of molecular assemblies in T 
cell signaling is the interaction between 
SOS1, GRB2 and LAT. SOS1 has a proline-
rich region of approximately 200 amino ac-
ids containing four consensus SH3 domain-
binding motifs. Interactions of GRB2 with 
short peptides corresponding to one of 
these motifs have Kds in the range of 20-
400 μM [91, 92]. However, GRB2 has two 
SH3 domains and, as a consequence of a 
bivalent interaction, binds the full SOS1 
protein with an affinity that is at least 50 
times higher [93]. In addition, the latter 
study showed that the GRB2-SOS1 com-
plex has a higher affinity for phos-
photyrosine peptides than GRB2 alone 
even though SOS1 does not have structural 
subunits capable of binding phosphory-
lated amino acids. This phenomenon can 
be explained by the complex containing 
more than a single copy of both SOS1 and 
GRB2, thereby increasing the number of 
binding sites for phosphotyrosines. De Mol 
et al. [94] have reported that the two SH3 
domains in GRB2 can bind two SOS1 pro-
teins and Houtman et al. [95] have 
collected strong evidence that a single 
SOS1 protein forms a complex with two 
GRB2 molecules and that this complex can 
in turn serially link multiple LAT proteins 
(LAT-GRB2-SOS1-GRB2-LAT).  
LAT forms another important signaling 
complex with the signaling proteins GADS, 
SLP76 and PLCγ1. GADS and SLP76 are 
constitutively in complex with each other 
[96-98] and are recruited to LAT through 
an interaction between GADS and either 
one of two phosphotyrosines on LAT 
(pY171 and pY191) [33, 54]. PLCγ1 binds 
LAT with its N-terminal SH2 domain at 
pY132 and also interacts with SLP76 
through its SH3 domain. The interaction of 
PLCγ1 with SLP76 is not absolutely neces-
sary for the recruitment of PLCγ1 to LAT 
but the PLCγ1-SLP76 interaction stabilizes 
the complex and is required for the phos-
phorylation and activation of the enzyme 
[99]. Furthermore, mutations of GADS-
binding tyrosines to phenylalanines reduce 
LAT-PLCγ1 complex formation, indicating 
the importance of multivalent interactions 
in the LAT-GADS-SLP76-PLCγ1 signaling 
complex. 
Altogether these studies indicate that pro-
tein interactions in T cell signaling cannot 
be described as simple bimolecular inter-
actions of two isolated domains but 
require the context of the whole protein 
and even proteins not directly involved in 
the interaction. 
 
Protein microclusters in T cell signaling 
Multivalency of interactions is also one of 
the factors contributing to the formation 
of microclusters on a supramolecular level. 
In T cell signaling, protein microclusters 
are understood as aggregations of signal-
ing proteins formed in or at the plasma 
membrane at the T cell-APC interface (Fig-
ure 2). Besides multivalent protein-protein 
interactions [90, 95, 100-102], the underly-
ing processes causative of the formation of 
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microclusters are thought to be the inter-
action of proteins with lipid-based 
membrane domains [102-104] and reor-
ganization of the cytoskeleton [105-107]. 
However, a consensus as to what degree 
each of these phenomena contribute to 
clustering has not been reached to date.  
Microclusters are visible immediately after 
a T cell makes contact with an APC and will 
coalesce to form a larger organized ar-
rangement known as the supramolecular 
activation complex (SMAC) or immune 
synapse (IS) [108, 109]. Before TCR 
microclusters were recognized to play a 
role in the initiation of signaling, the IS was 
thought to be the key structure in T cell ac-
tivation. The IS was described to be a 
structure in which receptors with extracel-
lular domains that extend relatively little 
form the cell surface, such as the TCR and 
CD28, were localized in a central bullseye, 
or central SMAC (cSMAC), surrounded by a 
ring containing the adhesion proteins lym-
phocyte function-associated antigen 1 
(LFA1) and talin, called the peripheral 
SMAC (pSMAC). The area outside of the 
pSMAC was later referred to as the distal 
SMAC (dSMAC) and contains large glyco-
proteins like CD45 [110].  
It was known, however, that calcium sig-
naling is initiated long before a mature IS is 
established. Grakoui et al. [109] and 
Krummel et al. [111] showed that the cal-
cium flux coincided with the formation of 
much smaller TCR clusters upon the initial 
T cell-APC contact and that these 
microclusters subsequently migrated to-
wards the center of the IS to form the 
cSMAC. Bunnell et al. [112] then demon-
strated that many non-receptor proteins, 
such as ZAP70, LAT, GRB2, GADS and 
SLP76, also aggregate into microclusters 
 
Figure 2. LAT microclusters in murine CD4
+
 T cells. Cultured CD4
+
 CD25
-
 murine T cells (1∙10
5
 cells) 
[195] were serum starved and incubated on spotted stimulatory surfaces for 3 minutes. Cells were 
fixed with 3% paraformaldehyde and immunolabeled with rabbit α-phosphorylated-Tyr226-LAT (sec-
ondary: Alexa Fluor 488). Stimulatory surfaces were prepared through microcontact printing using 
polydimethylsiloxane stamps coated with 50 μg/ml α-murine CD3, 50 μg/ml α-murine CD28, and 7 
μg/ml goat-α-rat Alexa Fluor 546. An overlay of 15 μg/ml α-LFA was used to functionalize the non-
stamped areas of the microscopy slides and improve cellular adhesion. Scanning confocal microscopy 
images from left to right: transmission image, phosphoLAT, composite image of the stamped pattern 
(blue) and phosphoLAT (grayscale). 
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with high phosphotyrosine levels. Moreo-
ver, they showed that these microclusters 
had dynamic interactions with each other 
and varied in degrees of persistence and 
migration. 
It was initially thought that the formation 
of a stable IS was a requirement for the full 
activation of T cells [109]. However, de-
pending on the APC encountered, the 
interface between the T cell and the APC 
can have different forms. It has been re-
ported for example, that in the case of 
DCs, not a single cSMAC is formed but that 
the synapse structure is concentric con-
taining multiple patches of CD3 and LFA1 
with varying degrees of colocalization 
[113]. There is certainly evidence that un-
der some conditions of weak TCR agonists, 
the cSMAC enhances signal transduction 
[114]. However, as phosphorylation levels 
are often highest in newly formed 
microclusters at the periphery of the IS, it 
is now assumed that activating signals are 
mostly sustained at the periphery and that 
the cSMAC serves predominantly as a 
regulatory center for the recycling of re-
ceptors. This attributes a central role to 
protein microclusters in T cell signaling 
[105, 106, 115, 116]. 
 
Quantitative analysis of microcluster for-
mation 
To understand signaling in microclusters at 
a molecular level, quantitative analyses are 
required. Estimates for the number of 
TCRs per microcluster depend on the tech-
niques used and range from monomers 
and trimers [102, 117] to 150 receptors in 
large clusters of up to 500 nm in diameter 
[115]. However, that clusters exist in vary-
ing sizes and grow upon stimulation is 
generally agreed upon [55].  
The necessity of TCR clustering for T cell 
activation was recently addressed by Manz 
et al. [118]. They limited the number of 
available peptide-MHC (pMHC) complexes 
per TCR cluster by presenting T cells with a 
segmented lipid bilayer using micrometer 
sized grids. By varying the grid size but not 
the total antigen content of the bilayers 
the authors deduced that, in their model, T 
cells must encounter clusters of at least 
four pMHC complexes to trigger calcium 
signaling. This indicates that multiple in-
teractions need to occur in close proximity 
to one another for the induction of signal 
transduction. The activation of T cells 
through the artificial dimerization of TCRs 
is common practice in T cell research. In 
combination with the work by Manz et al. 
[118] a strong case is now being made that 
TCR clustering is essential for the activa-
tion of T cells. Interestingly, the authors 
demonstrated that the threshold was low-
ered to two pMHC complexes per TCR 
cluster if cells were costimulated by en-
gagement of CD28, illustrating that in vivo 
this basic principle is subject to regulation 
by other surface receptors. 
Since microclusters represent the initial 
sites of T cell activation it is important to 
have methods available to quantitatively 
study microclusters in an unbiased fashion. 
In this thesis, a method was developed, 
combining microcontact printing [119] 
with the coincubation of two different cell 
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lines in a single sample to study the effects 
of various factors on important micro-
cluster parameters such as distribution, 
composition and density.  
 
Analyzing T cell signaling with micro-
structured surfaces and micromanipula-
tion techniques 
Over the last two decades, advanced tech-
niques have been utilized to greatly 
increase our understanding of microcluster 
formation and behavior. After their initial 
discovery by Grakoui et al. [109], it was 
shown that besides the TCR many cyto-
plasmic signaling proteins form dynamic 
microclusters [112]. To investigate cluster-
ing, Bunnell et al. [112] imaged cells on 
coverslips coated with stimulatory anti-
bodies. In this manner the group 
demonstrated that tyrosine phosphoryla-
tion did not take place until after the 
formation of TCR clusters and occurred at 
sites of colocalization of the TCR and 
ZAP70. In addition, using fluorescence re-
covery after photobleaching (FRAP) they 
showed for ZAP70, that proteins can freely 
move in and out of recently formed 
microclusters without disrupting the clus-
ters themselves.   
Coated coverslips are excellent for the 
study of initial microcluster formation and 
as a screening method to examine which 
proteins assemble into microclusters. Be-
cause cells will be positioned on a flat 
surface parallel to the field of view of the 
microscope, in contrast to a physiological 
contact with an APC, microclusters can be 
imaged at maximal lateral resolution. It is, 
however, less suitable for studying cluster 
persistence and kinetics over time. This is 
due to the immobilization of the stimulus. 
Whereas pMHC complexes embedded in 
the membrane of an APC can move lateral-
ly, stimulatory antibodies fixed on a 
surface are static and therefore hinder the 
migration of their interaction partners. 
One strategy employed to overcome this 
problem is the stimulation of cells on sup-
ported planar bilayers [120, 121].  
In general, supported planar bilayers are 
generated by the fusion of unilamelar lipo-
somes on a substrate such as glass or 
quartz. Incorporating specific membrane 
proteins or other compounds in these bi-
layers can be achieved by preloading the 
liposomes with the molecules of interest. 
However, unlike transmembrane proteins 
in native membranes, in glass-supported 
bilayers transmembrane proteins are lat-
erally immobile. Their lateral mobility can 
be restored, however, by linking the 
transmembrane proteins to anchors that 
only interact with the upper leaflet of the 
bilayer such as glycosylphosphatidyl-
inositol (GPI). The first study that clearly 
visualized microclusters utilized supported 
planar bilayers loaded with GPI anchored, 
fluorescently labeled pMHC complexes to 
stimulate T lymphocytes [109]. Since then 
supported bilayers have been extensively 
used to investigate microcluster co-
localization and migration and IS formation 
[105, 106, 115, 122-125].  
The interaction of T cells with supported 
planar bilayers is considered to be a good 
approximation of the interface between T 
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cells and APC when considering micro-
cluster behavior. The great advantage of 
planar bilayers compared to native APCs is 
that imaging of the interface can be done 
at a very high resolution with living T cells 
due to its orientation, especially when em-
ploying total internal reflection fluor-
escence microscopy (TIRF). The method is, 
however, a simplification of the native in-
teraction of a T cell with an APC.  
Supported bilayers generally incorporate 
only a fraction of the proteins expressed 
by natural APCs and furthermore lack an 
underlying cytoskeleton, a signaling ma-
chinery and the potential for cytokine 
secretion that will contribute to the regu-
lation of the interaction. One clear 
example of a phenomenon impossible to 
occur on supported bilayers is the protru-
sions made by pseudopodia deep into an 
APC [126]. 
The first studies to visualize the IS used 
fixed, interacting T cells and APCs [108]. 
Since then, microcluster formation and IS 
development have repeatedly been stud-
ied using fixed, but also living, native APCs 
[110, 111, 127]. These studies, however, 
have not reached the resolution achieved 
by the techniques discussed above. This is 
mainly due to the fact that the images of 
the interaction interface have to be recon-
structed from image stacks with fields of 
view perpendicular to the IS but also be-
cause TIRF cannot be utilized to suppress 
cytosolic fluorescence. The necessity for 
image stacks also reduces imaging speed, 
making the method less suitable for study-
ing cluster dynamics. These issues have 
been at least partially resolved due to the 
positioning of the contact site in the field 
of view using optical tweezers [128, 129]. 
However, since the orientation of the con-
tact cannot be changed until after the 
contact has been established this method 
is less suitable for the first moments of in-
teraction. 
The methods described all have provided 
valuable insights into the formation and 
function of microclusters and the IS under 
various complementary angles.  
Micropatterned surfaces as used in this 
thesis lack the fluidity of glass-supported 
planar bilayers or living APCs. This, of 
course, makes them a less representative 
model of native APCs, but also makes them 
a unique tool for the study of different 
patterns of stimuli that can currently not 
be created in fluid membranes. Micro-
patterned surfaces have been employed to 
show that changing specific microscale ar-
rangements of stimuli and costimuli can 
have strong effects on cellular responses. T 
cells were perturbed in their polarization 
towards the stimulus and produced lower 
levels of IFNγ when the pattern of stimulus 
presentation was changed from focal to 
annular [130]. Moreover, T cells produced 
higher levels of IL2 when a CD3 stimulus 
was surrounded with, instead of 
colocalized with, a CD28 stimulus [131]. 
Even though the specific patterns present-
ed to cells in these studies are, in a 
physiological T cell response, encountered 
only briefly, the work contributes to the 
understanding of the role in T cell signaling 
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and function of particular protein ar-
rangements in the T cell APC contact.  
 
Super-resolution analysis of microclusters  
Multiple groups have started to employ 
super-resolution microscopy to study sig-
naling complexes at or near the single 
molecule level in T cell signal transduction. 
Stimulated emission depletion (STED) mi-
croscopy, photoactivated localization 
microscopy (PALM) and stochastic optical 
reconstruction microscopy (STORM) re-
vealed phosphorylated clusters so small 
they could not be resolved with confocal 
or TIRF microscopy. These studies revealed 
that some features considered as 
microclusters using confocal microscopy 
and TIRF were in fact composed of several 
nanoscale clusters [55, 132, 133]. The 
studies with these new techniques have 
yet to lead to a uniform model of micro- 
and nanocluster functioning. Initial reports 
by several groups have come to varying 
conclusions about the localization of clus-
ters prior to stimulation, their size 
distributions and which clusters are most 
important for early signal transduction 
processes in T cells [55, 102, 134, 135]. Be-
sides the variation in the experimental 
setup, the differences in analytical and sta-
tistical methods employed in these studies 
are likely to be a causal factor for the vary-
ing conclusions drawn by these groups. For 
example, larger clusters tend to be empha-
sized when using Ripley’s K statistics, while 
pair-correlation functions are more sensi-
tive towards small scale clustering [55, 
102]. Furthermore, the temporal resolu-
tion of super-resolution microscopy tech-
niques such as PALM and STORM is 
limited, making the imaging of the highly 
dynamic signaling processes in living T cells 
challenging. STED microscopy techniques, 
however, have recently reached sufficient 
imaging speeds to start investigating living 
cells at the molecular level [136]. As men-
tioned above, it has been troublesome to 
study the development of the IS and be-
havior of microclusters at a high resolution 
from the moment of first contact between 
T cells and APCs because of the orientation 
of the plane of interaction [128, 129]. With 
further developments in STED microscopy 
and the depletion of fluorescence in the 
axial direction it is to be expected that also 
these restrictions will soon be overcome 
[137]. As more super-resolution studies 
are reported, a more uniform picture will 
emerge of the roles played by the different 
micro- and nanoclusters in T cell signaling 
events. 
 
Modulation of signal transduction with 
synthetic peptides inside the cell 
To modulate intracellular signaling, bioac-
tive molecules need to be imported into 
the cell. Generally, molecules as large and 
hydrophilic as most peptides have poor 
plasma membrane permeability. Com-
pounds can be delivered into the cell by 
transient disruption of the plasma mem-
brane, such as electroporation [138], 
magnetofection [139] or microinjection 
[140]. These techniques are, however, 
mostly limited to in vitro applications. Al-
ternatively, cargo delivery can be achieved 
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through use of cariers such as nanoparti-
cles [141], liposomes [142, 143] and viral 
particles [144, 145]. For peptides import is 
often achieved by conjugation to cell-
penetrating peptides (CPPs) [146, 147]. 
CPPs are short peptides that mediate cellu-
lar entry in a receptor-independent 
manner. CPPs have been shown to use 
multiple mechanisms of entry such as di-
rect translocation across the membrane 
[148-150], endocytosis [151, 152], inverted 
micelle formation [153-155] and pore for-
mation [156]. CPPs can be linked to their 
cargo covalently or through non-covalent 
complex formation. Advantages of CPP-
mediated import over other methods are 
their often low toxicity, their clinical ap-
plicability and their high internalization 
efficiency [147]. Furthermore, for import 
of peptides, the CPP and bioactive peptide 
can be synthesized as a single molecule.  
Individual branches of a signal transduc-
tion pathway are attractive targets for 
therapeutic compounds as they can poten-
tially modulate cell behavior more 
specifically than inhibiting or stimulating 
cell activity in general by targeting cell sur-
face receptors [157, 158]. Using synthetic 
peptides to affect signaling processes in-
side cells is a well-established concept 
[159]. In many cases the design of synthet-
ic peptides acting as inhibitors of protein-
protein interactions is straightforward, as 
signaling domains bind to linear sequence 
motifs within another protein [160]. Along 
this line, peptides have been designed to 
occupy binding pockets of signaling pro-
teins and thereby inhibit signal trans-
duction (see below). Alternatively, pep-
tides can competitively inhibit signaling 
enzymes by blocking the active site. 
Various peptides have, for example, been 
shown to increase or decrease the activity 
of PKCs and protein kinases A (PKAs). The 
peptides either bind these kinases directly 
or bind their regulating proteins, receptors 
for activated C kinase (RACKs) and A kinase 
anchoring proteins (AKAPs), respectively 
[161, 162]. By disrupting the interaction 
between the kinase and its regulating pro-
tein as competitive inhibitors the peptides 
influence kinase activity by impeding the 
recruitment of the enzymes to their sub-
strates. The peptide RI anchoring disruptor 
(RIAD) was designed using bioinformatic 
predictions based on the amphipathic heli-
cal motifs of several AKAPs specific for 
type I PKA. RIAD was then optimized 
through a series of peptide array screens 
resulting in a peptide that was highly spe-
cific for type I PKA over type II PKA [163]. 
Type I PKA negatively regulates T cell acti-
vation through the activation of the C-
terminal SRC kinase (CSK) that in turn 
phosphorylates and deactivates LCK [164]. 
When RIAD was rendered cell permeable 
by C-terminal ligation of a CPP, in the form 
of 11 arginines, it displaced type I PKA 
from the T cell plasma membrane and in-
creased LCK phosphorylation (Figure 1) 
[163]. The recruitment of type I PKA to the 
plasma membrane is established through 
an interaction with the AKAP ezrin. A cyto-
solic ezrin mutant in which the PKA binding 
motif was replaced with RIAD competed 
with endogenous ezrin and caused re-
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duced plasma membrane recruitment of 
type I PKA and an enhanced T cell respon-
siveness. Mice expressing the ezrin mutant 
showed reduced development of murine 
AIDS and lower viral loads in lymph nodes 
after infection with LP-BM5, a complex 
mixture of murine leukemia viruses [165].  
Similarly, signaling has been inhibited by 
the prevention of nuclear translocation of 
transcription factors. The nuclear localiza-
tion sequence (NLS) of NFκB has been 
introduced into Jurkat T leukemia cells by 
its ligation to a CPP. The peptide construct 
prevented the binding of NFκB, activator 
protein 1 (AP1), NFAT and STAT1 to 
importin αβ and thereby impeded the nu-
clear translocation of these transcription 
factors (Figure 1) [166].  
In contrast to rational design, peptides 
with intracellular activity can be isolated 
from random libraries. In some cases these 
peptides have shown strong physiological 
effects without exact knowledge concern-
ing the exact binding site of the peptide on 
its target protein or the natural interac-
tions of this protein that are being 
affected. Forkhead box protein P3 (FOXP3) 
is a transcription factor found in Treg cells 
and as of yet the most specific biomarker 
for these lymphocytes [167]. Using a phage 
displayed random peptide library, Casares 
et al. [168] identified a CPP that binds 
FOXP3 and reduces the suppressive func-
tion of Treg cells in vitro and in vivo. 
Treatment of cells with the 15 amino acid 
peptide P60 inhibited the nuclear translo-
cation of FOXP3 and its inhibition of NFAT 
and NFκB activity was overturned. In addi-
tion, P60 was shown to reduce the inhibi-
tion by Treg cells on the proliferation of 
effector T cells. In vivo the peptide caused 
newborn mice to develop a lympho-
proliferative autoimmune syndrome simi-
lar to scurfy mutant mice. Scurfy mice 
express a mutant form of FOXP3 lacking 
the forkhead domain that enables nuclear 
translocation and DNA binding of FOXP3. 
Finally, the study showed that treatment 
with P60 strongly increased the effect of 
both viral and tumor vaccination in adult 
mice. 
In the case of proteins with quaternary 
structure, signaling can be blocked by pre-
venting a fully functional enzyme to 
assemble. Guergnon et al. [169] targeted 
serine/threonine protein phosphatases 
type 1 (PP1) and 2A (PP2A) holoenzymes. 
Conjugates of a cell-penetrating CK2α mo-
tif and PP1 or PP2A subunit-binding 
peptides were designed and introduced in 
several cell lines to prevent the binding of 
the catalytic core of the phosphatases to 
their regulatory subunits.  
The cytoplasmic tail of CD28 contains a 
binding site for a PP2A regulatory subunit 
[170] and in CD28 costimulated T cells 
PP2A has been shown activate cofilin, an 
actin-depolymerizing protein [171]. In the 
study by Guergnon et al. [169] the PP2A 
binding sequence of CD28 was conjugated 
to the cell-penetrating CK2α sequence and 
induced apoptosis in Jurkat T cells treated 
with this construct (Figure 1). Okadaic acid, 
an inhibitor of PP1, PP2A and PP2B had 
previously been shown to increase cofilin 
phosphorylation and induce apoptosis in T 
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lymphoma cells [172] indicating that this is 
the molecular mechanism that was af-
fected by the peptide. Intriguingly, how-
however, is that the inhibitory coreceptor 
CTLA4, that is a direct competitor of CD28 
for binding CD80 and CD86, has also been 
reported to interact with PP2A in T cells 
[170]. 
Other signaling pathways that have been 
targeted by peptide interference are WNT 
pathways, a collection of signaling cas-
cades that are crucial during embryonic 
development [173]. Aberrations in WNT 
signaling can induce tumorigenesis [174]. 
Dishevelled (DVL) scaffold proteins are 
part of WNT signaling and the overexpres-
sion of DVL has been observed in cases of 
non-small cell lung cancer and mesotheli-
oma [175, 176]. Secreted WNT 
glycoproteins bind Frizzled transmem-
brane receptors that in turn lead to the ac-
tivation of DVL proteins and the nuclear 
translocation of β-catenin to the nucleus 
where it regulates transcription. Zhang et 
al. [177] used a peptide that binds DVL 
PSD95/DLG1/ZO1 (PDZ) domains to inhibit 
the canonical β-catenin pathway upon 
WNT stimulation of human embryonic kid-
ney 293 (HEK293S) cells. To make the 
peptide cell permeable it was fused to an 
antennapedia homeobox sequence [178]. 
A different approach had previously been 
used to stimulate the canonical β-catenin 
pathway [179]. In this case a signaling en-
zyme was targeted directly in its catalyticly 
active site. Normally, in the absence of a 
WNT signal, the glycogen synthase kinase 
3 β (GSK3β) phosphorylates β-catenin and 
thereby labels the protein for degradation. 
Piao et al. [179] used a synthetic, phos-
phorylated peptide derived from the 
cytoplasmic tail of low-density lipoprotein 
receptor-related protein (LRP6) to inhibit 
GSK3β in vitro. LRP6 is another substrate 
of GSK3β and involved in the inactivation 
of GSK3β during WNT signaling which halts 
degradation of β-catenin. When the LRP6 
peptide was injected into Xenopus laevis 
embryos together with WNT8, reinforced 
β-catenin signaling was indicated by the 
formation of a second body axis in these 
embryos. In T cells WNT signaling has 
mainly been implicated in T cell develop-
ment [180] and has recently been shown 
to inhibit FOXP3 mediated suppression by 
Treg cells [181]. 
The protein tyrosine phosphatase 1B 
(PTP1B) is predominantly known as a 
phosphatase for the activated insulin re-
ceptor [182-184], but has been implicated 
in tumorigenesis as well. Like GSK3β, 
PTP1B has also been targeted in its sub-
strate binding site. A cell-penetrating 
peptidic inhibitor for PTP1B was developed 
and shown to increase phosphorylation 
levels of insulin receptors in breast cancer 
cells [185]. For this purpose, the peptide 
sequence around pY530 of the c-SRC ki-
nase, a natural substrate of PTP1B was 
optimized and a hydrolysis-resistant 
phosphotyrosine mimic, difluoro-
phosphono-methylphenylalanine was in-
corporated. Six C-terminal arginines were 
added to facilitate cell penetration. 
In spite of these demonstrations of activi-
ty, the susceptibility of peptides to 
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proteolysis reduces their potential as ther-
apeutic agents significantly. Methods to 
enhance peptide stability are therefore 
sought after. Numerous methods for stabi-
lization have been conceived, ranging from 
terminal capping and peptide cyclization to 
backbone modifications such as using ret-
ro-inverso D-peptides, β-peptides, peptoids 
or isostere replacement of the amide bond 
[186-188].  
All the examples described above follow 
one of two general strategies: inhibition of 
enzymatic function or disruption of molec-
ular interactions. An interesting avenue 
that has remained largely unexplored is in-
creasing connectivity between signaling 
molecules. As described earlier, 
multivalency plays a major role in the for-
mation of signaling complexes. Multivalent 
presentation of compounds has the poten-
tial to greatly enhance their effectiveness 
without needing to increase their overall 
concentration [189, 190].  
Cell surface receptors, for example, have 
increased avidity and show stronger re-
sponses when treated with multivalent 
ligands [191, 192]. Moreover, multivalent 
linking of CPPs can greatly enhance their 
internalization [193]. Also inside the cell, 
multivalency can enhance peptide activity 
[194]. The enhancement of protein cluster 
formation, however, remains to be shown. 
Multiple protein ligands linked to an artifi-
cial backbone potentially can establish 
new intracellular protein-protein contacts 
and thereby strengthen or alter existing 
signaling complexes resulting in the modu-
lation of cellular signaling pathways. The 
use of such synthetic scaffold proteins 
could form a valuable tool to study the ef-
fects of varying connectivity in T cell 
signaling networks and thereby assist in 
the development of new therapeutic 
agents. 
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Outline of this work 
The initiation of T cell signaling coincides 
with the formation of microclusters and 
although much has been learned about the 
composition and dynamics of these clus-
ters over the last few years, their exact 
role in signal transduction has not yet been 
unraveled. Strikingly, mechanisms that 
control the number of microclusters and 
the effects of varying cluster densities 
have been addressed only sparingly. This 
work aimed to further extend our 
knowledge on microcluster formation in a 
quantitative manner.  
To this end, in chapter two, a method for 
the quantitative analysis of microclusters 
in T cell signaling is presented.  
Microcontact printing was used to gener-
ate parallel stripes of different stimulatory 
and costimulatory antibodies. By pre-
labeling one of two cell lines prior to their 
coincubation on such a surface it was pos-
sible to eliminate variation between 
samples and identify very small differences 
between cell lines and stimuli in a single 
sample with high fidelity. The method was 
used to show that the knock down of the 
PTP SHP2 only increases overall and PLCγ1-
specific phosphotyrosine levels, whereas 
CD28 costimulation also increases 
microcluster densities. These findings ex-
tend our knowledge on the mode of action 
of this key costimulatory molecule and this 
important regulator of signaling. 
The intracellular stability of peptides cor-
responding to interaction motifs of T cell 
signaling proteins is investigated in chap-
ter three. For this study fluorescein-
labeled peptides were introduced into cells 
by electroporation and confocal microsco-
py was employed to measure intracellular 
residence times of peptides. Fluorescence 
of negatively charged phosphotyrosine 
peptides generally had longer retention 
times than that of neutral proline-rich pep-
tides. Proteolytically stable retro-inverso D-
peptides were used to verify that the loss 
of fluorescence over time was due to pro-
teolysis of the peptides. FCS was used to 
show that in cell lysates and intact cells a 
proline-rich SLP76 peptide was indeed de-
graded faster than a phosphotyrosine 
containing LAT peptide. Overall these stud-
ies revealed that without further modi-
fications, proteolytic degradation strongly 
limits the application of peptides inside 
cells, also as experimental tools. 
In chapter four Jurkat T cells, erythrocytes 
and HeLa cells are treated with a conjugate 
of a dextran backbone with nonaarginine 
(R9) peptides to test the effect of the mul-
tivalent presentation of CPPs on a linear 
scaffold. In contrast to a multivalent 
presentation of this CPP on globular scaf-
folds as presented previously, this 
conjugate compromised membrane integ-
rity in all cell types and especially in T cells 
multivalency caused an enormous increase 
in toxicity. As erythrocytes and Jurkat T 
cells express relatively little glycosamino-
gclycans on their surface these effects may 
relate to the interaction of the construct 
with the lipid head groups in the plasma 
membrane. Interestingly, however, the 
large construct was internalized at least 
partially through nucleation zones, a mode 
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of direct translocation across the mem-
brane leading to rapid delivery into the 
cytoplasm. Previously this uptake route 
had only been described for low molecular 
weight molecules. Finally, the chapter 
shows that in cell lysates, both R9 and the 
conjugate can disrupt protein-protein in-
teractions involved in signal transduction 
pathways demonstrating the potential for 
unspecific side effect on cellular signaling. 
The concepts of the previous chapters are 
integrated in chapter five where the mul-
tivalent presentation of a peptide 
corresponding to a proline-rich domain of 
SLP76 is shown to function as a synthetic 
scaffold in T cell signaling pathways. In cell 
lysates, the hydroxypropyl methacrylamide 
(HPMA) coupled peptide increased the as-
sociation of GADS to several T cell signaling 
peptides on a microarray compared to a 
decrease caused by its monovalent equiva-
lent. This result can best be explained by 
the formation of larger complexes through 
the multivalent conjugate. Using 
micropatterned surfaces in an arrange-
ment mimicking the immunological 
synapse in combination with the quantita-
tive image analysis and statistical methods 
developed in chapter two, it is shown that 
cells generate higher densities of GADS 
clusters upon treatment with the com-
pound.   
Chapter six summarizes the results de-
scribed in this thesis and presents a 
general discussion of the findings and di-
rections for further research.  
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Abstract 
T cell signaling is triggered through stimu-
lation of the T cell receptor and co-
stimulatory receptors. Receptor activation 
leads to the formation of membrane-
proximal protein microclusters. These clus-
ters undergo tyrosine phosphorylation and 
organize multiprotein complexes thereby 
acting as molecular signaling platforms. 
Little is known about how the quantity and 
phosphorylation levels of microclusters are 
affected by costimulatory signals and the 
activity of specific signaling proteins. We 
combined micrometer-sized, microcontact 
printed, striped patterns of different 
stimuli and simultaneous analysis of differ-
ent cell strains with image processing 
protocols to address this problem. First, 
we validated the stimulation protocol by 
showing that high expression levels CD28 
result in increased cell spreading. Subse-
quently, we addressed the role of co-
stimulation and a specific phospho-
tyrosine phosphatase in cluster formation 
by including a SHP2 knock-down strain in 
our system. Distinguishing cell strains using 
carboxyfluorescein succinimidyl ester ena-
bled a comparison within single samples. 
SHP2 exerted its effect by lowering phos-
phorylation levels of individual clusters 
while CD28 costimulation mainly increased 
the number of signaling clusters and cell 
spreading. These effects were observed for 
general tyrosine phosphorylation of clus-
ters and for phosphorylated PLCγ1. Our 
analysis enables a clear distinction be-
tween factors determining the number of 
microclusters and those that act on these 
signaling platforms. 
 
 
Introduction 
The formation of membrane-proximal pro-
tein clusters upon engagement of the T cell 
receptor (TCR) is a hallmark of early T cell 
signaling [1-3]. Cluster formation is the re-
sult of protein interactions, driven by 
phosphorylation of immunoreceptor tyro-
sine-based activation motifs (ITAMs) in the 
TCR complex itself and of tyrosines in scaf-
folding proteins such as the linker for 
activation of T cells (LAT) [4-7] and reor-
ganization of the cytoskeleton [8] but the 
exact mechanisms remain to be further 
elucidated [9]. These protein clusters rep-
resent the molecular platforms of early T 
cell signaling and ultimately coalesce to 
form an immunological synapse (IS) [2, 10-
17].  
Besides the TCR, costimulatory receptors 
are of vital importance for T lymphocyte 
functioning. Cluster of differentiation 28 
(CD28) provides the most prominent 
costimulatory signal and regulates cyto-
kine production, inhibits apoptosis and is 
required for full T cell activation [18-20]. 
CD28 signaling occurs primarily via Phos-
phatidylinositol 3-kinase (PI3K)-dependent 
pathways [21-27]. One of the downstream 
effectors is phospholipase C-γ1 (PLCγ1) for 
which CD28 costimulation leads to in-
creased activation and tyrosine phos-
phorylation [28, 29].  
Numerous studies have addressed the role 
of CD28 in T cell signaling and activation. 
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Manz et al. [30] have even shown that 
CD28 costimulation decreases the number 
of engaged peptide-major histocompatibil-
ity complexes (pMHCs) per TCR cluster re-
required for T cell activation. Additionally, 
CD28 has recently been observed to form 
microclusters that colocalize with TCR clus-
ters upon stimulation with CD80. CD28 
subsequently recruits protein kinase C θ 
(PKCθ) clusters and both CD28 and PKCθ 
clusters migrate to subregions of the cen-
tral supramolecular activation cluster 
(cSMAC) that are distinct from TCR subre-
gions [31]. Importantly, however, the 
quantitative impact of CD28 costimulation 
on cluster phosphorylation has not been 
addressed so far.  
 
Procedures for T cell stimulation incorpo-
rating receptor ligands on planar surfaces 
have proven to be highly powerful in ana-
lyzing the dynamics and molecular 
composition of protein microclusters in a 
highly defined manner [11]. The incorpora-
tion of TCR ligands into lipid bilayers has 
been key to developing the molecular con-
cept of IS formation [2], and has among 
others been applied to analyzing the deliv-
ery of cytolytic granules and the formation 
of SRC family kinase microclusters upon 
TCR engagement on cytotoxic T lympho-
cytes [32] and signaling induced by viral 
envelope proteins [33]. The latter study al-
so highlights the advantages that planar-
supported substrates offer for quantitative 
analyses of signaling. 
Conversely, microstructured surfaces have 
been employed to elucidate the molecular 
mechanisms that underlie the formation of 
the specific geometric arrangement of the 
IS [34] as well as the role of specific pat-
terns in the arrangement of stimuli and 
costimuli in generating a T cell response 
[35]. The latter study employed micro-
contact printing for the generation of vari-
ous patterns of TCR and CD28 stimuli. 
 
Microcontact printing is a robust method 
for the generation of microstructures of 
functional proteins in various geometries 
in micrometer dimensions [36, 37]. 
Through printing of stripe patterns, func-
tional analysis of different stimuli has been 
conducted side-by-side for single cells [38]. 
This side-by-side arrangement of stimuli is 
of particular interest for quantitatively ad-
dressing the impact of costimulation on 
protein cluster formation and tyrosine 
phosphorylation. Here we describe an ac-
cessible procedure that combines 
microcontact printing, confocal microsco-
py, high-content image analysis and 
statistics to study, in parallel, the effect of 
different stimuli on tyrosine phosphoryla-
tion, cluster formation and membrane 
spreading during early T cell signaling. 
Within this setup we additionally include 
the simultaneous analysis of two different 
cell types and cells with different levels of 
receptor expression. We demonstrate that 
the main effect of CD28 costimulation is an 
increase in the number of microclusters 
formed as well as the formation of a larger 
contact area with the stimulating surface. 
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Moreover, we address the impact of defi-
ciency of SH2-containing protein tyrosine 
phosphatase 2 (SHP2) on cluster for-
mation. SHP2 is a cytoplasmic protein-
tyrosine phosphatase (PTP) that is ubiqui-
tously expressed [39]. Intriguingly, unlike 
its close relative SHP1, which is widely ac-
cepted as a negative regulator of T cell 
signaling [40], SHP2 has been implicated in 
both, the inhibition of T cell signaling [41-
44], as well as sustained activation of the 
mitogen-activated protein kinase (MAPK) 
pathway by the TCR [40, 45] and many 
growth factor and cytokine receptors [46]. 
The T cell signaling proteins PLCγ and PI3K 
might be directly regulated by SHP2 since 
it has been shown that these proteins and 
SHP2 bind to growth factor receptor-
bound protein 2 (GRB2)-associated binding 
protein (GAB)-family adapter proteins 
which are activated upon activation of T 
and B cell receptors as well as insulin, 
growth factor and cytokine stimulation 
[47-49]. When addressing the impact of 
SHP2 on the phosphorylation of signaling 
microclusters, we show that the deficiency 
of this PTP leads to a significant increase in 
overall phosphotyrosine levels and, more 
specifically, phosphorylation of PLCγ. 
 
 
Experimental Procedures 
 
Reagents 
Reagents were purchased from Carl Roth 
(Karlsruhe, Germany) unless otherwise 
specified. αCD3 (mouse monoclonal IgG2a, 
clone OKT3) and αCD28 (mouse monoclo-
nal IgG2a, clone 9.3) antibodies were kind-
ly provided by Prof. Dr. Gundram Jung 
(Department of Immunology, University of 
Tübingen, Germany). The unspecific mouse 
IgG2a isotype antibody (clone UPC 10) was 
purchased from Sigma-Aldrich (Deisen-
hofen, Germany), the αphosphotyrosine 
antibody (mouse monoclonal IgG1, clone 
P-Tyr-100) from Cell Signaling Technology 
(Leiden, The Netherlands) and αpY783-
PLCγ1 (rabbit polyclonal, sc-12943-R) from 
Santa Cruz Biotechnology (Heidelberg, 
Germany). The Celltrace CFSE cell prolifer-
ation kit containing the carboxyfluorescein 
diacetate succinimidyl ester (CFDA-SE), 
Zenon mouse IgG labeling kits and second-
ary Alexa Fluor-conjugated antibodies 
were obtained from Molecular Probes, 
Invitrogen (Breda, The Netherlands). The 
αIL2 antibodies (cat. 555051 and cat. 
555040) and streptavidin-HRP (cat. 
554066) were purchased from BD 
Pharmingen (Erembodegem, Belgium) and 
the TMB substrate solution from Thermo 
Scientific (Etten-Leur, The Netherlands). 
 
Cell Culture 
The Jurkat T cell leukemia line (ACC-282) 
was acquired from the DSMZ 
(Braunschweig, Germany). Additionally, 
Jurkat E6.1 SHP2 knock-down cells (SHP2 
KD) (see below) were compared to unmod-
ified Jurkat E6.1 T cells (TIB-152, ATCC) 
termed ‘wild type’ (wt) in this work. 
Cells were cultured in RPMI 1640 with sta-
ble glutamine and 2.0 g/l NaHCO3 
supplemented with 10% heat-inactivated 
fetal bovine serum (FBS) at 37°C and 5% 
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CO2 under humidified conditions (medium 
and serum were both from PAN biotech 
GmbH, Aidenbach, Germany). Cultures 
were passed every 2-3 days and grown to 
densities of on average 7 ∙ 10
5
 cells/ml.  
 
Cell Transfection 
5 ∙ 10
6
 Jurkat cells (ACC-282) in 100 μl se-
rum free RPMI medium were transfected 
with 5 μg CD28-GFP (RG211318; OriGene 
Technologies Rockville, MD, USA) in a 2 
mm electroporation cuvette (Cell Projects 
Limited, Kent, UK). Transfection was per-
formed by electroporating the cells at 0.18 
kV, 960 μF and 200 Ω (Gene Pulser; Bio-
Rad Laboratories, Veenendaal, The Nether-
lands). The cells were then transferred to 5 
ml RPMI medium with 5% FBS and incu-
bated at 37°C for 48 h. After the first 24 h 
an additional 5 ml of medium with 5% FBS 
was added to the cells. 
 
Jurkat E6.1 SHP2 Knock-Down Cells 
Plasmid pLKO.1 vectors encoding five 
nonvalidated shRNA targeting sequences 
for ptpn11 (SHP2) were obtained from 
Sigma-Aldrich (Mission shRNA lentivirus 
mediated transduction system, SHGLY-
NM_002834.3). Targets were validated us-
ing transduction of lentiviral particles into 
293T cells (ACC 635, DSMZ). With shRNA 
NM_002834.3-1570s1c1 (targeting se-
quence CGCTAAGAGAACTTAAACTTTC) a 
down regulation of SHP2 level to 10% was 
obtained on western blot (data not 
shown). For production of lentiviral parti-
cles 293T cells were transiently transfected 
with the pLKO.1-derivative plasmid carry-
ing shRNA NM_002834.3-1570s1c1 in 
combination with pRev, pEnv-VSV-G and 
pMDLg using polyethyleneimine (PEI; de-
scribed recently by Arora et al. [50]). Jurkat 
E6.1 cells were infected three times with 
the pseudotyped particles in the presence 
of 8 μg/ml polybrene (1,5-dimethyl-1,5-
diazaundecamethylene 
polymethobromide, Sigma-Aldrich) for 8, 
16, and 24 h. Selection of cells with 2 
μg/ml puromycin was started 48 h after 
transduction. 
 
Microcontact Printing 
Microstructured master templates for the 
fabrication of poly(dimethylsiloxane) 
(PDMS) stamps were produced using pho-
tolithography [36]. The microstructures 
were designed in autoCAD 2007 (Auto-
desk, München, Germany) and ordered as 
laser-written chromium masks (ML&C, Je-
na, Germany). A silicon wafer coated with 
a 2.5 µm thick ma-P 1225 photoresist 
(Microcoat, Berlin, Germany) was 
microstructured via photolithography with 
the chromium masks in a cleanroom facili-
ty. After resist development and a 
hardbake (95°C over 1 h) the micro-
structured master was finalized with a pro-
tective silane coating of low-pressure 
vapor-deposited (3,3,3-Trifluoropropyl)-
trichlorosilane (ABCR, Karlsruhe, Germa-
ny). 
Stamps were generated by mixing an elas-
tomer base and a cross-linking agent 
(Sylgard 184 silicone elastomer kit, Dow 
Corning, Wiesbaden, Germany) in a 10:1 
ratio (w/w). The degassed prepolymer was 
Chapter 2 
 
48  
 
poured onto the silicon master and cured 
at 65°C overnight. The PDMS layer was 
demoulded and cut into individual 8 × 8 
mm stamps. Stamps were coated for 1 h at 
RT with 100 µl of in total 107 µg/ml anti-
body solution. These solutions comprised 
of 7 µg/ml goat αguinea pig Alexa Fluor 
647 for visualization of stamped features, 
75 µg/ml unspecific IgG2a for titration of 
the stimulus and lastly a stimulus of either 
25 µg/ml αCD3, 25 µg/ml αCD28 or a com-
bination of 12.5 µg/ml αCD3 and 12.5 
µg/ml αCD28. Additionally, control stripes 
were stamped using antibody solutions in 
which the stimulus was replaced by an ad-
ditional 25 µg/ml unspecific IgG2a. 
Meanwhile, microscope slides (75 × 25 × 1 
mm) were cleaned through rubbing with 
demineralized water, rinsing with 70% 
ethanol and acetone and finally dried in a 
stream of filtered nitrogen. Coated stamps 
were rinsed with demineralized water, 
dried with filtered nitrogen and brought 
into contact with microscope slides for a 
few seconds. After careful removal of the 
stamp from the slide an adhesive frame of 
1 × 1 cm (In situ frame, Peqlab; Erlangen, 
Germany) was stuck around the stamped 
area as an incubation chamber. Parts of 
the surface that had not been in contact 
with stamp features were functionalized 
through a 30 min incubation with 100 µl of 
a 20 µg/ml antibody solution comprised of 
15 µg/ml unspecific IgG2a and a stimulus 
of either 5 µg/ml αCD3, 5 µg/ml αCD28 or 
a combination of 2.5 µg/ml αCD3 and 2.5 
µg/ml αCD28. Control surfaces were coat-
ed with 20 µg/ml unspecific IgG2a only. 
After a wash step with 150 μl PBS, slides 
were blocked with 1% BSA in PBS for 30 
minutes. Before cell seeding slides were 
washed with 150 μl PBS once more (Re-
viewed in [37]). 
 
Cell Stimulation and Immunocytochemis-
try 
After either transfection or (mock) labeling 
of cells with 1 μM CFDA-SE at 1∙10
6
 
cells/ml according to the supplier’s proto-
col, cells were serum starved in order to 
reduce background levels of phosphoryla-
tion. 1∙10
5
 serum starved cells in RPMI 
1640 medium were seeded onto function-
alized glass surfaces and stimulated for 10 
min at 37°C before they were fixed with 
3% (w/v) paraformaldehyde (Merck, 
Darmstadt, Germany) for 10 min at 4°C fol-
lowed by 15 min at RT, washed three times 
with PBS for five min and permeabilized 
with saponin buffer (0.1% saponin, 0.1% 
BSA in PBS) for 15 min. The αphosphoTyr 
antibodies were fluorophore conjugated 
by formation of non-covalent immuno-
complexes with Zenon Alexa Fluor 546 la-
beling kits following the supplier’s 
protocol, diluted in saponin buffer and in-
cubated with the cells for 1 h. Alternatively 
the cells were incubated with 2 μg/ml 
αpY783-PLCγ1 in saponin buffer for 1 h, 
washed with saponin buffer for 5 min 
three times and incubated with 4 μg/ml 
goat αrabbit Alexa Fluor 546 in saponin 
buffer for 1 h. Finally, samples were 
washed three times (PBS, 5 min) and co-
verslips were mounted using Mowiol 
mounting medium (Merck; [51]). 
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Microscopy and Image Analysis 
Images were acquired with a TCS SP5 con-
focal laser scanning microscope equipped 
with an HCX PL APO 63× 1.2 N.A. water 
immersion lens and using the 488 nm line 
of an argon-ion laser, a 561 nm HeNe and 
a 633 HeNe laser (Leica, Rijswijk, The 
Netherlands) according to the used 
fluorophores and lateral sampling rates of 
120 nm. All images had a size of 2048 × 
2048 pixels. 
The fluorescence intensity of cellular areas 
at the contact plane of cells and function-
alized glass was analyzed in individual 
confocal slices acquired with a pinhole di-
ameter of 1 Airy unit, using ImageJ [52] 
with self-written macros (Supporting Mac-
ro S1 & Macro S2). Binary masks of the 
stripe image and the image of immuno-
labeled cells were generated. These masks 
and inverted duplicates thereof were 
combined and used to measure the inte-
grated intensities of the immunolabel in 
cells on different surfaces. The masks were 
further used to determine the size of the 
surface areas and, in combination with the 
integrated intensities, provided the mean 
intensity of cellular pixels. The values of 
surfaces lacking cells were used for back-
ground correction during data processing.  
For the discrimination between different 
cell types, binary masks were generated 
for CD28-GFP-high or CFSE-labeled cells 
and, combined with the immunofluores-
cence masks representing all cells, for the 
CD28-GFP-low or unlabeled cell popula-
tion. Cluster-selective masks were 
generated from the image of the phos-
photyrosine signal using the local maxima 
function of ImageJ and self-written code. 
The quantities of labeled and unlabeled 
cells were determined manually using the 
cell masks and transmission images.  
 
Data Transformation and Statistical Tests 
In the microcontact printing experiments, 
for each image, the data was normalized 
by dividing the value of a specific cell type 
on a specific surface by the average value 
of all combinations of cell types and sur-
faces. This enabled pooling of the data sets 
of different experiments for statistical 
analyses. Based on histograms of the data 
and one-sample Kolmogorov–Smirnov 
tests it was confirmed that data sets of all 
subgroups could be considered to be nor-
mally distributed. Additionally, Levene’s 
test for equality of variances justified the 
comparison of populations using two-
sample T tests when only the effect of cell 
type had to be determined and two-way 
factorial ANOVAs when both the effect of 
stimulus and cell type had to be measured. 
To determine whether cell populations had 
spreading preferences for a certain stimu-
lus, surface-preference-scores (see 
Results) were subjected to one-sample T 
tests with a test value of 1. 
Generally, null hypotheses were rejected 
when p-values were below 0.05 but 
Bonferroni corrections were applied where 
necessary. Statistical tests were performed 
using SPSS 16.0 for Windows (SPSS Inc., 
Chicago, IL, USA) and IBM SPSS Statistics, 
version 20 (IBM Corp., Armonk, NY, USA). 
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Flow Cytometry 
Unspecific IgG2a, αCD3 or αCD28 antibod-
ies were conjugated with either Zenon 
Alexa 488 or Zenon Alexa 647 according to 
the supplier’s instructions. 1∙10
5
 cells were 
incubated with the fluorescently labeled 
antibodies for 1 h at room temperature 
and washed three times in PBS. To prevent 
exchange of the non-covalently bound 
Zenon reagent between the primary IgG2a 
antibodies, the cells were fixed with 3% 
paraformaldehyde for 10 min at room 
temperature and washed in PBS before 
analysis using a FACSCalibur flow cytome-
ter (Becton Dickinson, Beda, The 
Netherlands) counting
 
at least 2.5∙10
4
 
events per sample. 
 
IL2 ELISA 
Wells of a Microlon 96-well flat bottom 
plate (Greiner Bio-One, Alphen aan den 
Rijn, The Netherlands) were coated over-
night at 4°C with 1 µg/ml αCD3, 1 µg/ml 
αCD28 or a mixture of 1 µg/ml αCD3 and 1 
µg/ml αCD28 in PBS (100 µl per well). Ad-
ditional wells were treated with PBS only, 
either for negative controls or stimulation 
of cells with phorbol myristate acetate 
(PMA) and ionomycin. The plate was 
blocked for 30 min with 4% BSA in PBS and 
washed with RPMI medium. 1∙10
5
 cells 
were seeded per well and stimulated for 
22 h at 37°C, 5% CO2 and under humidified 
conditions. Positive control samples were 
incubated with 12.5 ng/ml PMA and 500 
ng/ml ionomycin. IL2 expression was de-
termined through a sandwich ELISA using 
the reagents mentioned above. Plates 
were measured on a Benchmark Plus 
microplate spectrophotometer (Bio-Rad 
Laboratories). ELISA results were analyzed 
with two-way factorial ANOVAs and 
Bonferroni post-hoc tests.  
 
 
Results 
 
Cells with high levels of CD28 expression 
have increased surface contact areas but 
lower local tyrosine phosphorylation 
when stimulated with αCD28 on 
microstructured surfaces 
We first aimed to determine to what ex-
tent different expression levels of the 
CD28 coreceptor result in different levels 
of T cell activation. On one hand these ex-
periments served the validation of 
microcontact printing for quantitative 
analyses, on the other we intended to 
compare TCR receptor engagement and 
the CD28 costimulus in the induction and 
distribution of tyrosine phosphorylation. 
One stimulus was transferred onto cleaned 
glass surfaces by stamping, the other stim-
ulus by incubation with a solution 
containing the stimulating antibody 
(termed ‘overlay’ in this work; Figure 1). It 
has been shown previously that in this 
manner each part of the surface contains 
only one type of stimulus [38]. 
For quantitative immunofluorescence mi-
croscopy at the contact site of cells with a 
surface, variation is prone to arise be-
tween different samples due to small 
differences in focal planes and 
immunolabeling efficiency. As a conse-
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quence, with the analysis of different sam-
ples, small but relevant differences in 
signal intensity between cells or stimuli 
may be deemed insignificant. In order to 
overcome this hurdle we developed a pro-
tocol to facilitate a comparison of two 
different cell types on a side-by-side basis 
(Figure 2A). 
 
Especially in early T cell signal transduc-
tion, propagation of the signal is mainly 
driven through tyrosine phosphorylation 
[5]. We therefore chose to use phos-
photyrosine levels as a marker to assess 
the impact of CD28 expression levels on 
early signal initiation. A Jurkat T cell strain 
with no to low CD28 expression was trans-
fected with CD28-GFP (Supporting Figure 
S1). After cultivation for two days without 
selective pressure, the cells were incubat-
ed on surfaces functionalized with alter-
alternating stripes of αCD3 and αCD28 
stimulating antibodies for 10 min. Cells 
were incubated on surfaces of which the 
αCD3 stripes were stamped and the αCD28 
stripes were overlaid (Figure 2B) and vice 
versa (Figure 2C) to correct for possible ef-
fects of the mode of surface preparation. 
After fixation, phosphotyrosine levels at 
the interface of the cells and surfaces were 
analyzed by confocal laser scanning mi-
croscopy using immunofluorescent 
staining. Labeling controls showed no 
aspecific clustering of the fluorophores 
(Supporting Figure S2). The 10-min time 
point was selected as it provided sufficient 
time for cell spreading to occur, yet tyro-
sine microclusters could still be detected 
 
Figure 1. Protocol for microcontact printing. A microstructured silicon master is used as a template 
for the generation of PDMS stamps. The stamp is coated with antibodies, including a fluorescently 
labeled indifferent antibody for visualization of stamped features. Stamping transfers a monolayer 
of antibodies to a clean microscope slide. The areas in between stamped patterns are coated by in-
cubation (‘overlay’) with a second antibody solution. Finally, the surface is blocked with BSA. 
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all over the cells. In order to sample large 
numbers of cells we scanned the maximal 
field of view at a lateral sampling frequen-
cy yielding diffraction limited resolution 
(for an example refer to Supporting Fig-
ure S3).  
 
When cells were stimulated with parallel 
stripes of αCD3 and αCD28 a clear accumu-
lation of the CD28 receptor was observed 
on the αCD28 stripes (Figure 2B & C). In 
contrast the formation of phosphorylated 
tyrosine clusters primarily took place on 
αCD3 stripes. Additionally, it appeared that 
Jurkat T cells expressing high levels of 
CD28, as judged by GFP intensity (CD28-
high cells), covered larger surface areas 
than CD28-low cells did. The CD28-high 
cells, however, appeared to have a lower 
degree of tyrosine phosphorylation than 
 
Figure 2. The effect of CD28 expression and segregated, stripe-shaped stimuli on tyrosine phos-
phorylation. The effect of receptor expression on signaling was studied using CD28-GFP transfected 
Jurkat ACC-282 T cells. After electroporation, cells were cultured for 48 h, serum starved for 6 h and 
then incubated on striped stimulatory surfaces for 10 minutes, fixed with 3% PFA and 
immunolabeled with αphosphotyrosine (A). The stimulatory surfaces were prepared using stamps 
coated with either 25 µg/ml αCD3 (B & D); 25 µg/ml αCD28 (C & G) or unspecific IgG2a only (E & F). 
The stamped areas were subsequently overlaid with 5 µg/ml αCD28 (B & F); 5 µg/ml αCD3 (C & E) or 
unspecific IgG2a only (D & G). B-G) Top left panels: transmission image; top right panels: CD28-GFP; 
bottom left: αphosphotyrosine; bottom right panels: overlay of the stamped pattern (blue) and the 
αphosphotyrosine label (grayscale). In the CD28-GFP and overlay panels the contrast and brightness 
are adjusted proportionally for clarity. Scale bars 20 µm. 
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CD28-low cells, both on αCD3 and on 
αCD28 stripes. In order to verify these ob-
servations we quantified the fluorescent 
intensities (Supporting Macro S1). To avoid 
artifacts as a result of the manner in which 
the stripes were prepared, the normalized 
results of both orientations of the experi-
ment (Figure 2B & C) were pooled. Data 
within images was normalized to the mean 
value within that image in order to elimi-
nate variations between samples and 
experiments. The protocol yielded un-
paired parametric statistical tests and 
provided information about relative quan-
titative differences between stimuli and 
cell types (Figure 3). Datasets for each 
condition had comparable variances and 
followed normal distributions. 
 
Quantification showed that cells indeed 
had a higher degree of tyrosine phos-
phorylation on αCD3 stripes than on 
αCD28 stripes (Figure 3A). This effect was 
independent of CD28 expression levels, 
meaning that there was no significant dif-
ference in the increase between CD28-high 
and CD28-low cells. Furthermore, it con-
firmed that, on both αCD3 and αCD28, 
CD28-high cells had significantly lower 
phosphotyrosine levels per surface area 
than CD28-low cells. Expression of CD3 had 
not been reduced as a consequence of 
CD28-GFP expression (Supporting Figure 
S1) and could therefore not have been the 
cause of this reduced phosphorylation. 
However, when the local phosphotyrosine 
densities were corrected for the increased 
cell spreading (Figure 3B), CD28-high cells 
seemed to have a slightly higher total tyro-
sine phosphorylation level, but after a 
Bonferroni correction this difference could 
not be shown to be significant (Figure 3C). 
Without CD28 costimulation (Figure 2D & 
E), no significant differences were found 
between CD3 stimulated CD28-low and 
CD28-high cells in the degree of tyrosine 
phosphorylation per surface area (Figure 
3D), interaction surface area per cell (Fig-
ure 3E) or total tyrosine phosphorylation 
per cell (Figure 3F). As expected, signifi-
cantly higher levels of phosphotyrosine 
were observed on αCD3 stripes in these 
samples. It should be noted that this dif-
ference was noted primarily on samples 
where αCD3 was applied as an overlay. 
When αCD3 was stamped, in many cells 
phosphotyrosine levels were observed to 
be higher on the overlay. However, as ex-
plained above, we corrected for this effect 
by pooling data from samples with in-
versed stamp-overlay orientations.  
Finally, when αCD28 stripes were com-
pared with IgG control stripes (Figure 2F & 
G) no significant differences were found in 
the phosphotyrosine signal per surface ar-
ea between stripes or cells (Figure 3G). The 
presence of αCD28 stripes did however 
stimulate the CD28 cells to form larger in-
teraction surfaces with the stripes (Figure 
3H). This indicates that Jurkat T cells can 
respond to CD28 stimulation alone when 
high levels of CD28 are expressed, albeit in 
a limited fashion. The increased surface 
area of CD28-high cells was accompanied 
by a proportionate increase in total phos-
photyrosine signal per cell (Figure 3I). As
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we expect this fluorescence to be of mem-
brane proximal, background phos-
phorylation levels independent of TCR and 
CD28 signaling, the proportionate increase  
 
in total phosphotyrosine signal per cell 
with increased cell spreading is unsurpris-
 
ing. Even though sample-to-sample varia-
tion imposes limits to comparisons 
between samples, cells clearly responded 
in a strongly reduced fashion to unspecific 
IgG2a coated surfaces as compared to 
αCD3/αCD28 patterned surfaces (Support-
ing Figure S4). For none of the com-
 
Figure 3. Quantification of the effect of CD28 expression on cell surface spreading and tyrosine 
phosphorylation. The original images of the experiment of Figure 2 were quantified (see Supporting 
Macro S1) and the values were normalized to the mean value of the measured property within that 
image. Normalized values of experiments with inverted stamp and overlay configurations were 
pooled. The graphs show the mean ± SEM. A-C) Cells stimulated with stripes containing αCD3 and 
stripes containing αCD28. (n = 10 images from two separate samples in which stamp and overlay 
stimuli were reversed (Figure 2B & C) in total counting 1010 CD28 low and 127 CD28 high cells). D-F) 
Cells stimulated with stripes containing αCD3 and stripes containing unspecific IgG2a only. (n = 10 
images from two separate samples in which stamp and overlay stimuli were reversed (Figure 2D & E) 
in total counting 921 CD28 low and 97 CD28 high cells). G-I) Cells stimulated with stripes containing 
unspecific IgG2a only and stripes containing αCD28. (n = 10 images from two separate samples in 
which stamp and overlay stimuli were reversed (Figure 2F & G) in total counting 1006 CD28 low and 
165 CD28 high cells). A, D & G) The background-corrected, αphosphotyrosine intensity per surface 
area. Corrected model p-values were determined by two-way factorial ANOVAs in which no interac-
tion terms were included. B, E & H) The contact surface area per cell. Two-sample T-tests were used 
to generate the p-values. C, F & I) The integrated, background-corrected, αphosphotyrosine intensi-
ty per cell (Two-sample T-tests). 
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binations of stimuli a significant interaction 
factor between CD28 expression and stim-
ulating surface was found when two-way 
factorial ANOVAs including interaction 
terms were applied. Therefore there were 
no detectable differences in the response 
to the different stimuli between CD28-low 
and CD28-high cells. In other words, even 
though the CD28-low cells had higher local 
phosphotyrosine signals, the increase of 
tyrosine phos-phorylation on αCD3 was 
comparable between the two cell types.  
Treatment with cytochalasin D, an inhibi-
tor of actin polymerization, drastically 
reduces cell adherence and spreading 
(Supporting Figure S5) indicating that 
Jurkat T cells do not passively adhere to or 
spread on the striped surfaces and that the 
observed affects are an effect of CD28 
costimulation. 
 
SHP2 depletion increases cluster phos-
phorylation but not cluster numbers and 
decreases IL2 production 
The analysis of phosphotyrosine levels, as 
described above, shows the potential of 
the striped pattern to perform a side-by-
side analysis of two different stimuli. Im-
portantly, we observed distinct differences 
in tyrosine phosphorylation and surface 
distribution between Jurkat T cells express-
ing different levels of CD28. Next, we 
intended to specifically address the role of 
the PTP SHP2 in cluster formation and 
phosphorylation and the CD28 depend-
ence of the observed effects. 
SHP2 is one of several PTPs involved in T 
cell signaling and its effects might there-
fore be relatively small. Moreover, the 
protein has been implicated to be involved 
in both activation and inhibition of cell sig-
naling. By comparing a SHP2 knock-down 
clone of Jurkat E6.1 (SHP2 KD) with the 
‘wild type’ Jurkat E6.1 line (wt) on striped 
surfaces we wanted to gain insight into 
whether this phosphatase noticeably af-
fects overall tyrosine phosphorylation. In 
addition the effect on the tyrosine residue 
783 of PLCγ1 in particular was tested as a 
candidate target of SHP2. In contrast to 
the combination of stimuli used above, in 
these experiments we intended to more 
closely capture the physiological setting of 
CD28 costimulation in early signaling, 
which is in colocalization with CD3 en-
gagement. Therefore αCD3+αCD28 
mixtures were compared to αCD3 alone.  
 
In Jurkat E6.1 SHP2 KD cells the phospha-
tase was down-regulated by expression of 
lentivirally transduced shRNA. In compari-
son to wt cells, SHP2 expression was 
reduced to 13% in these cells (Supporting 
Figure S6A), but this had no effect on re-
ceptor expression (Supporting Figure S6B 
& C). SHP2 KD and wt Jurkat cells were in-
cubated on stripes functionalized with a 
1:1 ratio of αCD3 and αCD28 alternating 
with stripes of only αCD3 for 10 min and 
stained for phosphotyrosine or phos-
phoY783 PLCγ1. By labeling one of two cell 
types with the cell tracer CFSE prior to in-
cubation on micropatterned surfaces 
(Figure 4A) the two types could easily be 
distinguished during microscopy (Support-
ing Figure S3). We confirmed that all CFDA-
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Figure 4. Detection of the stimulus dependence of total tyrosine phosphorylation (B) and 
phosphoY783 PLCγ1 (C) in Jurkat cells and SHP2 KD cells. A) For the side-by-side analysis of signal-
ing in Wt and SHP2 KD Jurkat E6.1 T cells, one of the lines was labeled with the cell tracer CFSE. 
After overnight serum starvation the cells are pooled and incubated on micropatterned, stimulat-
ing surfaces for 10 min. Subsequently, the cells are fixed with 3% PFA, permeabilized and 
immunolabeled for the detection of signaling clusters. B & C) In the top panels, SHP2 KD cells are 
CFSE labeled and in the bottom panels, wt cells are labeled. Panels from left to right: transmission 
images; CFSE; immunofluorescence; overlay of the stamped pattern (blue) and the immunolabel 
(grayscale). In the overlay panels the contrast and brightness for both channels were adjusted pro-
portionally for clarity. 12.5 µg/ml αCD3 + 12.5 µg/ml αCD28 coated stamps were used to generate 
a striped pattern which was overlaid with 5 µg/ml αCD3. CFSE channels were recorded with satu-
rated signals to facilitate image processing. Scale bars 20 µm 
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SE treated cells were fluorescently labeled 
(Supporting Figure S7). 
Again confocal images were acquired with 
the focus on the plane of the contact area. 
Both cell lines responded in a comparable 
heterogeneous fashion to the stripes (Sup-
porting Figure S3). For both Jurkat strains 
approximately 80% of the cells had formed 
microclusters of pY or pPLCγ1 and most 
cells had higher cluster numbers and in-
creased phosphotyrosine (Figure 4B) and 
pY783 PLCγ1 signals (Figure 4C) on the 
stripes containing both stimuli. However, 
some cells also formed large numbers of 
clusters on the αCD3 coated surface. In-
terestingly, the cluster brightness varied 
strongly between cells within images. Ad-
ditionally, cells spread more on stripes 
containing both stimuli than on stripes 
consisting of only αCD3 (Figure 4B & C). 
This contact difference was less pro-
nounced when αCD3 was stamped and 
αCD3+αCD28 was overlaid (Supporting 
Figure S3, S4 & S7), indicating that, as 
above, stamping resulted in a different ac-
tivity of the stimuli than functionalization 
by incubation with soluble antibodies. 
Therefore, experiments were also per-
formed in which the stamped and overlaid 
stimuli were switched (results not shown 
but included in the quantitative analyses 
below). Comparable results were obtained 
independent of which cell strain was CFSE 
labeled (compare top and bottom panels 
of Figure 4B & C). 
Due to the heterogeneity of the cell re-
sponse, quantitative analyses were 
necessary to extract subtle differences be-
tween SHP2 KD cells and the wt Jurkat 
cells. For this purpose we extended our 
image processing protocol for extensive 
quantification of clusters and cell surface 
distribution (Supporting Macro S2 & Fig-
ure 5). 
As before, the normalized values of multi-
ple images of several experiments, in 
which the orientation of stamped and 
overlaid surface and CFSE labeled and un-
labeled cells varied, were pooled. For each 
condition, datasets followed normal distri-
butions and groups showed comparable 
variances. 
 
Quantification of the images revealed 
small but significant differences in early 
signaling events between SHP2 KD and wt 
Jurkat T cells. SHP2 KD cells had a 7.7% 
higher phosphotyrosine signal than wt 
cells (95% confidence interval (CI) 4.5%-
10.9%; Figure 6A & Figure 7). In parallel 
the intensity of the phosphorylated tyro-
sine microclusters was 7.9% higher in 
these cells (CI 4.3%-11.5%; Figure 6B & 
Figure 7). Similarly, the specific phosphory-
lation of tyrosine residue 783 in PLCγ1 was 
6.3% higher (CI 3.2%-9.4%; Figure 6E & 
Figure 7) as was the cluster-specific inten-
sity (6.7%, CI 4.1%-9.3%; Figure 6F & Figure 
7) in cells not expressing SHP2. There were 
no significant differences between the cell 
strains in the number of microclusters
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Figure 5. Image processing of phosphoPLCγ1 signals and cluster formation. Overview of the image 
processing protocol as described in Experimental Procedures and used for the analysis of the exper-
iments described in Figure 4. In order to resolve clusters in print, an enlarged segment of a 
microscopy image labeled with αphospho-PLCγ1 (Supporting Figure S3) is shown as an example. Im-
age processing and quantification was done on a per image basis. Supporting Macro S2 describes the 
full procedure utilized to analyze the images. In short, the pPLCγ1 signal was thresholded to gener-
ate a binary mask of all cells. This image was inverted to generate a mask of the background signal. 
The CFSE image was thresholded and was used in combination with the mask of all cells to generate 
a mask of CFSE labeled cells and a mask of unlabeled cells. The image of the printed stripes was 
thresholded to generate a mask of the printed structures and inversed to also generate a mask of 
the overlaid areas. Combining the masks of the printed structures and overlaid areas with the masks 
of the cells formed the masks of the CFSE labeled cells on stamped stripes, the CFSE labeled cells on 
overlaid structures, the unlabeled cells on stamped stripes and the unlabeled cells on overlaid struc-
tures. These four masks were used to measure the surface areas the cells covered on both surfaces. 
Combining the stripe and overlay masks with the background mask enabled the measurement of 
surface areas not covered by cells. The last six generated masks were, in turn, applied to the original 
pPLCγ1 image and from the resulting images the total pPLCγ1 signal per condition could be deter-
mined.Together with the total surface areas of the specific condition, the signal intensity per μm
2
 
was calculated. Surface specific background corrections were applied. In addition, a binary cluster 
mask was generated from the pPLCγ1 image. This mask was segmented using the four masks of cells 
on surfaces creating four new masks. From these masks cluster numbers were counted and by ap-
plying them to the original pPLCγ1 image cluster intensities could be determined. Finally, the cell 
numbers per image were determined by eye using the original transmission images and the cell 
masks. The various colors correspond to the graphs in Figure 6 and indicate which masks and images 
are required to produce the particular data. 
 
 
(Figure 6C, D, G, H & Figure 7), cell size 
(Figure 6I) or surface preference (Figure 6J; 
see below). See Table 1 for absolute val-
ues. In addition to the effects of SHP2 
deficiency, there were also clear differ-
ences between αCD3 stimulation alone 
and αCD3+αCD28 costimulation. Cells 
formed 23.9% more phosphotyrosine mi-
cro-clusters per μm
2
 on stripes of mixed 
stimuli than on stripes of only αCD3 (CI 
17.2%-30.7%; Figure 6C & Figure 7). Also, 
the density of phosphorylated PLC1γ1 
microclusters was higher on αCD3+αCD28 
than on αCD3 surfaces (15.3%, CI 8.3%-
22.4%; Figure 6G & Figure 7). The variance 
of the absolute number of signaling clus-
ters per surface between images was 
much larger than the one of the normal-
ized figures and therefore did not give sig-
significant information (Table 1). 
This higher cluster density on αCD3+αCD28 
coated surfaces is reflected in the overall 
signal intensities of the cells on the differ-
ent surfaces. For phosphotyrosine this 
signal was 22.1% higher on αCD3+αCD28 
stripes than on αCD3 stripes (CI 18.9%-
25.3%; Figure 6A & Figure 7). The 5.5% in-
tensity increase of the clusters on mixed 
surfaces contributes relatively little to the 
large overall increase (CI 1.9%-9.1%; Figure 
6B & Figure 7). For phosphoPLCγ1 the 
overall signal was 12.2% higher (CI 9.1%-
15.3%; Figure 6E & Figure 7) and the 
microsclusters were5.4% more intense (CI 
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Figure 6. Quanti-
fication of the ef-
fects of CD28 
costimulation and 
SHP2 deficiency. 
The values acquired 
through image seg-
mentation as de-
scribed in Figure 5 
were normalized to 
the mean value of 
the specific property 
for that image. The 
information of mul-
tiple images from 
multiple experi-
ments was used for 
further analyses. The 
graphs depict the 
stimulus and SHP2 
dependence of 
spreading and tyro-
sine phosphorylation 
showing the mean ± 
SEM (based on 
number of images) 
of the respective 
property. KD =SHP2 
knock-down E6.1 
Jurkat cells; wt = 
wild type E6.1 Jurkat 
cells; 3 = stripes of 
αCD3 alone; 3+28 = 
αCD3+αCD28-
contain-ing stripes 
(Figure 4). The col-
ored squares 
correspond to the 
colors bordering im-
ages and masks in 
Figure 5 used to re-
trieve the data 
required for the 
graph in question. 
Corrected model p-
values were deter-
mined by two-way  
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factorial ANOVAs in which no interaction terms were included (A-C & E-G) or two-sample T-tests (D 
& H-J). A-D) Cells labeled with the αphosphotyrosine antibody (n = 15 images resulting from  three 
separate experiments with varying CFSE/unlabeled and stamp/overlay conditions in total containing 
861 KD and 615 wt cells). E-H) Cells labeled with the αphosphoY783-PLCγ1 antibody (n = 26 images 
resulting from  five separate experiments with varying CFSE/unlabeled and stamp/overlay conditions 
in total containing 1804 KD and 1502 wt cells). A & E) Average, background-corrected, overall inten-
sity per surface area. B & F) Average, background-corrected intensity of cluster pixels. C & G)
Average number of clusters per surface area. D & H) Average number of clusters per cell. I & J) The 
average contact surface area per cell (I) and surface-preference-score (J, see text) were determined 
from pooled data from the phosphoTyr and phosphoY783 PLCγ1 experiments (n = 41 images from 8 
experiments with varying CFSE/unlabeled and stamp/overlay conditions in total containing 2665 KD 
and 2117 wt cells).  
 
 
2.8%-8.0%; Figure 6F & Figure 7). 
After having determined a direct effect of 
CD28 expression on cell spreading we 
aimed to assess in more detail the effect of 
CD28 costimulation on membrane distri-
bution and spreading. In order to quantify 
the preference of cells for contacting one 
of the two surfaces we devised a surface-
preference-score (Figure 6J, eq. 1). The 
score for the αCD3+αCD28 surface is de-
fined as the ratio of cell surface on 
αCD3+αCD28 over cell surface on αCD3 
stripes corrected by the ratio of the total 
αCD3+αCD28 surface over the total αCD3 
surface. 
 
A surface-preference-score of 1 indicates 
no preference, a score > 1 indicates a pref-
erence for the cells to establish contact
 
 
Figure 7. Impact of CD28 costimulation and SHP2 deficiency on cluster numbers and phosphoryla-
tion. Effects with 95% confidence intervals of CD28 costimulation (left) and the knock down of SHP2 
(right) as predicted by ANOVAs on properties for which significant differences were found in Figure 
6. The effect is given as a fraction of the overall mean value for that specific property. 
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with αCD3+αCD28 and a score < 1 indi-
cates that the cells prefer αCD3 surfaces. 
Both cell strains had a clear preference for 
the αCD3+αCD28 surface as determined by 
one-sample T tests (p<0.001 for both; test 
value = 1). Together with the observed 
stretched shapes of the cells (Supporting 
Figure S3 & Figure 4) this clearly demon-
strates that CD28 engagement also 
increases cell spreading in a costimulatory 
setting. No difference in surface prefer-
ence was found between SHP2 KD and wt 
cells (Figure 6J).  
As before, no significant interaction factors 
between cell type and stimulating surface 
were found, indicating that there is no de-
tectable difference in the effect of CD28 
costimulation between wt and SHP2 KD 
cells. 
After having found that the inhibition of 
SHP2 expression stimulates the early T cell 
signaling response by increasing pY and 
pPLCγ1, we probed for the induction of IL2 
expression to address whether late T cell 
responses were also affected. SHP2 KD 
cells had a significantly reduced production 
of IL2 when stimulated with αCD3 and 
αCD28 compared to wt cells (Figure 8). 
This effect was not restricted to extracellu-
lar stimulation but was also observed 
when PMA and ionomycin were used. This 
difference is remarkably different from the 
positive impact of SHP2 deficiency on early 
tyrosine phosphorylation. A Bonferroni 
post-hoc test showed that there were no 
significant differences between cells stimu-
lated with PMA + ionomycin and cells 
stimulated with αCD3 + αCD28. One may 
argue that the difference in IL2 production 
observed is due to stimulation-dependent 
apoptosis. However, levels of apoptosis 
were not found to be different for wt ver-
sus SHP2 KD cells, indicating that the  
 Table 1. Measured cluster numbers and cell size 
Property SHP2 KD wt  
pY clusters per cell 15.1 ± 2.07 15.8 ± 2.27  
pPLCγ1 (pY783) clusters per cell 12.9 ± 0.77 13.0 ± 0.88  
cell contact surface (μm
2
) 167 ± 3.93 170 ± 4.24  
 
KD 3 KD 3+28 wt 3 wt 3+28 
pY clusters per 100 μm
2
  8.9 ± 0.97 11.7 ± 1.39 9.2 ± 1.17 11.4 ± 1.50 
pPLCγ1 (pY783) clusters per 100 μm
2
  7.8 ± 0.43 9.6 ± 0.73 8.0 ± 0.52 9.6 ± 0.68 
Values are given as mean ± SEM. KD= SHP2 knock-down E6.1 Jurkat cells; wt= wild type E6.1 Jurkat 
cells; 3= αCD3 stimulus alone; 3+28= αCD3+αCD28-containing stripes. 
 
(1)          
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observed difference could be attributed to 
an actual reduced IL2 production per cell 
(Supporting Figure S8). 
 
 
Discussion 
Protein cluster formation is a hallmark of 
early T cell signaling and has received sig-
nificant attention. Studies have addressed 
the effect of pMHC engagement, cluster 
migration, localization and colocalization 
of microclusters of many different signal
ing proteins over time [11, 17, 30, 31, 53-
56]. Recently, photo-activatable localiza-
tion microscopy and direct stochastic 
optical reconstruction microscopy have 
been used for a detailed, quantitative 
analysis of LAT clusters and their phos-
phorylation at resolutions down to 20 nm 
[57, 58]. 
 
Here, we established microcontact printing 
in combination with image processing for a 
quantitative analysis of stimulus-
dependent protein microcluster formation 
in early T cell signaling. In a first step, we 
established that different levels of CD28 
expression translated into different re-
sponses on antibody-coated surfaces. 
Consistent with a positive stimulatory role 
in signaling, Jurkat T cells expressing high 
levels of CD28 covered larger surface areas 
than CD28-low cells when stimulated with 
parallel stripes of αCD28 and αCD3 or 
combinations of αCD28 and IgG control 
stripes. Interestingly, we were not able to 
detect an increased level of tyrosine phos-
phorylation in CD28-high cells. When no 
CD28 costimulus was present, no signifi-
cant difference between the two cell lines 
was observed. This indicates that CD28-
GFP expressing cells had not been com-
promised in their potential for activation 
through the stimulation of CD3. It has been 
shown that CD4
+
 T cells of rheumatoid ar-
thritis patients express higher levels of 
CD28 and other markers of activated T 
cells than those of healthy controls [59]. 
The protocol presented here can serve as a 
tool to study how early signaling in such 
 
Figure 8. Effect of SHP2 depletion on IL2 ex-
pression. SHP2 KD and wt Jurkat E6.1 T cells 
were stimulated with PMA + ionomycin (+), 
αCD3 & αCD28, αCD3 alone, αCD28 alone or 
were left unstimulated (-) for 22 h. IL2 in the 
supernatants was quantified by sandwich 
ELISAs. Given are the absorption values ± SEM. 
The p-values are from a full factorial two-way 
ANOVA and represent the significance of the 
overall corrected model (corr m), the effect of 
CD28 expression (CD28 expr), the effect of the 
stimulus and the interaction factor (int fact) be-
tween stimuli and CD28 expression. For all 
conditions n = 3 samples, all from a single ex-
periment representative of four independent 
experiments.  
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aberrant cells is affected and possibly pro-
vide clues for suitable treatments. 
 
By performing a detailed side-by-side 
quantitative analysis of phosphotyrosine 
clusters on αCD3 and αCD3+αCD28 coated 
surfaces, we addressed to which extent 
the number and intensity of clusters were 
a function of the stimulus and the pres-
ence of an individual signaling protein. 
 
CD28 costimulation led cells to form an in-
creased density of phosphorylated 
microclusters (24% for pY and 15% for 
pY783 PLCγ1) and relatively small increas-
es in phosphotyrosine intensity of the 
clusters. Additionally, αCD3+αCD28 in-
duced stronger local spreading than αCD3 
alone. These results and the results dis-
cussed above show that CD28 plays a 
significant role in spreading of T cells sug-
gesting that CD28 stimulation induces a T 
cells to more thoroughly probe the surface 
or APC it is currently engaging, even in the 
absence of CD3 engagement.  
Costimulation of T cells with CD28 has 
been previously demonstrated to promote 
expression of proteins involved in cyto-
skeletal remodeling [60] and the CD28 
signal invokes actin reorganization and 
formation of lamellipodia through PI3K 
[21], cofilin [61] and Rho family GTPases 
[62]. Our data supports the notion that 
CD28 costimulation initiates qualitatively 
different signaling pathways than stimula-
tion of the TCR. 
The impact of SHP2 deficiency on cluster 
formation was qualitatively and quantita-
tively different from the impact of 
costimulation. In contrast to the effect of 
CD28 engagement, no significant differ-
ence in phosphorylated cluster density was 
observed. However, SHP2 deficiency did 
lead to a small but significant increase of 
overall and cluster tyrosine phosphoryla-
tion and PLCγ1 Y783 phosphorylation. PTP 
activity greatly exceeds kinase activity [63] 
and other PTPs may have overlapping sub-
strate specificity with SHP2. Nevertheless, 
knock down of this single phosphatase had 
a perceivable effect on overall phos-
photyrosine levels. This demonstrates that 
the loss of SHP2 cannot be fully compen-
sated by other phosphatases, such as 
SHP1, and therefore plays a non redundant 
role in T cell signaling. Interestingly, it has 
been recently found by Yokosuka et al. 
[44] that upon stimulation of the TCR and 
the negative regulator programmed cell 
death 1 (PD1), SHP2 itself forms clusters. 
In T cells expressing a phosphatase-dead 
dominant-negative form of SHP2 the 
phosphorylation of PD1 was increased 
which is in line with our observation of in-
creased tyrosine phosphorylation. 
In summary, these observations demon-
strate that CD28 engagement contributes 
to the formation of clusters acting as sig-
naling platforms, while SHP2 targets 
already formed signaling clusters. There 
were no indications that SHP2 specifically 
targets CD28 signaling. 
Interestingly, for late T cell activity a re-
versed and large effect of SHP2 deficiency 
was observed. While general phos-
photyrosine and phospho-PLCγ1 signals 
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were higher in the SHP2 KD cells during 
early signaling, IL2 production was lower 
as described previously [45]. This means 
that higher tyrosine phosphorylation levels 
during the first ten minutes of T cell stimu-
lation do not necessarily result in a 
stronger T cell response. It also shows that 
SHP2, despite being one of many PTPs in T 
cells, has a significant regulatory effect on 
T cell activation. CD3 and CD28 stimulation 
were both necessary to generate an IL2 re-
sponse. IL2 expression was also reduced 
for cells stimulated with PMA and 
ionomycin suggesting that SHP2 exerts this 
latter effect at a later stage of the signaling 
cascade than the initial dephosphorylating 
effect on PLCγ. The effect on cytokine se-
cretion observed is likely due to the 
positive effect of SHP2 on MAPK signaling 
[45, 46] which is crucial for IL2 production 
[64]. Further research, however, is re-
quired in order to verify this hypothesis. 
Remarkably, it appears that SHP2 plays a 
dual role in IL2 production as Yokosuka et 
al. [44] observed SHP2, through PD1, nega-
tively affected IL2 production.  
 
The combination of micropatterned sur-
faces with quantitative image processing 
as demonstrated here, adds a valuable and 
accessible tool to the repertoire of analyti-
cal techniques in the analysis of early T cell 
signaling. Image processing is applied to a 
cell population in an unbiased fashion. The 
stamping of stripes enables a highly sensi-
tive side-by-side analysis of different 
stimuli on a microscale level, which can be 
further extended to a side-by-side compar-
ison of different cell strains eliminating 
noise arising from sample-to sample varia-
tion. Even though state-of-the-art 
superresolution techniques provide the 
means to visualize single molecules within 
clusters, challenges such as cell-to-cell and 
sample-to-sample variation still apply to 
these more advanced techniques. 
In this study we addressed the role of the 
PTP SHP2 in cluster formation and phos-
phorylation using a SHP2 KD Jurkat strain 
next to wt Jurkat cells. However, quantita-
tive comparisons of signaling can benefit 
the analysis of T cell biology in multiple 
other ways. T effector cells and T regulato-
ry cells, for example, show very limited 
differences in the expression of signaling 
proteins, yet widely differ in their physio-
logical role [65]. The approach shown here 
can be of great benefit to the quantitative 
understanding of the functional implica-
tions of differences in early T cell signaling. 
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Supporting Information  
 
 
 
Figure S1. Over-
expression of 
CD28 does not 
affect CD3 ex-
pression. 
Expression levels 
of CD28 (middle 
row) and CD3 
(bottom row) 
were determined 
with flow 
cytometry for 
non-transfected 
Jurkat T cells 
(ACC-282; left) 
and CD28-GFP 
transfected cells 
(right). The top 
row shows a 
negative control 
in which cells 
were treated 
with unspecific 
IgG2a. Scatter 
plots with GFP 
expression on 
the X-axis and 
the immune-
labelled recep-
tors (Zenon 
Alexa 647) on 
the Y-axis are 
depicted. 
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Figure S2. Phospho tyrosine and phospho-PLCγ1 labelling control. Jurkat T cells were serum starved 
overnight and incubated on striped surfaces for 10 minutes. Surfaces were functionalized using 
stamps coated with 25 µg/ml αCD3 and overlaid with 2.5 µg/ml αCD3 + 2.5 µg/ml αCD28. Samples 
were immunolabeled with αphosphotyrosine conjugated with Zenon Alexa Fluor 546 component A 
andblocked with component B (A), the Zenon Alexa Fluor 546 component A blocked with compo-
nent B without specific antibody (B), phosphoY783 PLCγ1 and αrabbit Alexa Fluor 546 (C) or αrabbit 
Alexa Fluor 546 only (D). Images were acquired with a Zeiss LSM510 meta confocal laser scanning 
microscope using a 63× 1.4 N.A. PLAN APO objective and 543 nm and 633 nm HeNe lasers (Carl 
Zeiss, Sliedrecht, The Netherlands). Left panels: immunolabel. Right panels: stamped patterns. Con-
trast and brightness were adjusted proportionally. Scale bars 5 µm. 
 
 
Figure S3. Overlay of typ-
ical microscopy images 
used for analysis. One 
field of view at 2048 × 
2048 pixels. In this case 
stamps coated with 25 
µg/ml αCD3 were used to 
generate a striped pattern 
(blue) which was overlaid 
with 2.5 µg/ml αCD3 + 2.5 
µg/ml αCD28. The CFSE 
labeled (green) SHP2 KD 
Jurkat T cells are clearly 
distinguishable from the 
non-CFSE labeled wt 
Jurkat cells.  After  fixation  
with 3% PFA the cells were immunolabeled with αphospho-PLCγ1 (grayscale). For clarity, contrast 
and brightnessare adjusted proportionally. Scale bar main image 50 μm; scale bar enlargement 10 
μm. 
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Figure S4. Tyrosine phos-
phorylation on control 
surfaces. CD28-GFP transfect-
ed Jurkat ACC-282 T cells were 
serum starved for 6 h and then 
incu-bated on striped surfaces 
for 10 minutes, fixed with 3% 
PFA and immunolabeled with 
αphosphotyrosine. Surfaces 
were functionalized using 
stamps coated with 25 µg/ml 
αCD3 (A) or unspecific IgG2a 
only (B). The remainder was 
subsequently overlaid with ei-
ther 5 µg/ml αCD28 (A) or 
unspecific IgG2a only (B). Top 
left panels: transmission im-
age; top right panels: CD28-
GFP; bottom left: αphos-
photyrosine; bottom right 
panels: overlay of the stamped 
pattern (blue) and the 
αphosphotyrosine label 
(grayscale). For a better com-
parison no adjustments were 
made to the contrast or bright-
ness of the images. Scale bars 
50 µm. 
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Figure S5. Reduced adherence and spreading of cells treated with cytochalasine D. Jurkat T cells 
were serum starved overnight and were treated with 10 μM cytochalasine D (Tocris Bioscience, 
Bristol, UK) 10 minutes prior to, and during incubation on striped surfaces. Surfaces were function-
alized using stamps coated with 25 µg/ml αCD3 and overlaid with 2.5 µg/ml αCD3 + 2.5 µg/ml 
αCD28. Samples were immunolabeled with αphosphotyrosine. Images were acquired with a Zeiss 
LSM510 meta confocal laser scanning microscope using a 63× 1.4 N.A. PLAN APO objective and 543 
nm and 633 nm HeNe lasers (Carl Zeiss, Sliedrecht, The Netherlands). Panels from left to right: 
transmission image, immunolabel and stamped patterns. Scale bars 20 µm. 
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Figure S6. SHP2 expression in SHP2 knock-down cells is reduced to 13% of wild type levels but 
both lines express receptors at comparable levels. A) Total cell lysates of Jurkat E6.1 SHP2 KD cells 
and Jurkat E6.1 ‘wt’ cells were subjected to SDS-PAGE followed by immunoblotting of SHP2 expres-
sion using a SHP2 antibody (rabbit polyclonal, N-10) from Santa Cruz Biotechnology (Heidelberg, 
Germany) or β-actin antibodies (mouse monoclonal, AC-15, Sigma-Aldrich, Deisenhofen, Germany). 
After subsequent incubation with horseradish peroxidase–conjugated secondary antibodies, the 
blots were developed using Western Lightning chemiluminescence detection (Perkin Elmer Life Sci-
ences, Boston, MA, USA) and quantitatively evaluated using a CCD camera-based system (LAS3000; 
Fujifilm, Düsseldorf, Germany). SHP2 levels were quantified in relation to β-actin levels. Below, SHP2 
expression levels are given relative to levels in wt cells. B & C) Expression levels of CD3 (left panels, 
Zenon Alexa 488) and CD28 (right panels, Zenon Alexa 647) were determined with flow cytometry 
for SHP2 KD cells (B) and wt cells (C). The unfilled histograms show isotype controls while the filled 
histograms αCD3 and αCD28 labeled populations, respectively. 
 
 
 
 
Figure S7. CFSE fluorescence (green) is retained by all cells after fixation, permeabilization and 
immunolabeling. Stamps coated with 25 µg/ml αCD3 were used to generate striped patterns (blue) 
which were overlaid with 2.5 µg/ml αCD3 + 2.5 µg/ml αCD28. Jurkat E6.1 ‘wild type’ cells were la-
beled with CFDA-SE (A) or mock labeled (B), serum starved over night and subsequently incubated 
on the micropatterned surfaces for 10 minutes, fixed with 3% PFA and immunolabeled with 
αphospho-PLCγ1 (grayscale). A & B were recorded with identical microscopy settings and all three 
channels are overlaid for both. For clarity, contrast and brightness were adjusted proportionally. 
Scale bar 50 μm. 
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Figure S8. SHP2 knock down effect on phosphatidylserine exposure. Wells of a 96-well flat bottom 
plate were coated as described for the ELISA in the Experimental Procedures section. In these wells 
1∙10
5
 SHP2 KD or wt Jurkat T cells were stimulated with αCD3 & αCD28 (clone CD28.2; eBioscience, 
Frankfurt, Germany), αCD3 alone, αCD28 alone or were left unstimulated (-) for 24 (left) or 48 hours 
(right) at 37°C, 5% CO2 and under humidified conditions. Cells were subsequently stained with the 
Annexin V-PE 7-AAD Apoptosis Detection Kit I (BD Pharmingen, Heidelberg, Germany) using the sup-
pliers protocol. Phosphatidylserine exposure was determined using a FACS Canto flow cytometer 
(BD Biosciences, Heidelberg, Germany) and characterizing 1∙10
4
 cells per sample. The graph shows 
the percentage of annexin V negative cells ± SEM of three independent experiments. 
 
 
 
 
Macro S1. Macro used for data extraction from images of CD28-GFP transfected cells exposed to 
stripes of different stimuli. This self-written macro was used in combination with ImageJ to analyze 
the confocal images described in Figure 2. The macro separates CD28-low and CD28-high cells on 
the different stripes. Guidelines to determine threshold values are included in the macro. Macro S1 
can be found online at http://www.plosone.org. 
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Macro S2. Macro used for the cluster analyses in images of CFSE labeled and unlabeled cells on 
two different types of stimuli. This self-written macro was used in combination with ImageJ to ana-
lyze confocal images described in Figure 4. of samples generated as described in Experimental Pro-
cedures. The macro performs segmentation into CFSE labeled and unlabelled cells and signaling 
clusters on the different stripes as illustrated in Figure 5. Guidelines to determine threshold values 
are included in the macro. Macro S2 can be found online at http://www.plosone.org. 
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Abstract 
With significant progress in delivery tech-
nologies, peptides and peptidomimetics 
are receiving increasing attention as po-
tential therapeutics also for intracellular 
applications. However, analyses of the in-
tracellular behavior of peptides are a 
challenge; therefore, knowledge on the in-
tracellular pharmacokinetics of peptides is 
limited. So far, most research has focused 
on peptide degradation in the context of 
antigen processing, rather than on peptide 
stability. Here, we studied the structure-
activity relationship of peptides with re-
spect to intracellular residence time and 
proteolytic breakdown. The peptides com-
prised a collection of interaction motifs of 
SH2 and SH3 domains with different 
charge but that were of similar size and 
carried an N-terminal fluorescein moiety. 
First, we show that electroporation is a 
highly powerful technique to introduce 
peptides with different charge and hydro-
phobicity in uniform yields. Remarkably, 
the peptides differed strongly in retention 
of intracellular fluorescence with half-lives 
ranging from only 1 to more than 10 h. 
Residence times were greatly increased for 
retro-inverso peptides, demonstrating that 
rapid loss of fluorescence is a function of 
peptide degradation rather than the phys-
icochemical characteristics of the peptide. 
Differences in proteolytic sensitivity were 
further confirmed using fluorescence cor-
relation spectroscopy as a separation-free 
analytical technique to follow degradation 
in crude cell lysates and also in intact cells. 
The results provide a straightforward ana-
lytical access to a better understanding of 
the principles of peptide stability inside 
cells and will therefore greatly assist the 
development of bioactive peptides. 
 
 
Introduction 
Protein-protein interactions play a crucial 
role in intracellular signal transduction 
networks [1]. However, the pharmacologi-
cal disruption of protein interactions using 
small molecules still remains a challenge. 
As a promising alternative, peptides and 
peptidomimetics are gaining increasing at-
tention, and the first such drug candidates 
have entered clinical studies [2-4]. 
Rapid access to bioactive structures using 
rational design principles is a major advan-
tage of peptides: For several interaction 
domains, linear peptide motifs constitute a 
major part of the interaction interface [1]. 
Prominent examples are the interaction of 
phosphotyrosine-containing motifs, inter-
acting with SH2 domains, proline-rich 
motifs interacting with SH3 domains, and 
PDZ motifs interacting with PDZ domains 
[5-7]. In vitro, protein-protein interactions 
can be effectively disrupted by the addi-
tion of peptides corresponding to the 
respective interaction domains [8]. Large 
collections of different peptides can be 
synthesized by standardized parallel 
methods, and peptide microarrays enable 
a rapid profiling of biological activities [9-
12]. 
In spite of these apparent potentials and 
first success stories, the broad applicability 
of peptides in living cells is still hampered 
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by their poor plasma membrane permea-
bility and inadequate intracellular stability. 
Conjugation to cell-penetrating peptides 
(CPP) has been employed as an import 
strategy, and several examples exist for 
the introduction of bioactive peptides into 
cells [2]. Disruption of protein complexes 
that sequestrate proteins in specific spatial 
compartments within cells has been the 
basis for the development of novel pep-
tide-based therapeutic molecules for 
treating cardiovascular diseases [13, 14]. 
Nevertheless, in spite of its promises, this 
approach is far from generalizable, and 
guidelines for the implementation of a 
successful peptide-based approach do not 
exist.  
One major shortcoming is lack of insight 
into the intracellular pharmacokinetics of 
peptides. It is generally assumed that in-
side cells, peptides have a very short half-
life due to rapid proteolysis. For free pep-
tides serving as epitopes for MHC class I 
presentation, half-lives in the second range 
were reported [15]. Nevertheless, it was 
also proposed that some peptides originat-
ing from protein degradation accumulate 
to concentrations at which they may even 
modulate cell function [16, 17]. 
Furthermore, the documented intracellular 
activity of synthetic peptides is also diffi-
cult to reconcile with a general rapid 
breakdown. However, these peptides con-
tain modifications such as terminal 
capping that interfere with degradation by 
amino- and carboxypeptidases and there-
fore greatly increase stability [18]. 
Therefore, the ability to draw conclusions 
on the fate of synthetic peptides from ob-
servations made for endogenous peptides 
is limited. 
Methods that provide a deeper insight into 
the intracellular pharmacokinetics of pep-
tides are urgently needed. As one 
measure, it would be highly desirable to 
separately address import, degradation 
and export. In most cases of CPP-mediated 
import, the major part of molecules pas-
sages through endosomal compartments 
before release into the cytoplasm. Also in 
the endolysosomal compartment, degra-
dation occurs, resulting in cytoplasmic 
release of a mixture of intact and degraded 
peptides [19]. Therefore, analysis of the 
cytoplasmic concentration and cytoplasmic 
breakdown is complicated by the superpo-
sition of several concurrent transport and 
degradation processes. 
In contrast, electroporation enables a di-
rect delivery of molecules into the 
cytoplasm [20,21]. The method uses short 
high-voltage pulses for a transient pore 
formation in the plasma membrane. For an 
apoptosis-enhancing peptide, delivery by 
electroporation was superior to CPP-
mediated import as it yielded a direct de-
livery into the cytoplasm instead of 
endosomal sequestration [22]. Using elec-
troporation, dose-response functions of 
activity could be acquired reliably. 
In this study, we first explored to which ex-
tent electroporation achieved uniform 
import yields for peptides of similar size 
but with varying charge and hydrophobic-
ity. The peptides corresponded to 
interaction motifs of SH2 and SH3 do-
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mains. All peptides carried an N-terminal 
fluorescein moiety for monitoring cellular 
uptake, intracellular distribution and cellu-
lar retention of fluorescence. We then 
investigated the cellular half-life of fluo-
rescence. Using retro-inverso analogues of 
peptides, we show that a short intracellu-
lar half-life of fluorescence is the result of 
proteolytic breakdown and release of 
fragments rather than of the physico-
chemical characteristics of the peptide. 
Retro-inverso D-peptides mimic the struc-
tural and physicochemical characteristics 
of their L-amino acid counterparts as 
closely as possible, yet are resistant to pro-
teolysis [23,24]. Fluorescence correlation 
spectroscopy (FCS) was employed to de-
termine the sensitivity to degradation both 
in cell lysates and inside intact cells. With 
FCS, information on particle numbers and 
mobility is derived from temporal fluctua-
tions in fluorescence, caused by diffusion 
of fluorescently labeled molecules through 
a confocal detection volume [25]. Our re-
sults establish the measurement of the 
intracellular retention of fluorescence as a 
robust and straightforward protocol for 
obtaining information on intracellular pep-
tide stability. The results will therefore 
enable an efficient optimization of pep-
tides with respect to their pharmacokinetic 
parameters.  
 
 
Experimental Procedures 
 
Reagents. Peptides were purchased as 
peptide amides from EMC microcollections 
(Tübingen, Germany). At the N-terminus, 
peptides carried a fluorescein moiety con-
jugated via an aminohexanoic acid (Ahx) 
linker. Chemicals were obtained from 
Fluka (Deisenhofen, Germany). Cell culture 
media were purchased from PAN biotech 
(Aidenbach, Germany). Protease Inhibitor 
Cocktail Complete was obtained from 
Roche Diagnostics (Mannheim, Germany). 
Cell Line Nucleofector Kits V were provided 
by AMAXA Biosystems (Cologne, Ger-
many). When required, peptides were 
purified to > 90% purity by preparative re-
verse phase high-performance liquid 
chromatography (RP-HPLC) (Grom-SIL 120 
ODS-4 HE, 125 mm × 20 mm, C18 column, 
5 µm particle diameter; Grom, Herrenberg, 
Germany). The purity was determined by 
analytical RP-HPLC (Grom-SIL 120 ODS-4 
HE, 100 mm × 2 mm, C18 column, 5 µm 
particle diameter; Grom). The identity was 
validated via electrospray mass spec-
trometry with an LCQ Advantage Max 
mass spectrometer (Thermo Fisher Scien-
tific Inc., Waltham, MA). Concentrations 
were determined by UV/Vis spectroscopy 
based on fluorescein absorption. The pep-
tides were diluted 1000-fold in Tris/HCl 
buffer, pH 8.8, assuming an extinction co-
efficient for fluorescein E492 = 75000 L/(mol 
× cm). 
 
Electroporation. Jurkat E6.1 cells (ACC-
282, DSMZ, Braunschweig, Germany) were 
cultivated in RPMI medium supplemented 
with 10% fetal calf serum. For electropora-
tion, 10
6
 Jurkat E6.1 cells per sample were 
resuspended in 100 µL of Nucleofector So-
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lution V and peptide was added to the in-
dicated final concentration. Electro-
poration was performed in a Nucleofector 
device (AMAXA Biosystems) using the pre-
installed electroporation method “X-001”. 
Subsequently, 900 µL of RPMI medium was 
added carefully and the cells were incu-
bated for 5 min at room temperature. 
Finally, the cell suspension was washed in 
medium by centrifugation. 
 
Flow cytometry. 5 x 10
5
 electroporated 
Jurkat E6.1 cells were washed in PBS buffer 
and the median fluorescence of viable 
cells, gated based on forward and side-
ward scatter, was determined using a 
FACSCalibur System (BD Biosciences, San 
Jose, CA). 
 
Microscopy. Jurkat E6.1 cells were elec-
troporated with 30 µM peptide solutions 
as described above. After they were 
washed, 5 x 10
5
 electroporated Jurkat E6.1 
cells were transferred into 200 µL of phe-
nol red-free RPMI medium in an 8-well 
chambered coverglass (Nunc, Rochester, 
NY). After the cells had settled for 10 min, 
cells were periodically analyzed by confo-
cal laser scanning microscopy using a Leica 
SP5 confocal microscope equipped with an 
HCX PL APO 63 × N.A. 1.2 water immersion 
lens (Leica Microsystems, Mannheim, 
Germany) over a total period of 6 h. During 
this time, cells were maintained at 37 °C in 
a humidified atmosphere containing 5% 
CO2. Subsequently, the acquired images 
were analyzed by digital image processing. 
 
Image analysis. Intracellular fluorescence 
in confocal microscopy images was ana-
lyzed by digital image processing using 
ImageJ 1.41 (freeware, National Institute 
of Health (NIH), United States) and Im-
agePro (MediaCybernetics, Bethesda, MD). 
Images were smoothed and converted into 
a binary mask for extraction of cell-
associated fluorescence using fluorescence 
intensity and size thresholds. A watershed 
operation allowed the separation of adja-
cent cells. For all cells, mean intensities 
were determined and used for further 
processing. 
 
Proteolytic stability. Jurkat E6.1 cells were 
resuspended to a density of 1 x 10
7
 
cells/mL in PBS lysis buffer containing 1% 
v/v Triton-X-100 and incubated for 1 h on 
ice. Subsequently, membrane debris was 
removed by centrifugation at 20000g for 
20 min at 4 °C. A 2 µM concentration of 
the peptides SLP179, SLP228, LATpY132, 
LATpY226 or the retro-inverso peptides ri-
slp179 or ri-latY132 were added to the cell 
lysate. The samples were incubated at 37 
°C. Periodically, aliquots of 5 µL were 
taken, mixed with 95 µL of protease inhibi-
tor cocktail and frozen until further 
analysis. Finally, an aliquot of 40 U/mL pro-
teinase K (2 U in 50 µL) was added to 
determine the stability toward high prote-
ase activities and the samples were 
incubated at 37 °C for another 3 - 32 h.  
For FCS measurements, the samples were 
thawed, 900 µL of Tris buffer (100 mM 
Tris-HCl, pH 8.8) was added and aliquots of 
50 µL were transferred into a 384-well 
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plate (175 μm, low-base design, MMI). 
Fluorescence autocorrelation measure-
ments were conducted employing the FCS 
unit of the Leica TCS SP5 confocal micro-
scope equipped with an HCX PL APO 63 × 
N.A. 1.2 water immersion lens. Autocorre-
lation functions were fitted with the ISS 
Vista software, version 3.6 RC (ISS, Cham-
paign, IL), using a 3D Gaussian model 
assuming two diffusional components and 
a triplet fraction. The diffusional autocor-
relation time τD for the low-molecular 
weight component was fixed to the one 
determined for the fully degraded samples 
and τD for the high-molecular weight com-
ponent to values determined for the intact 
peptides. 
 
Intracellular FCS measurements. For intra-
cellular measurements of peptide integrity 
and breakdown, Jurkat E6.1 cells were 
washed in HBS and resuspended in buffer 
R (Invitrogen, Bleiswijk, The Netherlands) 
to 2 x 10
7
 cells/mL. LATpY132, SLP179 or ri-
slp179 was added to a final concentration 
of 5 μM and the samples were micro-
porated with three pulses of 10 ms at 1325 
V in 10 μL tips using the Neon Transfection 
System (Invitrogen). The cells were al-
lowed to recover in 500 µL of RPMI with 
10% fetal calf serum for 1 h. Subsequently 
the cells were washed three times and re-
suspended in 500 μL of phenol red-free 
RPMI without serum.  
For intracellular FCS, 200 μL of a 
microporated cell sample was transferred 
to an 8-well chambered coverglass. Posi-
tions for intracellular FCS measurements 
were identified by imaging of the cells at a 
lateral sampling rate of 481 nm (512 × 512 
pixels) using avalanche photodiode (APD) 
imaging. Inside cells, nine measurements 
of 10 s with 3 s intermissions or 15 meas-
urements of 5 s with 2 s intermissions 
were performed. After FCS measurements, 
the cells were imaged again to confirm 
that the cell had maintained its position. 
For comparison, FCS measurements of the 
respective peptides at 500 nM and 200 nM 
were also performed in solution in Tris-HCl 
(pH 8.8). 
Autocorrelation functions were fitted to a 
triplet Gausian model containing one dif-
fusing component and a triplet term with 
the GlobalsWE software (Laboratory for 
Fluorescence Dynamics, University of Cali-
fornia, Irvine, CA). For calculation of the 
detection volume, the radius ω0 and the 
structure parameter s, reflecting the ratio 
of radii along the optical axis and ω0, were 
derived from a fit to an autocorrelation 
function of fluorescein. A diffusion con-
stant of 300 μm
2
/s was assumed. The 
detection volume was calculated using V = 
π
3/2
 ω0
3
s, yielding a detection volume of 
0.17 fL. Molecule numbers N of subse-
quent intracellular measurements were 
fitted to a one-phase-exponential-decay 
model, using the software Prism Version 
4.00 (GraphPad Software Inc., La Jolla, CA), 
to determine the peptide molecule num-
ber within a cell at t = 0, before the first 
measurement started bleaching the cell. 
Concentrations were calculated by dividing 
this molecule number through the detec-
tion volume. 
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Results 
 
Electroporation of peptides with different 
physicochemical properties. Electropora-
tion has been used for the cellular import 
of peptides by us and others before 
[22,26]. However, it had not been deter-
mined to which degree electroporation 
efficiency is a function of the charge and 
hydrophobicity of the peptides. For this 
purpose, we synthesized a collection of 
peptides of about 20 amino acids in length 
that corresponded to known interaction 
motifs for SH2 and SH3 domains in T cell 
signaling (Table 1).  
All peptides were terminally capped by C-
terminal amidation and N-terminal exten-
sion with an aminohexanoic acid spacer 
and a carboxyfluorescein. Peptides varied 
in total net charge from -10 to +1. The 
 
 
Figure 1. Electroporation of peptides having comparable length and different physicochemical 
properties. Jurkat E6.1 cells were electroporated with 30 µM solutions of each peptide (Table 1) or 
fluorescein. Subsequently, the cells were washed with medium and observed by flow cytometry (A). 
The fraction of fluorescein-positive cells (B), the cell viability as determined by propidium iodide 
staining (C) and the median fluorescence per cell (D) were determined. 
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fluorescein moiety contributed -2 to this 
net charge. Jurkat E6.1 cells were electro-
porated with 30 μM peptide solutions. 
Jurkat cells were selected because they di-
rectly related to potential applications of 
these peptides as inhibitors of molecular 
interactions and because of cell growth in 
suspension.  
The fraction of fluorescence-positive cells, 
the cell viability and the median fluoresce-
in fluorescence of the cells were 
determined by flow cytometry (Figure 1). 
Electroporation was highly efficient, and 
nearly all cells were loaded with peptides. 
Cell viability, as measured by exclusion of 
propidium iodide for determination of 
membrane integrity, decreased by approx-
imately 10 - 35%. Intracellular fluorescence 
varied by about a factor of 4 between dif-
ferent peptides. In repetitions of the same 
experiment, these variations were not 
specific for a given peptide and have there-
fore to be considered as a quantitative un-
uncertainty intrinsic to the experimental 
method. There was no correlation of up-
take efficiency with peptide size or charge 
in the range of the respective parameters 
covered by this collection of peptides. 
 
Loss of intracellular fluorescence. Typical-
ly, after electroporation cells are allowed 
to recover before continuing further ex-
periments. In addition, experiments on 
cellular signaling also proceed over 
minutes to hours. For peptides intended to 
interfere with interactions in signaling, in-
tracellular retention and integrity are 
required over the time course of the ex-
periment. Therefore, for the collection of 
peptides and free fluorescein, we moni-
tored the retention of cellular fluorescence 
over time. Jurkat cells were electroporated 
Table 1. Peptides Used in This Study 
name sequence
1
 MW [Da] net 
charge
2
 
LATpY226 Fluo-Ahx-EVEEEGAPD(pY)ENLQELN-NH2 2528 - 10 
LATpY132 Fluo-Ahx-EDEDDYHNPG(pY)LVVLPDSTP-NH2 2825 - 9 
CD3zpY72/83 Fluo-Ahx-NQL(pY)NELNLGRREE(pY)DV-NH2 2868 - 6 
LATpY191 Fluo-Ahx-EASLDGSRE(pY)VNVSQEL-NH2 2446 - 6 
GAB2pY614 Fluo-Ahx-KSTGSVD(pY)LALDFQPS-NH2 2278 - 5 
PAK1_6 Fluo-Ahx-LDIQDKPPAPPMRNT-NH2 2164 - 2 
SLP179 Fluo-Ahx-SGKTPQQPPVPPQRPMAAL-NH2 2471 0 
SLP228 Fluo-Ahx-AKLPAPSIDRSTKPPLDRS-NH2 2520 0 
GAB2_509 Fluo-Ahx-QPPPVNRNLKPDRKAKPTPLD-NH2 2853 + 1 
ri-latY132 Fluo-Ahx-ptsdplvvlygpnhyddede-NH2 2745 - 8 
ri-slp179 Fluo-Ahx-laamprqppvppqqptkgs-NH2 2471 + 0 
fluorescein  332 - 2 
5(6)-carboxy-fluorescein  376 - 3 
1
Ahx: aminohexanoic acid, Fluo: 5(6)-carboxyfluorescein, -NH2: C-terminal amidation; 
2
For conju-
gated carboxyfluorescein a charge of -2 is assumed. 
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with solutions of the respected peptides at 
concentrations of 30 μM, washed and ob-
served by confocal microscopy over 6 h at 
37 °C.  
The unprocessed confocal images indi-
cated that for the highly negatively 
charged phosphotyrosine peptides, intra-
cellular fluorescence was retained 
considerably longer than for the proline-
rich peptides with a neutral or slightly 
positive net charge (Figure 2). For further 
quantitative analysis of fluorescence loss, 
the mean cell-associated fluorescence was 
determined by digital image processing.  
Fluorescence half-lives varied from ap-
proximately 1 h to more than 10 h (Figure 
3). The longest half-lives of fluorescence 
were observed for negatively charged pep-
tides (Figure 4). In contrast, hydrophobicity 
had no impact on residence time (Support-
ing Figure S1). Free fluorescein had a 
residence time of about 30 min, which was 
significantly shorter than the one of all 
peptides included in this study. In some of 
the fluorescence decay curves, we noted 
an initial increase of fluorescence. A more 
detailed analysis revealed that electro-
poration led to a transient swelling of cells,  
 
Figure 2. Loss of peptide-associated fluorescence over time. Jurkat E6.1 cells were electroporated 
with 30 μM solutions of peptides or fluorescein. Subsequently, the cells were washed twice with 
medium, transferred into 8-well chambered coverglass microscopy slides and incubated at 37 °C. 
Confocal images were generated by laser scanning microscopy at the indicated times. An average 
number of 84 ± 10 cells was imaged for each peptide. The scale bar denotes 50 μm. 
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and only after 1 to 2 h, cells had returned 
to their original volume (not shown). The 
reduction in cell volume resulted in the 
observed increase in the mean fluores-
cence per pixel.  
 
Intracellular localization of peptides. At 
this point, the question arose whether dif-
ferences in residence time were correlated 
with different subcellular localizations of 
peptides. Such differences could be indica-
tive of a sequestration of peptides with a 
long residence time into intracellular struc-
tures, which would then lead to retention 
of fluorescence inside cells. Therefore, the 
cellular distribution of fluorescence was 
addressed by high-resolution confocal mi-
croscopy, directly after electroporation 
and after a 6 h incubation time.  
Initially, for all peptides, fluorescence was 
distributed homogeneously throughout 
the cells. For peptides that were retained 
within the cells, this homogeneous distri-
bution was maintained over the full 6 h 
time course of the experiment. Only for 
those peptides, for which most of the fluo-
rescence was lost, was a heterogeneous 
distribution of fluorescence observed at 
the end of the incubation time (Figure 5). 
These results indicate that sequestration 
cannot explain the observed differences. 
 
Cellular peptide release of L- and retro-
inverso D-peptides. Because free fluo-
rescein showed a rather short residence 
time, in spite of its negative charge, we 
next considered differences in proteolytic 
breakdown as the explanation for the ob-
served differences. For this purpose, a 
phosphotyrosine-containing peptide 
(LATpY132) and a proline-rich peptide 
(SLP179), which differed in residence half-
life by more than 10 h, were synthesized as 
retro-inverso D-peptides (ri-latY132 and ri-
slp179, respectively). For economical rea-
sons, in this case, a nonphosphorylated 
analogue of the phosphotyrosine-
containing peptide was generated. Pep-
 
Figure 3. Kinetics of fluorescence loss. The peptides (A) LATpY226, (B) LATpY132, (C) CD3zpY72/83, 
(D) LATpY191, (E) GAB2pY614, (F) PAK1_6, (G) SLP179, (H) SLP228, (I) GAB2_509, and (J) fluorescein 
were electroporated into Jurkat E6.1 cells and the cells were incubated over time. The confocal im-
ages generated by laser scanning microscopy were analyzed by digital image analysis. Error bars 
correspond to the standard deviation of the mean cell-associated fluorescence. The resulting values 
were fitted with a first order exponential decay depicting the fluorescence loss of the cells. 
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tides were introduced into the cells by 
electroporation and the cellular residence 
times were determined by confocal mi-
croscopy and digital image analysis, as 
before (Supprting Figure S2).  
Both retro-inverso D-peptides, ri-latY132 
and ri-slp179, showed very long and com-
parable cellular residence half-lives > 10 h 
(Figure 6). In contrast, in agreement with 
our previous results, the L-peptides again 
showed significant differences. Whereas 
LATpY132 had a half-maximal cellular resi-
dence time longer than 10 h, SLP179 was 
exported rapidly with a half-life of 1.7 ± 0.6 
h (mean ± SD). Carboxyfluorescein again 
had a half maximal residence time < 1 h. As 
for the L-peptides with long residence 
times, fluorescence remained homoge-
nously distributed within the cells for the 
retro-inverso peptides as well (Supporting 
Figure S3). The considerable difference in 
residence times between SLP179 and ri-
slp179 indicated that rapid loss of fluores-
cence may indeed be associated with sen-
sitivity to proteolytic breakdown. 
 
Long residence times correlate with high 
proteolytic stability. To directly address 
differences in proteolytic sensitivity, the L-
peptides LATpY226, LATpY132, SLP179 and 
SLP228 and the retro-inverso counterparts 
ri-latY132 and ri-slp179 were incubated 
with Jurkat cell lysate and degradation was 
followed over time using FCS. The cell lys-
ate served as a source of proteolytic 
activity that reflected activities encoun-
tered by the peptides inside the 
cytoplasm. Autocorrelation functions were 
fitted with a two-component model that 
accounted for intact peptide and degrada-
tion product. Using a series of smaller 
peptides, we confirmed that the loss of 10 
amino acids resulted in a detectable shift 
in diffusional autocorrelation times (Sup-
porting Figure S4). 
In cell lysates, LATpY226, even though hav-
ing a slightly shorter residence time in 
comparison to LATpY132, proved to be 
more stable by a factor of 2. However, 
half-lives of both LAT-peptides were 8 - 15 
times higher than those of the SLP pep-
tides SLP179 and SLP228, demonstrating 
that a short residence time of fluorescence 
correlated with high proteolytic sensitivity 
(Figure 7). We realized that for different 
experiments, total proteolytic activity in 
the lysates varied. Therefore, experiments 
were normalized to total proteolytic activ-
ity. Moreover, the retro-inverso peptides 
were fully resistant to proteolytic degrada-
tion, further extending the validity of our 
 
Figure 4. Peptide residence half-lives in de-
pendence on the peptide net charge. Error 
bars reflect the error range of the exponential 
fits to the cellular loss of fluorescence (Figure 
3). 
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concept (Figure 7C). The stability of the 
retro-inverso peptides was further sub-
stantiated by their resistance toward 
addition of 40 U/mL proteinase K and sub-
sequent incubation for another 32 h. 
 
Intracellular FCS. We next aimed to de-
termine whether the differences in 
proteolytic sensitivity in vitro could also be 
confirmed inside living cells. Therefore, fol-
lowing electroporation of peptides, 
intracellular FCS measurements were per-
formed according to previously described 
protocols [27]. Inside cells, fluorescein-
labeled molecules were freely diffusive as 
reflected by the well-defined autocorrela-
tion functions (Figure 8). Amplitudes of 
autocorrelation functions increased with 
 
Figure 5. Time dependence of the intracellular localization of peptides. Electroporated Jurkat E6.1 
cells were observed by confocal microscopy before and after incubation of 6 h at 37 °C. The bright-
ness and contrast parameters of the images generated after 6 h were adjusted to improve the 
visualization of the intracellular distribution. The scale bar represents 20 μm. 
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subsequent measurements (Supporting 
Figure S5), reflecting a depletion of fluoro-
phores due to photobleaching as also 
detected in confocal images recorded be-
fore and after autocorrelation measure-
ments. One should note that this loss of 
fluorescence due to photobleaching is not 
related to the loss of fluorescence result-
ing from export of fluorescent peptide 
fragments. Autocorrelation functions were 
fitted with one diffusive component, which 
is the most robust method for detecting 
differences in overall molecular mobility. 
ri-slp179 had the smallest diffusion con-
stant, followed by LATpY132 and SLP179. 
The difference between SLP179 and 
LATpY132 was not as pronounced as ex-
pected from the in vitro measurements. 
However, inside cells, it was not possible 
to follow degradation kinetics. Moreover, 
some association with intracellular com-
ponents may occur. In contrast, in buffer, 
all peptides had the same diffusion con-
stant, which were all higher than those 
measured inside cells. The lower intracellu-
lar diffusion constants are a consequence 
of the higher viscosity of the cytoplasm in 
comparison to aqueous buffer. The differ-
ences in intracellular diffusion constants of 
the individual peptides can readily be ex-
plained by degradation of SLP179 resulting 
in release of a small, fluorescein-labeled 
fragment, maintenance of integrity of ri-
slp179 and partial degradation of 
LATpY132.  
By fitting the calculated fluorophore num-
bers of subsequent measurements in a 
single cell to a one-phase exponential-
 
Figure 6. Comparison of fluorescence release for L- and retro-inverso D-peptides. The cellular fluo-
rescence of Jurkat cells, electroporated with 30 µM solutions of (A) LATpY132, (B) ri-latY132, (C) 
5(6)-carboxyfluorescein, (D) SLP179 and (E) ri-slp179 peptide, was followed over time by confocal 
microscopy. The temporal decay of the mean cell-associated fluorescence, as determined by digital 
image processing, was fitted with a first order exponential function. Error bars correspond to the 
standard deviation of the mean cell-associated fluorescence. 
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decay model, it was also possible to de-
determine the internal peptide concentra-
tion before the first measurement 
(Supporting Figure S5). The average con-
centrations in the measured cells were 1.4 
± 1.2 µM (mean ± SD) for LATpY132, 270 ± 
100 nM for SLP179 and 760 ± 360 nM for 
ri-slp179. These are overestimations of the 
average concentrations in all cells in the 
respective samples, since the cells with the  
 
lowest concentrations of fluorophores 
were not suitable for multiple measure-
ments due to rapid bleaching. 
Nevertheless, the rapid breakdown and 
cellular release of SLP179 are reflected in 
these numbers, as the cells were meas-
ured 2 - 3.5 h after electroporation in the 
order presented. The average concentra-
tions in the measured cells, as a fraction of 
the concentration of 5 µM originally elec-
 
Figure 7. Proteolytic sensitivity of L- and retro-inverso D-peptides. Peptides at a concentration of 2 
µM were incubated with Jurkat cell lysate at 37 °C. At the indicated times, aliquots were taken, pro-
tease inhibitor cocktail was added and the samples were frozen until FCS measurements. The 
fraction of intact peptide was derived from two-component fits to the autocorrelation functions. To 
probe for the degradability of peptides, 40 U/mL proteinase K (addition indicated by arrows in pan-
els A and C) was added after 2 h and incubated for another 3 - 34 h at 37 °C. (A) Representative 
degradation experiment of four L-peptides. (B) Average relative half-life and SEM of the peptides 
tested in A (n = 3). The relative half-life is the half-life normalized for by total proteolytic activity in 
the lysate. Normalization was based on the sums of the half-lifes of all peptides in the respective ex-
periments. (C) representative degradation experiment including retro-inverso peptides.  
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troporated with, were 0.28 ± 0.24 (mean ± 
SD) for LATpY132, 0.05 ± 0.02 for SLP179 
and 0.15 ± 0.02 for ri-slp179. 
As can be seen from the standard devia-
tions, a wide range of cells with different 
levels of initial fluorescence was analyzed 
for each peptide. However, no correlation 
was observed between the diffusion con-
stants and the fluorophore concentrations 
in the cells.  
 
Discussion 
The results implement electroporation in 
combination with the analysis of the cellu-
lar retention of fluorescence as a straight-
forward approach for obtaining infor-
mation on intracellular peptide metabo-
lism. Electroporation efficiency was largely 
independent of the physicochemical pa-
rameters of the peptides. Initially, for all 
peptides, fluorescence was distributed 
homogenously throughout the cells. For 
peptides, for which fluorescence was re-
tained over 6 h, this homogeneous 
distribution was maintained, demonstrat-
ing that sequestration into intracellular 
structures could not account for the long 
residence time. The homogeneous distri-
bution of the fluorescein-labeled peptides 
as well as of the free fluorescein also fur-
 
Figure 8. Intracellular diffusion coefficients of electroporated peptides. Following electroporation 
of fluorescein-labeled peptides, FCS measurements were performed in individual, living cells. (A, B) 
Confocal image of a cell before (A) and after (B) intracellular FCS measurements. The location of the 
measurement is indicated by a cross hair and the scale bar is 10 µm. (C) Representative, intracellular 
autocorrelation functions of the indicated peptides normalized with respect to the autocorrelation 
amplitude. (D) Calculated diffusion coefficients (mean ± SEM) of the three peptides in Tris-HCl (n = 2) 
and in Jurkat E6.1 cells (LATpY132, n = 8; SLP179, n = 6 and ri-slp179, n = 7; with n indicating the 
number of measured cells). 
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ther validates that fluorescein does not 
aspecifically interact with intracellular 
structures [28]. Therefore, in spite of its 
acknowledged weaknesses such as sensi-
tivity to photobleaching, pH dependence 
of fluorescence and concentration quench-
ing, fluorescein is a fluorophore of choice 
for fluorescence-based analyses of intra-
cellular pharmacokinetics of small 
molecules.  
In comparison to flow cytometry, the anal-
ysis of retention of fluorescence by 
confocal microscopy had the advantage of 
requiring a significantly lower amount of 
cells. One cell population could be fol-
lowed over time. The about 100 cells that 
were present in one field of view enabled 
the quantitative analysis of cell-associated 
fluorescence by quantitative image analy-
sis. In flow cytometry, it had been required 
to remove aliquots from one larger cell 
population.  
Negatively charged peptides had the long-
est residence times. In cell lysate, the 
negatively charged LATpY132 peptide was 
also more resistant against degradation 
than the proline-rich SLP179 peptide. Gen-
erally, there is the notion that inside the 
cytoplasm, degradation of peptides occurs 
within seconds and the degradation kinet-
ics have little dependence on individual 
amino acids or on length of the peptide 
[29]. This degradation occurs through the 
interplay of endo- and aminopeptidases, 
which differ in their length require-
ments/preferences. Tripeptidylpeptidase II 
is an amino-tripeptidylpeptidase with a 
length preference of more than 15 amino 
acids [30]. Thimet oligopeptidase (TOP) 
cleaves peptides of less than 17 amino ac-
ids in length with preference for those 
containing 7 - 14 amino acids [14], which 
are then further degraded by amino-
peptidases [31-33]. In spite of the rather 
broad substrate specificity of these pepti-
dases, individual peptides are nevertheless 
enriched to high enough concentrations to 
be detected in cell lysates by proteomic 
techniques and are poor substrates for 
TOP in spite of their appropriate length 
[17].  
Very clearly, there seems to be an as of yet 
largely unexplored repertoire of peptides 
that make poor substrates for the entirety 
of protease activities, thereby demonstrat-
ing that inside the cell, there is a niche for 
peptides to escape degradation. Most im-
portantly, the intracellular proteolytic 
stability of this specific pool of peptides
 
may be related to their endogenous bio-
logical function [34]. 
Research on cellular peptides so far fo-
cused rather on mechanisms of 
degradation in the context of antigen 
presentation rather than stabilization 
against degradation. To which degree, 
binding to high molecular weight proteins 
or sequestration inside the nucleus is a 
prerequisite has to be explored further 
[15,35]. The documented specific biologi-
cal activity of peptides introduced into the 
cytoplasm by electroporation in concentra-
tions in the lower micromolar range can 
also be considered clear functional coun-
terevidence of a generalized rapid 
breakdown [22-26].
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In our case, peptides were longer than TOP 
substrates and this characteristic might 
contribute to the stability of these pep-
tides. Moreover, the N-terminal 
fluorescein label blocks degradation by 
amino-peptidases and possibly also com-
promises accessibility by tripeptidyl-
peptidase II. Additionally, it has been 
shown before that phosphorylation pro-
tects peptides from degradation by TOP, 
which may provide an explanation for the 
higher stability of phosphotyrosine-
containing peptides [36]. A high negative 
net charge, as was the case for our collec-
tion of peptides, does not seem a 
prerequisite for intracellular stability as 
peptides isolated from cell lysates had an 
average net charge of -1 to 0 (Supporting 
Figure S6) [17]. 
FCS proved to be a highly powerful meth-
od for probing peptide breakdown, bothin 
lysates and inside cells. The method is sep-
aration-free, thereby obviating the need of 
separating degradation products and in-
tact peptides as is the case for standard 
HPLC-based methods. Furthermore, the 
sensitivity of the method permitted us to 
follow degradation at nanomolar concen-
trations. As a consequence, the sample 
size could be reduced significantly, ena-
bling the use of cell lysates as a source of 
proteolytic activity. In lysates, autocorrela-
tion functions were fitted with a two-
component model accounting for intact 
molecules and fully degraded peptide. 
While this is a simplification that did not 
account for the presence of partially de-
graded peptides, the results demonstrated 
that this model readily enabled a detection 
of differences in stability. Nevertheless, it 
is important to realize that the half-lives 
determined in this experiment do not re-
flect absolute half-lives of the peptides 
inside cells. Cell lysates were adjusted to a 
density that yielded breakdown kinetics 
that could be conveniently followed over 
time. 
From the amplitudes of the autocorrela-
tion functions, also intracellular peptide 
concentrations were extracted. To correct 
for photobleaching, we employed a proto-
col in which the initial concentration in the 
absence of bleaching is extrapolated from 
a monoexponential fit to molecule num-
bers obtained from subsequent measure-
ments. With an extracellular concentration 
of 5 µM for electroporation, intracellular 
concentrations of about 1 µM were 
reached, demonstrating that electropora-
tion is able to deliver peptides in a 
concentration at which, with binding con-
stants in the lower micromolar range, 
activity as inhibitors may be expected. 
In summary, our results introduce electro-
poration as a powerful means to dissect 
the intracellular pharmacokinetics of pep-
tides with respect to intracellular break-
down. Cellular export of fluorescence was 
directly related to proteolytic sensitivity of 
the peptides. Measurement of cellular loss 
of fluorescence therefore constitutes an 
easily accessible surrogate parameter for 
addressing of intracellular peptide stabil-
ity. An exception will apply to those 
peptides that rapidly exit the cells also in 
the intact state. Quite noteworthy, our 
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method required the introduction of only 
one fluorophore. So far, fluorescence-
based analyses of peptide stability re-
quired the synthesis of quenched peptides 
carrying two fluorophores. The introduc-
tion of a second fluorophore is associated 
with a significant additional synthesis ef-
fort [37]. Moreover, introduction of an 
additional fluorophore may more strongly 
affect the behavior of the peptide in com-
parison to the unlabeled one.  
All peptides included in this study corre-
sponded to interaction motifs of protein 
binding domains and therefore constitute 
potential candidates as competitive inhibi-
tors of protein-protein interactions inside 
cells. However, the peptides varied con-
siderably in their proteolytic stability as re-
flected by their intracellular residence half-
lives. Taking account of the intracellular 
pharmacokinetics of peptides is therefore 
an important element in the development 
of peptides and peptide-mimetics as in-
hibitors of intracellular interactions. Our 
results are therefore of major significance 
for the development of peptide-based 
therapeutics.  
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Supporting Information 
 
 
Figure S1. Correlation of residence times with net charge (A) and total hydrophobicity (B). Hydro-
phobicity is expressed by the CCS scale, a combined consensus hydrophobicity scale. It was derived 
from two consensus scales; a general consensus scale (GCS) based on 160 normalised and filtered Hi 
scales of all types found in the literature, and an experimental consensus scale (XCS) based on 
33normalized and filtered Hi literature scales obtained by experimental methods [38]. 
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Figure S2. Loss of fluorescence after electroporation of L- and retro-inverso D-peptides. Jurkat 
E6.1 cells were electroporated with peptides or 5(6)-carboxyfluorescein. The cells were washed 
twice with medium, seeded into 8-well chambered coverglass microscopy slides and were incu-
bated at 37 °C and observed by laser scanning microscopy. The scale bar represents 50 μm. 
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Figure S3. The intracellular localization of L- and retro-inverso D-peptides in dependence on incuba-
tion time. Jurkat E6.1 cells were electroporated with 30 µΜ solutions of the peptides (A,F) LATpY132, 
(B,G) ri-latY132, (C,H) SLP179, (D,I) ri-slp179 and (E,J) 5(6)-carboxyfluorescein and observed by con-
focal microscopy (A-E) before and (F-J) after incubation of 6 h at 37 °C. The brightness and contrast 
parameters of the images generated after 6 h were adjusted for all peptides to improve the visualiza-
tion of the intracellular distribution. The scale bar represents 20 μm 
 
 
 
 
Figure S4. Dependence of diffusional autocorre-
lation times from peptide length. Next to the 
original 20-amino acid SLP179 peptide, autocorre-
lation measurements were performed for a 
fragment comprising the first 10 amino acids and 
a 4-amino acids N-terminal fragment. 
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Figure S5. Determination of intracellular molecule numbers for calculation of intracellular concen-
trations. (A) Subsequent FCS measurements of 10 s each. The autocorrelation amplitude increases 
with each measurement due to photodepletion of fluorophores. (B) Monoexponential fit to the 
molecule numbers derived from the amplitudes of subsequent autocorrelation measurements. The 
amplitude of a given autocorrelation measurement corresponds to the average over the total meas-
urement interval. Therefore, the molecule number for the first measurement, from 0 – 10 s was 
placed at 5 s and so forth. The molecule number in the absence of any photobleaching was deter-
mined by extrapolation towards t = 0. Using the detection volume, these molecule numbers were 
converted into intracellular concentrations. 
 
 
 
 
Figure S6. Net charge of endogenous peptides 
isolated from cell lysates of HEK293 cells and 
identified by mass spectrometry. The graph 
was compiled from data published by Berti et 
al. [39]. 
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CHAPTER 4: 
MULTIVALENT PRESENTATION OF THE CELL-PENETRATING PEPTIDE 
NONA-ARGININE ON A LINEAR SCAFFOLD STRONGLY INCREASES ITS 
MEMBRANE-PERTURBING CAPACITY 
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ABSTRACT  
Arginine-rich cell-penetrating peptides 
(CPP) are widely employed as delivery ve-
hicles for a large variety of macro-
molecular cargos. As a mechanism-of-
action for induction of uptake cross-linking 
of heparan sulfates and interaction with li-
pid head groups have been proposed. 
Here, we employed a multivalent display 
of the CPP nona-arginine (R9) on a linear 
dextran scaffold to assess the impact of 
heparan sulfate and lipid interactions on 
uptake and membrane perturbation. In-
creased avidity through multivalency 
should potentiate molecular phenomena 
that may only play a minor role if only in-
dividual peptides are used. To this point, 
the impact of multivalency has only been 
explored for dendrimers, CPP-decorated 
proteins and nanoparticles. We reasoned 
that multivalency on a linear scaffold 
would more faithfully mimic the arrange-
ment of peptides at the membrane at high 
local peptide concentrations. On average, 
five R9 were coupled to a linear dextran 
backbone. The conjugate displayed a direct 
cytoplasmic uptake similar to free R9 at 
concentrations higher than 10 µM. How-
ever, this uptake was accompanied by an 
increased membrane disturbance and cel-
lular toxicity that was independent of the 
presence of heparan sulfates. In contrast, 
for erythrocytes, the multivalent conjugate 
induced aggregation, however, showed 
only limited membrane perturbation. 
Overall, the results demonstrate that 
multivalency of R9 on a linear scaffold 
strongly increases the capacity to interact 
with the plasma membrane. However, the 
induction of membrane perturbation is a 
function of the cellular response to pep-
tide binding.  
 
 
Introduction  
Conjugation to cell-penetrating peptides 
(CPPs) is considered a highly promising 
strategy to mediate cellular delivery of 
molecules that otherwise poorly enter cells 
[1-3]. Natural and synthetic CPPs are con-
tinuously being (re-)designed to improve 
delivery [4, 5]. In contrast to the original 
concept of the CPP acting as a Trojan horse 
that passages passively through the plas-
ma membrane by virtue of its structural 
characteristics it has become clear that 
with the exception of direct membrane 
permeation at low concentrations [6, 7] 
CPPs actively induce cellular uptake [8]. In 
particular for large molecular weight car-
gos, endocytosis is the route of uptake [9]. 
Furthermore, at concentrations above 
about 10 µM, arginine-rich CPPs induce ac-
tivation of acid sphingomyelinase, which 
leads to rapid cytoplasmic import via 
ceramide-rich membrane microdomains 
[10, 11]. 
While the molecular mechanism underly-
ing the activation of acid sphingomyelinase 
has not been resolved, for induction of en-
docytosis, it has been proposed that 
binding to negatively charged oligosaccha-
rides of the glycocalyx leads to a clustering 
of syndecans [12], which activates Rac-
dependent actin remodeling [13]. Howev-
er, uptake is also observed for cells that 
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are poor in glycosaminoglycans such as 
Jurkat T cell leukemia cells which calls for 
the involvement of additional processes 
[11].  
Strikingly, in spite of its activity as a CPP, 
for nona-arginine (R9) little to no enrich-
ment at cellular membranes is observed. 
Only when internalization is compromised, 
a staining of the plasma membrane is visi-
ble which can be attributed to the 
interaction with glycosaminoglycans [14]. 
This indicates that in spite of a document-
ed ability to interact with the head groups 
of the lipid bilayer and the capacity to par-
tition into a hydrophobic environment in 
the presence of negatively charged chelat-
ing groups [15-17], on cells there is little 
enrichment at the level of the plasma 
membrane. Also, among a panel of nine 
tested CPPs R9 had the least membrane-
disruptive potential [18], overall indicating 
that enrichment at the plasma membrane 
plays only a small role in the uptake of this 
CPP. 
The geometry in which positive charge is 
presented greatly influences uptake effi-
ciency. On one hand, it has been 
demonstrated that import can be en-
hanced through rigidifying the peptide 
backbone through cyclization [19]. On the 
other hand, multivalency is a well-
established principle to potentiate molecu-
lar interactions through introduction of 
avidity [20-22]. Multivalent interactions in 
nature include binding of DNA at several 
sites by transcription factors, like the ret-
inoid X receptor [20] or immunogenic 
recognition by multivalent antibodies such 
as IgM [23]. In the context of CPPs, 
oligoarginines are an example for a multi-
valent display of the guanidino-group and 
up to a certain length, activity of oligo-
arginines increases with the number of 
residues [24, 25]. With respect to a multi-
valent display of CPPs, multivalency has 
been investigated for TAT, oligolysine, 
HSV-1 VP22, oligoarginine, Antp, (reviewed 
in [26]), zinc coordinated oligotyrosine 
peptides [27] and recently for TP10, pVEC 
and polyproline helix SAP [28]. A tetrava-
lent presentation of deca-arginine fused to 
the p53 protein was shown to improve de-
livery efficiency even at low concentrations 
without increasing toxicity [29]. In the lat-
ter study, this increased activity was 
associated with enhanced interactions 
with cell surface heparan sulfates. Howev-
er, these multivalent arrangements were 
either based on globular scaffolds or 
branched dendrimers, geometries that 
confine the area of interaction with the 
membrane components of the cell. To be 
effective for promoting uptake, a stretch 
of arginines has to be present. A dispersed 
presentation of individual arginines on a 
polymer results in considerably reduced 
uptake also at higher charge density [30]. 
Overall, the multivalent geometries that 
have been investigated so far for CPPs are 
more restricted than those addressed for 
antimicrobial peptides for which presenta-
tion along linear scaffolds has also been 
investigated, already [31]. 
In all these applications, the multivalent 
CPPs were well tolerated, showing little 
signs of toxicity. Also, individual oligo-
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arginine peptides are generally well toler-
ated to concentrations in the mean 
micromolar range [11, 24]. 
Beyond yielding a benefit in efficiency, so 
far, the multivalent display of CPPs has 
yielded little insights into the molecular 
mechanisms triggering import. Also, no 
functional characteristics were reported 
that differed greatly for those of the indi-
vidual CPPs. As for individual CPPs, it has 
been proposed that the multivalent sys-
tems crosslink glycosaminoglycans follow-
ed by endocytosis [32]. This may be due to 
the globular nature of these structures 
that renders them very similar to CPPs 
linked to macromolecules.  
Therefore, in the present study we com-
pared a multivalent configuration of nona-
arginine (R9) in which on average five cop-
ies of the CPP were coupled to a linear and 
flexible dextran backbone (Dex-(R9)5) to 
the monovalent R9 counterpart. We hy-
pothesized that in comparison to multi-
valent displays on globular structures, this 
configuration would result in contact of 
the molecule with a larger surface area of 
the plasma membrane or in a structurally 
adaptive binding due to the flexibility of 
the dextran backbone. In particular, we 
hoped that this configuration would shed 
further light into the structural require-
ments for triggering the rapid sphingo-
myelinase-dependent uptake mechanism. 
All data presented so far, indicated that 
this import route is restricted to free CPPs 
or CPPs conjugated to small molecular 
weight cargo [9, 10]. 
Next to addressing uptake and toxicity for 
HeLa and Jurkat cells we also included hu-
man erythrocytes in our studies. These 
cells lack endocytosis and should therefore 
reveal to which degree a membrane-
disruptive activity is a function of the con-
jugate-membrane interaction or the 
triggering of a cellular response. Since 
multivalency can generate strong interac-
tions for low affinity binders, we also 
addressed whether inside the cell the mul-
tivalent display of R9 leads to the 
disruption of protein-protein interactions. 
Our results demonstrate that the multiva-
lent display strongly enhances interactions 
with the plasma membrane. The re-
striction of toxicity to cells that show 
uptake demonstrates that toxicity is a con-
sequence of the reaction of the cells to 
these conjugates. Interactions of the con-
jugates with the plasma membrane alone 
are insufficient to evoke strong toxicity.  
 
 
Experimental Procedures 
 
Reagents 
Nona-arginine (R9) with an amidated C-
terminus and an N-terminal carboxy-
fluorescein was purchased from EMC 
microcollections (Tübingen, Germany). 
Dex-(R9)5 was synthesized using a 10 kDa 
dextran (Dex) backbone comprising on av-
erage of 62 glucose monomers. 
Carboxyethyl groups were introduced us-
ing acrylamide followed by amide 
hydrolysis to form 2-carboxyethyl dextran 
(CED). N-(2-aminoethyl)maleimide was 
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synthesized and coupled to the modified 
polymer. Using maleimide-thiol coupling, 
in a single step N-cysteinyl-lysinyl-5(6)-
carboxyfluorescein and N-cysteinylnona-
arginine amide were coupled to the modi-
fied dextran achieving an average loading 
of five nona-arginine peptides and one 
fluorophore per polymer as determined by 
quantitative amino acid analysis and NMR 
[22]. Dex-(R9)5 had a final molecular 
weight of 22 kDa (for details see Support-
ing Information S1). Dex and CED were 
used as negative controls. Imipramine, 
resazurin and Tween-20 were from Sigma-
Aldrich (Zwijndrecht, the Netherlands). 
Propidium iodide and Alexa-647-labeled 
Annexin-V were from Invitrogen (Eugene, 
USA) and Ficoll-Paque from GE Healthcare 
(Uppsala, Sweden). Complete Ringer (pH 
7.4) solution was prepared using 32 mM 
HEPES, 125 mM NaCl, 5 mM glucose, 5 
mM KCl, 1 mM MgSO4, 2.5 mM CaCl2. 
 
Tissue culture 
Jurkat T cell leukemia cells (ACC-282, 
DSMZ, Braunschweig, Germany) and HeLa 
cells (CCL-2, ATCC, LGC Standards, Wessel, 
Germany) were cultured in RPMI1640 with 
stable glutamine and 2.0 g/L NaHCO3 (PAN 
Biotech, Aidenbach, Germany) supple-
mented with 10% heat inactivated fetal 
bovine serum (FBS; PAN Biotech). Cells 
were maintained at 37 °C in a humidified 
incubator containing 5% CO2. Jurkat cells 
were passaged every 2 - 3 days when the 
cells had grown to a density of approxi-
mately 4 × 10
5 
cells/mL while HeLa cells 
were passaged every 2 days at around 80% 
- 90% confluency. 
 
Confocal microscopy 
Confocal laser scanning microscopy was 
performed on a TCS SP5 confocal micro-
scope (Leica Microsystems, Mannheim, 
Germany) equipped with an HCX PL APO 
63× 1.2 N.A. water immersion lens. Cells 
were maintained at 37 °C on a tempera-
ture-controlled microscope stage. For 
multichannel recordings with propidium 
iodide (PI) or Annexin-V in addition to the 
labeled R9 or Dex-(R9)5, images were rec-
orded using the 488 nm line of an argon-
ion laser and a HeNe 561 or 633 nm laser. 
To avoid crosstalk, fluorescence was rec-
orded sequentially where necessary. 
 
Dex-(R9)5 uptake 
HeLa cells (4 × 10
4
/well) were seeded in 8-
well microscopy chambers (Nalge Nunc In-
ternational, New York, USA), 24 hours 
prior to peptide addition. Cells were incu-
bated with 4 µM Dex-(R9)5 or 20 µM R9 in 
RPMI 1640 supplemented with 10% FBS 
(heat inactivated) for 20 minutes. For as-
sessing the effect of imipramine on 
peptide uptake, cells were pre-incubated 
for 45 minutes with 30 µM imipramine in 
RPMI 1640 without serum. For subsequent 
incubation with peptide, 30 µM imipra-
mine was co-incubated with peptide in 
medium containing 10% FBS. Cells were 
washed twice with medium. To check for 
membrane-integrity as well as cell viability, 
cells were incubated with 5 µg/mL PI and 
immediately imaged by microscopy. For 
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studies in Jurkat cells, 200 µL of a 5 × 10
5
 
cells/mL Jurkat cell suspension in RPMI 
1640 without phenol red and 10% FBS 
were transferred per well into 8-well mi-
croscopy chambers coated with a 20 
μg/mL fibronectin solution in PBS for 30 
minutes at room temperature (RT). At time 
point t = 0, 5 μM or 10 μM of R9 or 1 μM 
or 2 μM of Dex-(R9)5 were added to the 
wells. 
 
Image enhancement 
Image J (version 1.46j, freeware, NIH) was 
used to modify brightness and contrast of 
the confocal microscopy images. 
 
Image quantification 
Image J (version 1.46j, freeware, NIH) was 
used to analyze the confocal microscopy 
images. Images were first smoothened and 
then converted into a binary mask using 
thresholds for fluorescence intensity and 
size. This mask was used to extract cell-
associated fluorescence in the original 
background-corrected images. To separate 
adjacent cells a watershed function was 
applied to the binary mask. Mean intensi-
ties (represented as intracellular fluor-
escence) were measured from all cells 
within one image frame (at least 50 cells 
were analyzed).  
 
Cytotoxicity assay 
HeLa cells (7.5 × 10
3
 cells/well) were seed-
ed in 96-well microtiter plates and grown 
overnight. The next day, cells were treated 
with varying concentrations of R9/Dex-
(R9)5/Dex/CED for 24 hours at 37 °C. Cell 
viability was measured using the resazurin 
assay. Resazurin is a non-fluorescent dye 
that is reduced to the highly fluorescent 
resorufin by metabolically active cells [33, 
34]. Cells were incubated with resazurin 
(100 µg/mL) for 4 hours. Fluorescence was 
read with a Synergy 2 single-channel 
microplate reader (BioTek Instruments, 
Winooski, USA). Percentage cell viability 
was calculated as [(Ti–T0)/(C–T0)]×100 for 
concentrations in which Ti ≥ T0 and [(Ti-
T0)/T0]×100 for concentrations in which Ti 
< T0. Ti is the fluorescence of the test-well 
after a 24-hour period of exposure to the 
treatment, T0 is the fluorescence at time 
zero (i.e. before addition of compounds) 
and C is the fluorescence after 24 hours of 
cell seeding. This parameter can have val-
ues from +100 to -100 [35].  
 
Effect of Dex-(R9)5 on erythrocytes 
Blood was drawn from healthy volunteers. 
The study was performed following the 
guidelines of the local medical ethical 
committee and in accordance with the 
declaration of Helsinki. Written informed 
consent was obtained from all blood do-
nors participating in this study. To isolate 
erythrocytes, fresh blood was centrifuged 
at 1500 × g for 10 minutes. Erythrocyte 
pellets were washed twice with calcium-
free Ringer to prevent complement activa-
tion and once with complete Ringer. 
Erythrocytes were resuspended in 100 µL 
Ringer and diluted to 1 million cells/well in 
chambered coverslips. R9 or Dex-(R9)5 
were added to the cells in an equal volume 
of Ringer at the indicated concentrations 
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and imaged by time lapse confocal micros-
copy. Alexa-647-labeled Annexin-V was 
also added at a dilution of 1:25. Cells were 
manually counted to quantify exposure of 
phosphatidylserine, changes in morpholo-
gy and lysis. 
 
Impact of Dex-(R9)5 on protein-protein in-
teractions 
In order to induce activation-dependent 
protein complex formation, Jurkat cells 
were treated with 0.5 mM of the broad-
range phosphatase inhibitor pervanadate 
(PV) in HBS or as a control with HBS for 10 
minutes at 37 °C. Cell lysates were pre-
pared by suspending 1 million cells per 
subarray in 50 µL lysis buffer (1% Triton X-
100, 50 mM n-octyl-D-glucopyranoside 
(Fluka, Taufkirchen, Germany), 20 mM Tris, 
1 mM EDTA, 150 mM NaCl, 1 mM Na3VO4, 
pH 7.5, and complete protease inhibitor 
cocktail (Roche Applied Science, Mann-
heim, Germany)). N-octyl-D-gluco-
pyranoside ensured the efficient extraction 
of signaling proteins from lipid rafts. After 
lysis on ice for 1 hour, the crude lysates 
were cleared by centrifugation at 20,000 × 
g at 4 °C for 15 minutes. Afterwards, 5 µM 
R9 or 1 µM Dex-(R9)5 was added to cell ly-
sate. Finally, lysates were incubated on 
microarrays as described below. Peptide 
microarrays presenting known interaction 
motifs for proteins involved in T cell signal-
ing were prepared as described before 
[36]. One microarray substrate carried 16 
identical subarrays. For incubation of these 
subarrays with different samples a 16-well 
clip-on frame (ProPlate Multiarray System, 
Grace Biolabs, Molecular Probes, Eugene, 
OR, USA) was mounted onto the microar-
ray slides. Microarrays were incubated 
with 50 µL of lysate from 1 million cells per 
subarray for 1 hour at 4 °C and washed 
three times with washing buffer (PBS, 
0.05% (wt/vol) BSA, 0.05% (wt/vol) Tween-
20). For the detection of bound protein by 
indirect immunofluorescence, microarrays 
were incubated with 2 µg/mL primary an-
tibody (α-PLCγ1, Santa Cruz Biotechnology, 
Heidelberg, Germany, sc-81; α-LAT, Milli-
pore 05-770, Schwalbach, Germany) 
diluted in washing buffer for 15 minutes at 
RT and washed three times with washing 
buffer. Afterwards, microarrays were incu-
bated with 1 µg/mL secondary goat-anti-
rabbit antibody conjugated with Alexa-633 
and goat-α-mouse secondary antibody 
conjugated with Alexa-546 (A21070, 
A11003, Invitrogen) for 10 minutes at RT 
followed by a final washing step with 
washing buffer. As a negative control, one 
subarray was immunostained without in-
cubation with lysate. Finally, microarrays 
were dried with nitrogen and scanned 
(ProScanArray, PerkinElmer Life Sciences, 
Waltham, MA, USA). Processing of the sig-
nals occurred as described previously using 
ArrayPro Analyzer (Media Cybernetics, Sil-
ver Spring, MD, USA) [36]. Signals on 
microarrays were obtained by subtraction 
of the median signal of a local ring-shaped 
background from the mean of signal inten-
sities on a peptide spot. 
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Results  
 
Dex-(R9)5 exhibits sphingomyelinase-
dependent uptake and nucleolar staining 
Previous work on multivalent cationic pep-
tides and protein transduction domains 
elucidated that multivalency greatly im-
proves cellular import of these conjugates 
[29]. Uptake occurred by endocytosis, con-
sistent with the general assumption 
according to which macromolecular CPP-
complexes and conjugates are taken up 
along this route and direct translocation 
and rapid cytoplasmic uptake are restrict-
ed to free CPPs and CPPs conjugated to 
small molecular weight cargo [9, 10]. How-
ever, so far, multivalent configurations 
were nanoparticulate, potentially restrict-
ing the ability of these molecules to 
engage with larger areas of the plasma 
membrane. Therefore, we here synthe-
sized a highly flexible multivalent CPP 
conjugate by coupling on average five cop-
ies of nona-arginine to a 10-kDa dextran 
backbone. A fluorescein moiety was intro-
duced to monitor the cellular distribution 
and uptake.  
HeLa cells were incubated with 20 µM R9 
or 4 µM Dex-(R9)5, corresponding to the 
same concentration of CPP and the distri-
  
 
Figure 1. Cellular distribution 
and imipramine-sensitive up-
take of Dex-(R9)5. (A) Following 
a 45 minute pretreatment 
with/without imipramine (imi) in 
serum-free RPMI, HeLa cells 
were incubated with 20 μM R9 
or 4 μM Dex-(R9)5 for 20 
minutes at 37 °C in the presence 
or absence of 30 μM imipramine 
followed by washing and imaging 
with confocal microscopy. Mi-
croscopy settings for image 
acquisition of all samples were 
adjusted for R9 to avoid satura-
tion. One confocal slice is shown 
for all the microscopy images. 
Scale bars correspond to 20 μm. 
One representative experiment 
of at least three experiments is 
shown. Homogenous staining of 
R9 is observed in 70% of cells 
(for whole field-of-view of imag-
es see Supporting Infromation 
S2). Brightness and contrast have 
been   adjusted  for  visualization 
purposes using the same parameters for fluorescence images and parameters to yield the best pos-
sible result for transmission images. (B) Imipramine-sensitive uptake quantified from A (raw, 
unmodified images); at least 50 cells were counted. Error bars represent S.E. 
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bution of fluorescence was observed by 
confocal microscopy in living cells. As re-
ported before, at this concentration R9 
exhibited a uniform homogeneous staining 
of cells with only few endocytic vesicles 
[11] (Figure 1 and Supprting Information 
S2). This is the typical distribution of fluo-
rescence observed for sphingomyelinase-
dependent import through nucleation 
zones [10, 11]. Also for Dex-(R9)5 cells 
showed an intense cytoplasmic fluores-
cence, however, this fluorescence was 
distributed less homogenously than for R9 
and also showed a distinct nucleolar stain-
ing as was observed for the D-amino acid 
analog of R9 [14]. Areas of more intense 
fluorescence were reminiscent of nuclea-
tion zones. Also, cell shapes were more ir-
regular for Dex-(R9)5-treated cells than for 
cells incubated with free peptide, suggest-
ing a stronger membrane-perturbing effect 
of the multivalent conjugate. Interestingly, 
cell-associated fluorescence for Dex-(R9)5 
was about the same as for R9 (Figure 1B). 
Considering, that one conjugate carried 
one fluorophore for five peptides, this in-
dicates that on a per-peptide basis, uptake 
was in about the same range (maximum 
five fold higher per peptide) than for R9. 
 
Sensitivity to imipramine which acts as an 
inhibitor of acid sphingomyelinase was 
identified as a characteristic of nucleation 
zone-dependent uptake [10]. However, as 
 
 
Figure 2. Uptake of Dex-(R9)5 is associated with only partial loss of membrane integrity. HeLa cells 
were treated with 4 μM Dex-(R9)5 or 20 μM R9 for 20 minutes at 37 °C in the presence or absence 
of 30 μM imipramine (imi) as stated before. After washing, PI (5 μg/mL) was added and cells were 
imaged without any further washing step by confocal microscopy. Tween-20 (0.25%) was used as a 
positive control for membrane disruption. Scale bars correspond to 20 μm. Brightness and contrast 
have been adjusted for visualization purposes using the same parameters for fluorescence images 
and parameters to yield the best possible result for transmission images. 
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detailed above this route of uptake was 
limited to free CPPs or CPPs conjugated to 
small cargos [9, 10]. A polymer-conjugate 
of similar size but with only 3 nona-
arginines was unable to enter via this 
route [37, 38]. To investigate whether Dex-
(R9)5 nevertheless exploited this mecha-
nism or whether uptake occurred as a 
consequence of membrane disruption, up-
take was assessed in the presence of 
imipramine. Imipramine abolished cyto-
plasmic fluorescence of both, R9 and Dex-
(R9)5 in a major part of cells supporting a 
role of sphingomyelinase-dependent up-
take in both cases (Figure 1 and Supporting 
Information S2). To exclude that the reduc- 
 ing effect was due to an interference of 
the imipramine with the pep-
tides/conjugate at the plasma membrane, 
we compared the effect of a pre-
incubation with imipramine with the one 
of a pre- and co-incubation. Indeed, in the 
latter case the reduction was stronger 
demonstrating that some direct interfer-
ence occurs (Supporting Infromation S3). 
 
Considering the more irregular cell shape 
for the Dex-(R9)5-treated cells we also 
probed for membrane damage which does 
not occur for sphingomyelinase-dependent 
uptake [11]. Cells were exposed to conju-
gates for 20 minutes and after washing PI 
was added to monitor changes in mem-
brane integrity. For the multivalent 
conjugate there was a loss of membrane 
integrity for some cells (Figure 2). Remark-
ably, the number of PI-positive cells was 
decreased by the presence of imipramine 
indicating that membrane damage is a 
consequence of uptake rather than the in-
teraction of the conjugate with the plasma 
membrane (Figure 2). This increased 
membrane-disruptive potential was also 
reflected by a higher reduction in cell via-
bility over a 24-hour incubation (Figure 3). 
A strong reduction in cell viability was no-
ticed for 1 μM Dex-(R9)5 (corresponding to 
an overall peptide concentration of 5 μM) 
compared to 11 μM R9 over 24 hours. Dex 
and CED, which were used as negative 
controls, did not show any significant tox-
icity indicating that neither the native nor 
the carboxyethylated dextran backbone 
were responsible for the toxicity of Dex-
 
Figure 3. Multivalency of nona-arginine in Dex-
(R9)5 increases toxicity. HeLa cells were treat-
ed with the indicated concentrations of Dex-
(R9)5 (with respect to the polymer backbone) 
for 24 hours and cell viability was determined 
using a resazurin assay in comparison to R9. 
CED (carboxyethyl dextran) and Dex (native 
dextran) were used as controls. Data represents 
average ± SEM of three independent experi-
ments, each carried out in triplicate, which 
means N = 9. 
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Figure 4. Time lapse 
microscopy of the 
membrane-disruptive 
behavior of Dex-
(R9)5 in Jurkat cells. 
Jurkat cells were ex-
posed to (A) 5 μM R9, 
(B) 10 μM R9, (C) 1 μM 
Dex-(R9)5 and (D) 2 μM 
Dex-(R9)5 at 37 °C and 
fluorescence and 
transmission recor-ded 
with 2 images/min. 
Concentrations of Dex-
(R9)5 were with respect 
to the polymer back-
bone. CED of 2 μM (E) 
was used as control. 
Peptide/conjugate was 
added at the time of 
image acquisition by 
careful pipetting into 
the sample. The start of 
exposure of cells to 
peptide/conjugate is 
visible from the in-
crease in fluorescence 
outside the cells. Scale 
bars correspond to 
25 μm. Also see Sup-
porting Information S4, 
Videos S4-M1 to M5. 
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(R9)5.  
HeLa cells have a high density of heparan 
sulfates and other negatively charged oli-
gosaccharides [38] that serve as binding 
sites for arginine-rich peptides [39]. We 
were therefore interested to assess the 
impact of the linear, multivalent Dex-(R9)5 
conjugate on Jurkat T cell leukemia cell 
that express significantly lower levels of 
heperan sulfates [38]. At 5 µM (Figure 4A 
and Supporting Information s4 Video S4-
M1), over time course of the experiment, 
R9 showed only internalization in a few 
cells with no signs of toxicity. At 10 µM 
(Figure 4B and Supporting Infromation S4 
Video S4-M2), R9 fluorescence rapidly en- 
 
 
Figure 5. Dex-(R9)5 induces erythrocyte aggregation and phosphatidylserine exposure. (A) 0.6 μM 
Dex-(R9)5 and 6 μM R9 were added to erythrocytes in Ringer and imaged by confocal microscopy at 
37 °C after 20 minutes. Annexin-V was also added to cells at a dilution of 1:25 to stain for 
phosphatidylserine. Scale bars correspond to 50 μm. (B) Erythrocyte aggregates formed after the 
addition of 0.6 μM Dex-(R9)5. The scale bar corresponds to 10 μm. Also see Supporting Information 
S5 Videos S5-M6 and S5-M7. 
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tered the cytoplasm reminiscent of nuclea-
tion zone-dependent uptake [11]. For the 
free peptide, uptake occurred in the ab-
sence of visible membrane staining. In 
contrast, Dex-(R9)5 (Figures 4C, 4D and 
Supporting Information S4 Videos S4-M3 
and S4-M4), already at a concentration of 
1 µM with respect to backbone caused 
massive membrane staining and cell death 
accompanied by formation of membrane 
blebs Control CED had no effect on cell vi-
ability (Figure 4E and Supporting Infor-
mation S4 Video S4-M5). 
 
Dex-(R9)5 but not R9 binds to erythrocyte 
membranes and induces cell aggregation 
Concomitant with increased toxicity, for 
Dex-(R9)5 we observed an increased mem-
brane staining which was absent for R9. 
Two possible explanations were consid-
ered for this membrane staining. First, the 
multivalent display of guanidino-groups 
could afford sufficient avidity for interac-
 
Figure 6. Impact of R9 and Dex-(R9)5 on protein–protein interactions. Peptide microarrays were in-
cubated with Jurkat cell lysates in the presence and absence of free R9 or the conjugate. Colored 
squares indicate ratios of signals of treated cell lysates over untreated lysates on respective peptides 
and respective coefficients of variation (CV). A cross relates to a signal that was lost in the presence 
of peptide or conjugate. Cells were either resting (HBS) or stimulated with the broad-range phospha-
tase inhibitor pervanadate (PV). All data are mean values of three independent experiments. Shown 
are those nine out of thirty one peptides on the arrays for which signals could be observed. 
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tion with the plasma membrane also in the 
absence of a massive disturbance. Second, 
staining could be a consequence of the 
membrane-disruptive effect of the conju-
gate, leading to exposure of negatively 
charged phosphatidylserine that would 
then in turn lead to a membrane accumu-
lation of the peptide. In this second case, it 
would be interesting to learn whether dis-
ruption was again a function of the peptide 
alone, or of the cellular response to the 
peptide. In order to distinguish these 
mechanisms, we employed erythrocytes as 
a model system. In contrast to nucleated 
cells, erythrocytes do not exhibit endocy-
tosis. Cationic amphipathic, membrane-
active peptides like mastoparan [40], 
gramicidinS [41], mellitin [41] and several 
other drugs [42] have been shown to cause 
shape changes and cell lysis in erythro-
cytes. For CPPs only few studies about the 
impact on erythrocytes exist. One study 
addressed the uptake of α- and β-
oligoarginines in normal versus parasite-
infected erythrocytes [43] demonstrating 
that both types of oligoarginines did not 
enter healthy erythrocytes but only the 
parasite-infected ones. TAT only showed 
activity in combination with a phototoxic 
effect [44]. 
Erythrocytes were incubated with Dex-
(R9)5 in the presence of fluorescently la-
beled Annexin-V and the impact on 
erythrocyte morphology and phos-
phatidylserine exposure was determined 
by time lapse confocal microscopy (Figures 
5A and Supporting Information S5 Figure 
S5.1 and Video S5-M6). The multivalent 
conjugate bound to the membrane almost 
immediately after addition. For 37% of the 
cells (3 independent experiments with 605 
cells in total) this binding was followed by 
phosphatidylserine exposure (detected by 
binding of Annexin-V), indicating that dis-
ruption of membrane polarity was a 
potential consequence but not the cause 
of strong binding of the conjugates. 
Phosphatidylserine exposure was followed 
by disruption of membrane integrity as vis-
ible by entry of fluorescence into the 
cytoplasm. By 20 minutes, 9% of the cells 
were lysed. Interestingly, within the first 2 
minutes erythrocytes also formed aggre-
gates (Figure 5B and Supporting 
Information S5 Figure S5.1 and Video S5-
M6) that incorporated 50% of cells at 0.6 
µM of Dex-(R9)5. In contrast, addition of 6 
µM R9 to erythrocytes in Ringer exhibited 
weaker membrane staining and did not 
show any aggregates (Figure 5 and Sup-
porting Information S5 Figure S5.2 and 
Video S5-M7). No cell entry was observed. 
Moreover, only a minor percentage of cells 
(around 4% from 2 different experiments, 
595 cells in total) showed shape changes 
and formed echinocytes (by 20 minutes) 
without exposure of phosphatidylserine 
(Supporting Information S5 Figure S5.2 and 
Video S5-M7). CED, the dextran backbone 
control, induced no changes in erythrocyte 
morphology (Supporting Information S6). 
To explore to which degree the membrane 
aggregating behavior of Dex-(R9)5 would 
extend to potential in vivo applications, 
erythrocytes were also exposed to the con-
jugate in the presence of human serum. 
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Serum completely neutralized the effects 
of Dex-(R9)5 on erythrocytes observed in 
Ringer (Supporting Information S6).  
 
Both, Dex-(R9)5 and R9 interfere with pro-
tein-protein interactions involved in early 
T-cell signal transduction  
The observations for Jurkat cells and eryth-
rocytes demonstrated that the multivalent 
display of R9 strongly potentiated the ca-
pacity to interact with lipid membranes 
independent of the presence of heparan 
sulfates. Clearly, on the linear backbone, 
multivalency yielded sufficient avidity to 
support interactions with the lipid head 
groups. Given a recent report of interac-
tions of arginine-rich peptides with 
microfilaments [45], we were interested to 
learn whether multivalency also conferred 
an increased capacity to interfere with 
protein-protein interactions. To this end, 
we took advantage of a peptide-based mi-
croarray approach which we had used 
before to probe in parallel for signaling-
dependent changes in the formation of 
protein complexes in Jurkat T cells [36]. 
The peptide arrays comprised a collection 
of phosphotyrosine-containing and 
proline-rich peptides which interact with 
SH2 and SH3 domains that play a major 
role in the organization of signaling path-
ways [46, 47]. Binding of proteins from cell 
lysates was probed by indirect immunoflu-
orescence. We opted for PLCγ1 [48, 49] 
and the scaffold protein LAT [50, 51], two 
important players in early complex for-
mation within T cell signaling, as indicators 
for a possible impact on protein-protein in-
teractions. PLCγ1 can bind to peptides on 
the microarray via its SH2 and SH3 do-
mains. In contrast, LAT can only bind as 
part of a protein complex as it has no suit-
able domains to directly engage in 
interactions with peptides on the array. 
LAT should therefore be a sensitive indica-
tor for changes in protein-protein 
interactions. In order to trigger signaling 
events and induce formation of protein 
complexes, Jurkat cells were stimulated 
with the broad-range phosphatase inhibi-
tor pervanadate [52] or as a control for 
resting cells treated with HBS only. 
Pervanadate leads to the phosphorylation 
of tyrosines and as a consequence to SH2 
domain-mediated complex formation. Ad-
dition of R9 and Dex-(R9)5 caused the loss 
of several signals on proline-rich peptides 
but not on phosphotyrosine-containing 
peptides (Figure 6). Also LAT was affected 
more strongly than PLCγ1 consistent with 
the indirect binding of LAT as part of a pro-
tein complex which provides several points 
for interference with the interaction. How-
ever, there was little difference between 
R9 and Dex-(R9)5.  
 
 
Discussion 
Oligoarginines have gained ample atten-
tion as CPPs due to their high 
internalization efficiency [24, 25, 53, 54]. 
An increase of the valency of the 
guanidino-group through a multivalent 
display of oligoarginines further increases 
uptake efficiency [29]. So far, investiga-
tions of multivalency have focused on 
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uptake efficiency and intracellular traffick-
ing of globular molecular geometries [26]. 
For example, the tetravalent display of the 
TAT CPP increased uptake efficiency by 
1000-fold. Interestingly, to this point there 
were no indications that the multivalent 
configuration conferred qualitatively new 
characteristics to the interaction of these 
molecules with cells.  
In this study, we linked on average five 
nona-arginine CPPs to a linear dextran 
backbone. With this linear geometry, in a 
fully stretched conformation this multiva-
lent construct can engage plasma- 
membrane over a length of at least 25 nm 
(the dextran polymer backbone, Dex, ex-
hibits this length in the extended 
conformation [22]) and a width of 7 nm 
(two fully extended R9), yielding a maximal 
contact area of 175 nm
2
. In comparison, a 
streptavidin molecule which has been used 
as a globular scaffold has a diameter of 5 
nm which would be extended by fully 
stretched peptides to 12 nm and thus an 
equivalent contact area of 144 nm
2
. This 
similarity in size indicates that the ob-
served differences must to a large extend 
be a consequence of the flexibility of the 
dextran backbone. 
 
Remarkably, as derived from quantitative 
image analysis, uptake of the conjugate, 
when related to peptide, was enhanced by 
a factor of five at most in comparison of 
the free peptide. Therefore, this linear ar-
rangement of oligoarginines falls behind 
what was observed for the globular con-
figurations. However, very interestingly, 
this construct showed the same imipra-
mine-sensitive cytoplasmic uptake as the 
free peptide, in spite of a total molecular 
weight of 22 kDa (CED + peptides). So far, 
observations by us [10] and others [9] had 
shown that this uptake is restricted to 
small molecules only. In fact, elongation of 
nona-arginine by only a heptapeptide 
strongly reduced the efficiency of this up-
take route. The molecular details of the 
nucleation zone-dependent uptake still 
remain elusive. Based on the 
sphingomyelinase dependence and the 
formation of ceramide, a lipid that forms 
membrane microdomains [47], we pro-
posed a model according to which 
peptides enter along domain boundaries in 
a non-disruptive manner. Even though still 
speculative in nature, the uptake that we 
observed here demonstrates that a con-
tinuous display of arginines along a 
flexible, linear scaffold enables passage 
through these domain boundaries also for 
larger molecules. It is tempting to assume 
that the peptides act like pearls on a string. 
The ability to also drive larger molecules 
across the membrane by this mechanism 
further supports a privileged role for 
arginines for partitioning into lipid bilayers. 
Furthermore, local arginine density instead 
of the absolute concentration of molecules 
is decisive in triggering this uptake route as 
in both cases the concentration of nona-
arginine was 20 μM.  
Nevertheless, the nucleation zone de-
pendent entry was superimposed by a 
stronger membrane-perturbation, demon-
strating that a covalent linkage to a linear 
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scaffold is not equivalent to the addition as 
independent molecules. On HeLa cells, al-
ready at a peptide concentration of 1 μM 
the multivalent conjugate showed signifi-
cant long-term toxicity over a period of 24 
hours. This membrane-disruptive capacity 
was even enhanced on Jurkat cells. Jurkat 
cells possess only little glycocalyx [38]. 
While we cannot exclude that the 
glycocalyx present on Jurkat cells mediates 
the observed interaction, the strong mem-
brane perturbation induced by the 
conjugate on the Jurkat cells and enrich-
ment in the plasma membrane indicates 
that the peptide exerts a much stronger 
perturbating effect on the lipid bilayer. It is 
reasonable to assume that this is a conse-
quence of the peptide gaining more readily 
access to the lipid bilayer and interacting 
with lipid head groups. Exposure of nega-
tively charged phosphatidylserines further 
enhances this interaction. One may also 
envision that an initial local exposure of 
phosphatidylserine further promotes 
membrane association and thus mem-
brane perturbation. 
It is notable that the massive membrane 
staining was restricted to Jurkat cells and 
also that for Jurkat cells, the conjugate did 
not gain access to the cytoplasm. In our 
opinion, the most likely way of reasoning is 
that in Hela cells the conjugate induces 
rapid uptake and that interactions with the 
glycocalyx shield the lipid bilayer, while for 
Jurkat cells, in the absence of a pro-
nounced glycocalyx the perturbation of the 
lipid bilayer dominates and the peptide is 
sequestered by the plasma membrane and 
therefore not able to reach the cytosol. 
Our results differ from those of Kawamura 
et al. [29], who showed that the tetrava-
lent display of deca-arginine at the N-
terminus of the p53 tetramerization do-
main did not confer any toxicity to CHO 
cells at a peptide concentration of up to 25 
μM for 4 hours. This discrepancy suggests 
that a conformationally constrained ar-
rangement of oligoarginines as part of a 
macromolecule has a lower membrane-
disturbing potential, an observation in line 
with the absence of toxicity of CPP-
functionalized quantum dots [55] and na-
noparticles [56]. However, very 
interestingly, the capacity to engage in in-
teractions with the lipid bilayer by itself 
was not sufficient for causing severe toxici-
ty. The dextran conjugate also strongly 
bound to and even cross-linked erythro-
cytes. While this led to exposure of 
phosphatidylserine in a considerable num-
ber of cells, there was no disruption of 
cells and massive lysis. 
In contrast, at a concentration of 6 µM, R9 
was completely indifferent to erythrocytes. 
These observations demonstrate that with 
a higher degree of multivalency, when 
linked to a linear scaffold, oligoarginine 
acquires fundamentally new characteris-
tics. Several articles have reported on such 
aggregation behavior of erythrocytes being 
dependent on the size and concentration 
of polymers such as dextran and also on 
the surface charges on the erythrocyte 
membrane [57-59]. However, the mini-
mum size of dextran reported to cause 
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erythrocyte aggregation is 40 kDa at con-
centrations of 30 - 40 g/L corresponding to 
750 µM - 1 mM [57]. A smaller dextran 
with 20 kDa was not able to induce any ag-
gregation up to a concentration of 120 g/L 
corresponding to 6 mM [57]. For Dex-(R9)5 
no cross-linking occurred in the presence 
of serum, indicating a strong serum bind-
ing of the conjugate that competed for 
membrane interactions [60] (Supporting 
Information S6). Erythrocytes do not pos-
sess endocytosis and also lack sphingo-
myelinase demonstrating that the in-
creased toxicity for HeLa and Jurkat cells is 
a consequence of the reaction of the nu-
cleated cells towards the conjugate rather 
than a membrane disruption caused by the 
physicochemical characteristics of the con-
jugate. This is also supported by the 
reduced membrane disruption for HeLa 
cells in which the sphingomyelinase-
dependent uptake had been abolished by 
imipramine treatment. 
Since arginine-rich CPPs have already been 
shown to interact with actin and stabilize 
stress fibers [45], we set out to test 
whether R9 and Dex-(R9)5 also had an im-
pact on molecular interactions inside the 
cell. We opted for our peptide microarray-
based approach as it provides a straight-
forward means to probe for the 
perturbation of several interactions in par-
allel and furthermore also captures an 
impact on the formation of signaling com-
plexes. Both R9 and the Dex-(R9)5 
conjugate had a similar disturbing effect 
on interactions mediated by proline-rich 
peptides. It is difficult to predict to which 
degree this disruptive potential will be sig-
nificant in vivo. However, given the fact 
that polyvalency did not increase the dis-
rupting behavior, we consider it highly 
unlikely that also at significantly higher 
concentrations R9 will severely disturb 
protein-protein interactions in cellular sig-
naling. This is also in accordance with the 
fact that the massive cytosolic import that 
is observed for nucleation zone-dependent 
uptake does not cause any acute toxicity 
or perturbation of cell structure.  
 
 
Conclusions 
In summary, our analyses show that for ar-
ginine-rich CPPs multivalency on a linear 
scaffold affords a high avidity that critically 
affects the interaction with cellular mem-
branes. As demonstrated for binding of R9 
to erythrocytes, no binding is detected for 
the free peptide while strong binding and 
also cross-linking into erythrocyte 
stacks/aggregates occurs for the multiva-
lent Dex-(R9)5 conjugate. For HeLa and 
Jurkat cells, this multivalency strongly in-
creases toxicity. The observed toxicity for 
both cell lines demonstrates that this in-
crease in avidity is also observed for Jurkat 
cells with low levels of glycocalyx, indicat-
ing that interactions with lipids play a 
more prominent role. In addition, the 
membrane-disruptive behavior is a func-
tion of peptide uptake and not of the 
conjugate alone. These results clearly 
demonstrate that arginine-rich CPPs en-
gage membrane structures just strong 
enough to trigger uptake while avoiding 
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detrimental multivalent interactions that 
disturb membrane organization of larger 
areas.  
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Supporting Information 
 
 
S1. Synthesis of Dex-(R9)5 (Figure S1.1) 
2-Carboxyethyl dextran (CED) (2): In a 1 N 
NaOH solution (25 mL) dextran (5 g, 1 
mmol, MW 10 kDa, PDI = 1.58) was stirred. 
At a temperature of 30°C acryl amide (0.9 
g, 12.5 mmol) was added and stirred. After 
12 hours the temperature was increased 
to 50°C and the solution was stirred for an 
additional 24 hours. After neutralizing the 
solution, the oligosaccharide products 
were precipitated by dropwise addition of 
methanol under stirring. The solvent was 
removed by filtration, the residue washed 
with methanol and dried. The white solid 
was dissolved in water (25 mL) and dia-
lyzed (benzoylated dialysis tubing, pore 
size: 2000 NMWCO (nominal molecular 
weight cut-off), Sigma Aldrich) twice with 
0.1 N HCl (10 L) and water (2 × 10 L) over 
24 hours. After lyophilization, a white 
powder was obtained in a yield of 4 g 
(72%, 13 carboxyethyl groups per dextran). 
The average number of carboxyethyl 
groups per dextran was quantified by 
1
H
 
NMR spectroscopy and confirmed by titra-
tion against 0.1 N NaOH. 
1
H NMR (D2O, 300 MHz): δ = 2.65 (t, 2 H, 
CH2COOH), 3.25-4.1 (m, CH2CH2COOH, C(2-
6)H (glucose units)), 4.93 - 5.30 (m, 1 H, 
C(1)H) ppm; 
13
C NMR (D2O, 75 MHz):  δ = 
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34.20 (CH2COOH), 65.03 (OCH2CH2COOH), 
69.03 (C(4) glucose unit), 69.67 (C(2) glu-
cose unit), 70.89 (C(4) glucose unit), 
72.89(C(3) glucose unit), 97.18 (C(1) glu-
cose unit, 175.39 (CH2COOH) ppm;  
 
N-(tert-Butoxycarbonyl)-1,2-
diaminoethane (5): A solution of 1,2-
diaminoethane (27 mL, 400 mmol) in CHCl3 
(400 mL) was cooled to a temperature of 
0°C. Boc-anhydride (8.7 g, 40 mmol) dis-
solved in CHCl3 (200 mL) was added 
dropwise over 3 hours. That mixture was 
stirred for a further 30 minutes at 0°C and 
afterwards allowed to warm to room tem-
perature overnight. After removing the 
solvent by evaporation, the remaining res-
idue was dissolved in 3 N Na2CO3 (300 mL) 
 
and the mixture extracted with CHCl3 (3 × 
200 mL). The organic phase was dried over 
Na2SO4 and evaporated to provide the 
product as a colorless oil (yield: 6.4 g, 
98%). 
1
H NMR (300 MHz, CDCl3): δ = 1.35 (s, 9 H, 
CCH3), 2.69 (t, 2 H, CH2NHBoc), 3.07 (q,  2 
H, CH2CH2NHBoc), 5.11 (br s, 1 H, NHBoc) 
ppm; 
13
C NMR (75 MHz, CDCl3): δ = 27.87 
(CCH3), 41.36 (H2NCH2CH2), 42.93 
(CH2NHBoc), 78.52 (CCH3), 155.73 
(NHCOO) ppm; HRMS (ESI-TOF): m/z calcu-
lated for C7H16N2O2: 161.1285 [M+H]
+
. 
Found 161.1285 g/mol [M+H]
+
. 
 
N-(2-(tert-Butoxycarbonyl)aminoethyl)-
maleimide (6): To a solution of NEt3 (6.6 
mL, 47.79 mmol) and 5 (5.1 g, 31.9 mmol) 
 
Figure S1.1. Synthesis protocol for Dex-(R9)5. Native dextran was derivatized to an activated poly-
mer, which could then be functionalized with cysteine-containing peptides (8 & 9). Step (a): acryl 
amide, 1N NaOH, 30-50°C, 0.1N HCL; step (b): N-(2-Aminoethyl)maleimide (7), EDC, pH 6.5; step (c): 
8 (or 9), pH6.5. 
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in Et2O (60 mL), a solution of maleic anhy-
dride (3.1 g, 31.9 mmol) in Et2O (60 mL) 
was added dropwise at 0°C.  After com-
plete addition, the mixture was stirred for 
4 hours while being allowed to reach room 
temperature. The solvent was removed 
and the residue was dissolved in acetone 
(150 mL). Et3N (8.8 mL, 63.7 mmol) was 
added and the mixture was heated to re-
flux. After adding acetic anhydride (4.5 mL, 
47.8 mmol), the solution was refluxed for 
20 hours. The solvent was removed under 
reduced pressure and the remaining dark 
brown oily residue worked up by chroma-
tography of the over silica gel 
(EtOAc/hexane 1:1). After removing the 
solvent a white solid was obtained as 
product (yield: 3.7 g, 48.1%). 
1
H NMR (CDCl3, 300 MHz): δ = 1.4 (s, 9 H, 
CCH3), 3.34 (q, 2 H, J = 4.9 Hz, 
CH2CH2NHBoc), 3.66 (t, 2 H, J = 5.1 Hz, 
CH2CH2NHBoc), 4.74 (br s, 1 H, NHBoc), 
6.71 (s, 2 H, CHCHCON) ppm; 
13
C NMR 
(CDCl3, 75 MHz): δ = 27.83 (CCH3), 37.5 
(CH2CH2NHBoc), 38.91 (CH2CH2NHBoc) 
79.07 (CCH3), 133.96 (CHCHCON), 155.46 
(NHCOO), 170.34 (CONCO) ppm; HRMS 
(ESI-TOF): m/z calculated for C11H16N2O4: 
241.1183 [M+H]
+
. Found 241.1188 [M+H]
+
. 
 
N-(2-Aminoethyl)maleimide (7): A solu-
tion of 6 (4.6 g, 19.2 mmol) in DCM (35 mL) 
was cooled to 0°C. TFA (27 mL) was added 
and the solution was stirred for 1 hour 
while being allowed to reach room tem-
perature. After concentrating, the mixture 
was precipitated with cold Et2O (50 mL). 
Washing steps with cold Et2O (3 × 50 mL) 
followed by evaporation of remaining sol-
vent provided a white solid as product 
(yield: 2.5 g, 93%). 
1
H NMR (CDCl3, 300 MHz): δ = 3.18 (t, 2 H, 
J = 5.8 Hz, NH3
+
CH2CH2), 3.79 (t, 2 H, J = 5.8 
Hz, NH3
+
CH2CH2N), 6.86 (s, 2 H, 
COCH2CH2CON) ppm; 
13
C NMR (CDCl3, 75 
MHz): δ = 34.92 (NH3
+
CH2CH2), 38.28 
(NH3
+
CH2CH2), 134.6 (COCH2CH2CO), 
172.53 (COCH2CH2CO) ppm; HRMS (ESI-
TOF): m/z calculated for C6H8N2O2: 
141.0659 [M+H]
+
. Found 141.0662 [M+H]
+
. 
 
Maleimidoethyl amidoethyl dextran 
(Maleimide dextran) (3): CED 1 (0.2 g, 0.02 
mmol) bearing 13 carboxy groups (0.26 
mmol) and maleimide 4 (0.69 g, 
2.69 mmol) were dissolved in water (1 mL). 
After adjusting a pH value of 6.5-7, EDC 
(0.26 g, 1.35 mmol) was added. After 1 
hour further EDC (0.26 g, 1.35 mmol) was 
added and the solution was allowed to stir 
for 4 hours. After precipitating the mixture 
with methanol, the remaining solid was 
separated and washed with methanol and 
DMF several times. For final cleaning, the 
solid was dissolved in water (2.5 mL) and 
purified over Sephadex G-25. Lyophilisa-
tion led to a product as a white solid (yield: 
0.19 g, 82%). The quantification of 
maleimide groups per dextran was per-
formed using 
1
H NMR spectroscopy. It 
could be proven that under the used con-
ditions all carboxy groups on the dextran 
reacted to the corresponding 
maleimidoethyl amide groups. 
1
H NMR (D2O, 300 MHz): δ = 2.48 (t, 2 H, J 
= 4.7, CH2CH2COOH), 3.3-4.1 (m, 
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CH2CH2COOH, H (glucose units)), 4.98, -5.3 
(m, anomeric H), 6.89 (s, 2 H, COCHCHCO) 
ppm; 
13
C NMR (D2O, 75 MHz): δ = 36.38 
(CH2CONH), 37.12 (NHCH2CH2NH2), 39.97 
(NHCH2CH2N), 65.35 (C(6)H2), 65.58 
(C(OCH2CH2CONH), 67.94 (C(4) Glucose), 
71.41 (C(5) Glucose), 72.57 (C(3)H Glu-
cose), 74.68 (C(2) Glucose), 98.71 (C(1) 
Glucose), 179.29 (CONH), 181.82 
(CH2CONH) ppm. 
 
Peptide synthesis (8, 9): Peptides were 
synthesized manually or by automated 
Fmoc-SPPS on TentaGel S Ram amide (0.2 
mmol/g) resins. Peptides were identified 
by LCMS, HRMS and Maldi TOF. 
N-cysteinyl-lysinyl-5(6)-carboxyfluorescein 
(H2N-CK(Fluo)-CONH2) (8) 
N-cysteinyl-nona-arginine amide (H2N-
CRRRRRRRRR-CONH2) (9) 
 
Synthesis of nona-arginine dextran conju-
gates (4): Polymer 3 (10 mg, 1 µmol) 
loaded with 13 maleimide groups (13 
µmol) was dissolved in MES buffer (1 mL, 
pH 6.5). After degassing, and setting the 
flask under nitrogen atmosphere, N-
terminal cysteine-extended nona-arginine 
(R9) 9 (11 mg, 7 eq.) and cysteinyllysinyl 
fluorescein amide (CK(Fluo)) 8 (2 mg 3 eq.) 
were added. The pH value was checked 
and the mixture stirred for further 16 
hours. After concentrating the solution, 
the product was precipitated with MeOH. 
After several washing steps with MeOH 
and DMF the solid was dissolved in water 
(2.5 mL) and purified twice using PD-10 
columns. After lyophilisation the resulting 
conjugate was obtained as an orange 
powder. 
The numbers of attached peptides per 
dextran molecule was determined by 
quantitative amino acid analysis 
(Genaxxon Bioscience, Ulm, Germany). A 
weighed sample of the peptide polymer 
was subjected to peptide hydrolysis (6 N 
HCl at 110 °C in a closed pressure vessel). 
Under these conditions all amide bonds 
are cleaved quantitatively. Subsequently, 
all free amino acids were functionalized 
with a chromophore and analzyed by HPLC 
using the integration of peaks for quantifi-
cation. The results of quantitative amino 
acid analysis are summarized in Table S1. 
Table S1. Results of amino acid analysis for the peptide-dextran. On the basis of the measured 
peptide concentrations, the numbers of the peptides per polymer could be determined. 
 
Compound # Name 
Concentration / mg peptide 
polymer [nmol] 
Composition of peptide poly-
mers 
 CK(Fluo)
-peptide 
R9 pep-
tide 
dextran 
Fluo-groups 
per dextran 
R9-groups per 
dextran 
 
4 
Dex-5R-
CK(Fluo) 
89 487 95 0.9 5.2 
 *dextran loaded with peptides and N-cysteinyl-lysinyl-5(6)-carboxyfluorescein (H2N-CK(Fluo)-
CONH2) 
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Compound 4 was found to contain 4.383 
µmol of arginine per g, corresponding to a 
loading of 487 nmol of nona-arginine per 
g. Taking into account that the sample con-
tained 95 nmol/g dextran this resulted in a 
loading of 487/95 = 5.12 nona-arginine 
copies per dextran molecule. Loading 
quantification was confirmed by 1H-NMR 
analysis at 300 MHz in D2O (see Figure 
S1.2) and by measuring the absorption of 
carboxyfluorescein. 
With this synthesis procedure and based 
on previous analysis [61, 62], it is expected 
that the nona-arginines are distributed 
randomly over the polymer.  
Carboxyethylation was found to be selec-
tive for the 2-hydroxy position of the 
glucose monomers, probably due to the 
 
Figure S1.2. 1H-NMR-spectrum (300 MHz, D2O) of nona-arginine loaded, carboxyfluorescein-
labeled peptide dextran 4. The anomeric protons of the dextran monomers (glucose units) are at 
4.9-5.1 ppm, the beta- and gamma-methylene groups of the arginine side chain at 1.2-1.9 ppm and 
the aromatic protons or the carboxyfluorescein at 6.7-7.6 ppm. To quantitate the degree of substitu-
tion, the integrated peaks of the fluorescein and arginine-methylene protons were related to the 
signal intensity of the anomeric protons of the glucose. With on average 62 glucose units per dex-
tran the degree of substitution could be determined and cross-validated against the amino acid 
analysis and UV/Vis-measurements (fluorescein). 
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higher acidity of this position. Therefore, it 
can be excluded that more than one func-
tional group is located at one glucose 
monomer and it can be assumed that 
carboxyethylation is randomly distributed 
on the glucose units.  
 
S2. Dex-(R9)5 exhibits sphingomyelinase-
dependent uptake and nucleolar staining 
 HeLa cells (4 × 10
4
/well) were seeded in 8-
well microscopy chambers (Nalge Nunc In-
ternational, New York, USA), 24 hours 
prior to peptide addition. Cells were incu-
bated with 4 µM Dex-(R9)5 or 20 µM R9 in 
RPMI 1640 supplemented with 10% FBS 
(heat inactivated) for 20 minutes (Fig-
ure S2). For assessing the effect of imipra-
mine on peptide uptake, cells were pre-
incubated for 45 minutes with 30 µM imi-
pramine in RPMI 1640 without serum. For 
subsequent incubation with peptide, 30 
µM imipramine was co-incubated with 
peptide in medium containing 10% FBS. 
Cells were washed twice with medium and 
immediately imaged by microscopy. 
 
S3. Effect of imipramine on peptide inter-
nalization 
In order to investigate the direct interfer-
ence of imipramine with peptide 
internalization, uptake of R9 or Dex-(R9)5 
was compared in cells either pre-incubated  
 
 
Figure S2. Cellular distribution and imipramine-sensitive uptake of Dex-(R9)5. Following a 45 minutes 
pretreatment with/without imipramine (imi) in serum-free RPMI, HeLa cells were incubated with 20 
µM R9 or 4 µM Dex-(R9)5 for 20 minutes at 37°C in the presence or absence of 30 µM imipramine 
followed by washing and imaging with confocal microscopy. Microscopy settings for image acquisi-
tion of all samples were adjusted for R9 to avoid saturation. One confocal slice is shown for all the 
microscopy images. Scale bars correspond to 50 µm. One representative experiment of at least three 
experiments is shown. Brightness and contrast has been adjusted in the transmission images for vis-
ualization purposes using parameters to yield the best possible result for transmission images 
. 
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Figure S3. Effect of imipramine on peptide internalization. (A) Following a 45 minutes pretreatment 
with/without imipramine in serum-free RPMI, HeLa cells were incubated with 20 µM R9 or 4 µM 
Dex-(R9)5 for 20 minutes at 37°C in the presence or absence of 30 µM imipramine followed by wash-
ing and imaging with confocal microscopy. For the pretreatment samples (no co-incubation with 
imipramine), cells were washed thrice before incubation with R9 or Dex-(R9)5. One confocal slice is 
shown for all the microscopy images. Scale bars correspond to 20 µm. (B-C) Flow cytometric analysis 
of the same samples. Median fluorescence were normalized to R9 and Dex-(R9)5 respectively and 
represented as percentage. (wo = without imipramine, pre = pre-incubation only, pre+co = pre-
incubation and co-incubation). 
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with imipramine or in cells pre-incubated 
and co-incubated with imipramine (Figure 
S3). Briefly, HeLa cells (4 × 10
4
/well) were 
seeded in 8-well microscopy chambers 
(Nalge Nunc International, New York, USA) 
24 hours prior to peptide addition. Cells 
were pre-incubated for 45 minutes with 30 
µM imipramine in RPMI 1640 without se-
rum. Cells were washed thrice in RPMI 
1640 supplemented with 10% FCS (fetal 
calf serum) and incubated with 4 µM Dex-
(R9)5 or 20 µM R9 in RPMI 1640 supple-
mented with 10% FCS for 20 minutes in 
presence or absence of 30 µM imipramine. 
Cells were washed twice with medium and 
imaged with microscopy. After microscopy, 
cells were washed twice with HBS (HEPES-
buffered saline, HBS; 10 mM HEPES, 135 
mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM 
CaCl2, pH 7.4), trypsinized, centrifuged and 
finally resuspended in 200 μL RPMI 1640 
supplemented with 10% FCS. Fluorescence 
was measured with excitation at 488 nm 
using a BD FACSCalibur flow cytometer (BD 
Biosciences, Erembodegem, Belgium). 
1×10
4
 cells were gated using forward and 
sideward scatter and were analyzed with 
the Summit software (Fort Collins, USA). 
 
S4. Time lapse microscopy of the mem-
brane-disruptive behavior of Dex–(R9)5 in 
Jurkat cells 
In order to investigate the glycosaminogly-
can-independent uptake of Dex-(R9)5, 
Jurkat cells were selected as a model since 
these cells express only low levels of 
heparan sulfates [63]. 200 μL of a Jurkat 
cell suspension of 5 × 10
5
 cells/mL were 
 
 
Figure S5.1. Time lapse confocal microscopy to monitor cell aggregation and phosphatidylserine ex-
posure in erythrocytes induced by Dex-(R9)5. Washed erythrocytes were seeded in 8-well 
microscopy chambers in Ringer in the presence of Alexa-647-labeled Annexin-V and treated with 0.6 
µM Dex-(R9)5. Images were taken immediately after addition for a period of 20 minutes. Each image 
shows one confocal slice. Scale bar corresponds to 20 µm. See also Video S5-M6. 
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transferred per well into 8-well microscopy 
chambers coated with a 20 μg/mL 
fibronectin solution in PBS for 30 minutes 
at room temperature (RT). Varying 
amounts of R9 or Dex-(R9)5 were added to 
the wells at t = 0. Living cells were imaged 
using a TCS SP5 confocal microscope (Leica 
Microsystems, Mannheim, Germany) 
equipped with an HCX PL APO 63x 1.2 N.A. 
water immersion lens. Cells were main-
tained at 37°C on a temperature-
controlled microscope stage. Images were 
recorded using the 488 nm line of an ar-
gon-ion laser (2 images/minute). Videos 
can be found online 
(http://www.sciencedirect.com/science/ar
ticle/pii/S0005273614002831). Jurkat cells  
were exposed to 5 μM R9 (Video S4-M1), 
10 μM R9 (Video S4-M2), 1 μM Dex-(R9)5 
(Video S4-M3) or 2 μM Dex-(R9)5 (Video 
S4-M4). 2 μM CED (Video S4-M5) was used 
as control. t = 35 minutes, scale bars corre-
spond to 25 μm. Channels from left to 
right: fluorescein and bright field.  
 
S5. Time lapse microscopy to monitor cell 
aggregation and phosphatidylserine ex-
posure in erythrocytes treated with Dex-
(R9)5 or R9 
Fresh blood was drawn from a healthy vol-
unteer and centrifuged at 1500 × g for 10 
minutes. The erythrocyte pellet was 
washed twice with calcium-free Ringer to 
prevent complement activation and once 
 
 
Figure S5.2. Incubation of erythrocytes with R9. The free peptide does not induce erythrocyte ag-
gregation. Erythrocytes were treated as stated above with 6 µM R9. Images were taken immediately 
after addition over a period of 20 minutes with intervals of 10 seconds. Each image shows one con-
focal slice. Scale bar corresponds to 20 µm. See also Video S5-M7. 
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with complete Ringer. Erythrocytes were 
resuspended to 1 million cells/well in 100 
µL of Ringer and seeded in 8-well micros-
copy chambers. 0.6 μM Dex-(R9)5 (Figure 
S5.2 and Video S5-M6) or 6 μM R9 (Figure 
S5.2 and Video S5-M7) and Alexa-647-
labeled Annexin-V (1:25) were added in an 
equal volume of Ringer to the cells. Image 
acquisition was started immediately after 
addition and continued over a period of 20 
minutes with intervals of 10 seconds. Vid-
eos can be found online 
(http://www.sciencedirect.com/science/ar
ticle/pii/S0005273614002831). Scale bars 
corresponds to 25 μm. Channels from left 
to right: bright field, fluorescein and 
Annexin-V. 
 
S6. Neutralizing effect of serum on the 
erythrocyte binding capacity of Dex-(R9)5 
To investigate whether the membrane 
binding potential of Dex-(R9)5 would be 
maintained in full blood, erythrocytes were 
incubated with the multivalent conjugate 
in the presence of human serum. Fresh 
blood was drawn into coagulation tubes 
(BD Vacutainer SST gel tubes), kept undis-
turbed for 1 hour in an upright position 
and then centrifuged at 1300 × g for 10  
minutes. Serum was transferred into a 
 
 
Figure S6. Serum neutralizes the erythrocyte-binding capacity of Dex-(R9)5. Erythrocytes were sus-
pended in either Ringer or in serum and seeded in an 8-well microscopy chamber. 0.6 µM Dex-(R9)5, 
6 µM R9 or 0.6 µM CED were added and samples were immediately imaged with confocal microsco-
py for 20 minutes. Scale bar corresponds to 20 µm. 
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fresh tube and stored at 4°C until erythro 
cytes were ready for use. Erythrocytes 
were separated from plasma and white 
blood cells using the Ficoll-Paque reagent, 
washed in calcium-free Ringer and finally 
resuspended in isolated serum from the 
same volunteer. An 8-well chambered co-
verslip was used for confocal microscopy. 
Erythrocytes were diluted to 1 million 
cells/well in 100 µL of serum. R9/Dex-
(R9)5/CED were added in an equal volume 
of serum to the cells at the indicated con-
centrations and imaged by time lapse 
microscopy (Figure S6). 
 
 
 
Supporting References 
61. Richter, M., et al., Multivalent design of apoptosis-inducing bid-BH3 peptide-
oligosaccharides boosts the intracellular activity at identical overall peptide 
concentrations. Chemistry, 2012. 18(52): p. 16708-15. 
62. Koschek, K., M. Dathe, and J. Rademann, Effects of charge and charge distribution 
on the cellular uptake of multivalent arginine-containing peptide-polymer 
conjugates. Chembiochem, 2013. 14(15): p. 1982-90. 
63. Verdurmen, W., et al., Cell surface clustering of heparan sulfate proteoglycans by 
amphipathic cell-penetrating peptides does not contribute to uptake. J Control 
Release, 2013. 170(1): p. 83-91. 
 
 
 
Chapter 5 
 
138  
 
 
  
A peptide-functionalized polymer as minimal scaffold protein 
 
 139 
 
 
 
 
CHAPTER 5: 
A PEPTIDE-FUNCTIONALIZED POLYMER AS A MINIMAL SCAFFOLD PRO-
TEIN TO ENHANCE CLUSTER FORMATION IN EARLY T CELL SIGNAL 
TRANSDUCTION 
 
 
 
 
J. Joris Witsenburg
a
, Michael D. Sinzinger
a
, Oda Stoevesandt
b
, Ivo R. Ruttekolk
a
, Günter 
Roth
c,d
, Merel J. W. Adjobo-Hermans
a
 & Roland Brock
a 
 
 
 
a
 Department of Biochemistry, Radboud Institute for Molecular Life Sciences, Radboud 
University Medical Centre, Nijmegen, The Netherlands 
b
 Protein Technology Group, The Babraham Institute, Cambridge, UK 
c
 Laboratory for Microarray Copying, Centre for Biological Systems Analysis (ZBSA), Univer-
sity of Freiburg, Freiburg, Germany 
d
 BIOSS-Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany 
 
Chembiochem 2015 Mar 2;16(4):602-10 
 
 
  
Chapter 5 
 
140  
 
Abstract: In cellular signal transduction, 
scaffold proteins provide binding sites to 
organize signaling proteins into 
supramolecular complexes and act as 
nodes in the signaling network. Further-
more, multivalent interactions between 
the scaffold and other signaling proteins 
contribute to the formation of protein 
microclusters. Such microclusters are 
prominent in early T cell signaling. Here, 
we explored the minimal structural re-
quirement for a scaffold protein by 
coupling multiple copies of a proline-rich 
peptide corresponding to an interaction 
motif for the SH3 domain of the adaptor 
protein GADS to an N-(2-hydroxy-
propyl)methacrylamide polymer backbone. 
When added to GADS-containing cell ly-
sates, these scaffolds (but not individual 
peptides) promoted the binding of GADS 
to peptide microarrays. This can be ex-
plained by the cross-linking of GADS into 
larger complexes. Furthermore, following 
import into Jurkat T cell leukemia cells, this 
synthetic scaffold enhanced the formation 
of microclusters of signaling proteins.  
 
 
Introduction 
Scaffold and adaptor proteins are pivotal 
in cellular signaling networks [1, 2]. They 
induce proximity between signaling pro-
teins with enzymatic activity, such as 
kinases, and their substrates, thereby inte-
grating and propagating signal inputs to 
down-stream effectors. To this end, these 
scaffolds form complexes with signaling 
proteins through protein interaction do-
mains. The composition of these complex-
es depends on the cell type and the nature 
of the signal input that the cell receives.  
One signaling network in which scaffold 
and adaptor proteins play a prominent role 
is T cell receptor (TCR)-dependent signal 
transduction in T lymphocytes. The trans-
membrane protein linker for activation of 
T cells (LAT) is the first scaffold protein in 
the TCR signaling cascade, and it is gener-
ally considered to be the central scaffold of 
the network [3, 4]. Upon TCR stimulation, 
multiple tyrosine residues on LAT are 
phosphorylated by ZAP70 (ζ chain-
associated protein kinase 70kDa) [5], leu-
kocyte C-terminal SRC kinase (LCK) and 
spleen tyrosine kinase (SYK) [6], and IL2-
inducible T cell kinase (ITK) [7]. These 
phosphotyrosines form binding sites for 
the SRC homology 2 (SH2) domains of an 
array of signaling proteins, among which 
are phospholipase C γ1 (PLCγ1), growth 
factor receptor-bound protein 2 (GRB2) 
and the GADS-SLP76 complex [8, 9]. To-
gether these proteins form an inter-
connected molecular framework that 
forms the basis of the main stimulatory 
signaling network in T cells.  
GRB2-related adaptor downstream of SHC 
(GADS) forms an ever-present complex 
with the adaptor SH2-domain-containing 
leukocyte protein of 76 kDa (SLP76) [10], 
by interaction of its C-terminal SH3 domain 
with the RSTK motif within the proline-rich 
region of SLP76 [11, 12]. Both proteins are 
required for normal T cell development 
[13-15]. The proline-rich region of SLP76, 
also acts as a binding site for PLCγ1 [16]. 
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The adaptor proteins GADS and GRB2 have 
single SH2 domains; nevertheless, both re-
quire at least two phosphorylated 
tyrosines for their association with LAT [9]. 
This can be explained by statistical rebind-
ing [17, 18] or by the fact that interactions 
with LAT are interdependent and mutually 
stabilize each other. PLCγ1 primarily uses 
pY132 on LAT for its association, but it is 
not stably recruited when interactions of 
GADS or GRB2 with LAT are obstructed [8, 
9].  
On a supramolecular scale, scaffold and 
adaptor proteins are necessary for the 
oligomerization of signaling complexes and 
the formation of microclusters during and 
prior to the assembly of the immune syn-
apse [19, 20]. Microclusters are 
membrane-associated aggregations (up to 
500 nm in diameter) of signaling proteins 
formed immediately after stimulation of 
the TCR [21, 22]. Clusters containing TCR 
and ZAP70 are recruited to the contact 
zone within seconds of the antigen pre-
senting cell (APC)-T cell contact, and 
clusters containing LAT, GADS, and SLP76 
follow soon after [23-25]. Initiation of T 
cell activation coincides with microcluster 
formation, as tyrosine phosphorylation 
colocalizes with newly formed clusters, 
and calcium fluxes start when the first 
microclusters are formed [20, 23-25]. 
The minimum structural requirements for 
a scaffold protein have not been elucidat-
ed. The question arises as to whether 
scaffold proteins act by inducing a specific 
structural arrangement of their interaction 
partners, or whether their function can be 
performed by a scaffold that simply pro-
vides a sufficient number of binding sites 
without specific geometry. Here we ex-
plored the minimum requirements for a 
synthetic scaffold in early T cell signaling 
by linking a peptide (corresponding to an 
interaction motif of an SH3 signaling do-
main) to a linear polymer in a multivalent 
arrangement. Competition experiments 
with fluorescence cross-correlation spec-
troscopy (FCCS) revealed that the peptide 
SLP228 (GADS interaction motif in the 
proline-rich region of SLP76) competes 
strongly with SLP76 for the binding of 
GADS in vitro [26, 27]. This peptide was 
cross-linked to an N-(2-hydroxy-propyl)-
methacrylamide (HPMA) backbone by na-
tive chemical ligation. By incubation of cell 
lysate with microarrays that display pep-
tides corresponding to interaction motifs 
in early T cell signaling [28], we show that 
these conjugates promote the formation 
of protein complexes. Following import in-
to Jurkat (leukemia) T cells, we 
demonstrate that our multivalent con-
struct increases GADS microcluster 
densities in T cells interacting with 
micropatterned surfaces of cluster of dif-
ferentiation 3- (CD3-) and CD28- 
stimulating spots. To the best of our 
knowledge this is the first direct demon-
stration of an increase in protein clustering 
induced by a synthetic molecular scaffold 
inside the cell. This work is a first step in 
the exploration of using multivalent syn-
thetic scaffolds to manipulate T cell 
signaling, with the ultimate aim of selec-
tively regulating T cell activity. 
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Results and Discussion 
 
In essence, the defining functional proper-
ty of a scaffold or adaptor protein is the 
provision of binding sites to induce proxim-
ity between two or more other proteins 
[1]. Here, we explored a minimal design of 
a scaffold protein capable of promoting 
cluster formation in early T cell signaling. A 
thioester-activated HPMA copolymer 
(28.5 kDa) served as a linear scaffold for 
the coupling of peptides [29, 30]. We have 
previously shown that for a dextran back-
bone functionalized with apoptosis-
inducing BidBH3 peptides, a multivalent 
display of peptides yielded increased activ-
ity, even inside the cell [31]. However, it 
has not been explored whether such a mo-
lecular design can also act as a scaffold for 
promoting protein cluster formation in cel-
lular signaling.  
Previously, we characterized the interac-
tions of T cell signaling proteins with 
microrarrayed peptides corresponding to 
protein interaction motifs [28]. Here we 
examined more closely the capability of 
monovalent peptides corresponding to in-
teraction motifs in the LAT signalosome to 
disrupt this complex in solution (Figure 1). 
Phosphorylation-dependent complex for-
mation was induced by pervanadate 
treatment before lysis. For the peptides 
LATpY132 and LATpY191, we previously 
showed a disruptive effect on the LAT-
PLCγ1 interaction in cell lysate [26]. Here 
we extended our analysis to peptides 
SLP179 and SLP228 (corresponding to two 
proline-rich motifs; Supporting Figure S1A). 
All four peptides had the capability to dis-
rupt interactions between proteins as 
measured by FCCS in cell lysates; 
LATpY132 and SLP228 showed the highest 
activity (Table 1, Supporting Figure S2A). 
For GADS-SLP76, an interaction was also 
observed in resting cells, consistent with 
the constitutive nature of this interaction 
(Supporting Figure S2B). Besides the GADS-
SLP76 complex, SLP228 also disrupted the 
interaction between SLP76 and PLCγ1. 
However, this could be an indirect effect, 
as the recruitment of SLP76 to the 
signalosome is mediated by the association 
of GADS with LAT, which stabilizes the 
binding of SLP76 with PLCγ1 [32]. 
 
Figure 1. Peptides employed for the disrup-
tion of protein-protein interactions in the LAT 
signalosome. The derived LATpY132, 
LATpY191, SLP179 and SLP228 peptides are in-
dicated in the LAT-GADS-SLP76-PLCγ1 signaling 
complex. The peptides were predicted to pre-
dominantly interfere with the interactions 
from which they were derived. 
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Disruption of the SH3 domain-mediated 
PLCγ1-SLP76 interaction by the SH2-
binding peptide LATpY132 is further evi-
dence for a mutual interdependence of 
interactions in the LAT signalosome.  
 
Based on this activity, we opted to synthe-
size a scaffold with SLP228. A multivalent 
SLP228-bearing construct could provide 
the opportunity to cross-link LAT-GADS 
complexes. By native chemical ligation, 
three SLP228 peptides (on average) were 
coupled per HPMA polymer (Supporting 
Figure S1B).  
In order to compare the influences of 
monovalent SLP228 and the HPMA-SLP228 
construct on complex formation in T cell 
signaling, we conducted peptide microar-
 
Figure 2. Effect of monovalent 
SLP228 and HPMA-SLP228 on the 
binding of GADS to microarray 
capture-peptides (indicated 
above the graphs). Lysates of both 
resting and pervanadate (PV)-
stimulated Jurkat T cells were in-
cubated on microarrays in the 
presence of either monovalent 
SLP228 or HPMA-SLP228. For 
SLP228 and HPMA-SLP228 the 
concentrations refer to that of the 
peptide. For HPMA-control the 
concentration of backbone was 
chosen to be the same as for 
HPMA-SLP228, (i.e., actual HPMA 
concentration was three times 
lower than given in the graph). Da-
ta points are mean values of three 
independent experiments. The 
signal intensities of each experi-
ment were normalized. Error bars 
reflect standard errors. 
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ray experiments with Jurkat T cell lysates. 
The microarrays contained peptides de-
rived from the interaction motifs of 
proteins involved in T cell signaling, includ-
ing the peptides used in the FCCS 
experiments. In total, 13 phosphotyrosine, 
seven proline-rich peptides and one pep-
tide containing a binding motif for WASP 
homology 1 (WH1) domain were immobi-
lized (see Supporting Table S1). The 
microarrays were incubated with lysates of 
resting and pervanadate-stimulated cells in 
the presence of monovalent SLP228, 
HPMA-SLP228 or HPMA alone (control). 
As expected, HPMA-control had no effect 
(Figure 2, Supporting Figure S3). Incuba-
tion with monovalent SLP228 led to a 
concentration-dependent decrease in (or 
even loss of) the signal for most peptides 
on the array, including SLP228. However, 
this loss of signal was not restricted to 
proline-rich peptides; interactionswere al-
so lost for phosphotyrosine-containing 
peptides. This may be explained by the fact 
that signals from the array result from the 
multivalent binding of complexes present 
in the lysate [28]. Disruption of a complex 
through SLP228 might thus decrease the 
valency for binding to phosphotyrosine-
containing peptides.  
HPMA-SLP228 also led to a decrease in (or 
loss of) signal for many peptides, including 
SLP228, GAB2-509 and CD28pY202 (Figure 
2). For the proline-rich peptides SLP228 
and GAB2-509, this can be explained by 
competitive binding to the SH3 domains of 
GADS. As CD28pY202 does not contain the 
consensus motif pYXNX [33] (where pY 
represents a phosphorylated tyrosineand X 
is any residue), it appears rather unlikely 
that the SH2 domain of GADS binds to this 
peptide. Instead, the competition for both 
SLP228 and HPMA-SLP228 suggests that 
GADS is actually binding to the proline-rich 
sequence APPRD within CD28pY202 with 
its SH3 domains. In contrast to the free 
peptide, HPMA-SLP228 induced an in-
crease in the GADS signal on LATpY191, 
LATpY226 and SHP1pY564 (Figure 2). In 
some cases this increase was stronger for 
lysates of resting cells than of pervana-
date-stimulated cells; this most likely re-
flects changes in the formation and 
composition of complexes (this could not 
be resolved in detail here). These increases 
were more pronounced at low concentra-
tions of the conjugate. This is consistent 
with the multivalent nature of the conju-
gate. At lower concentrations there is a 
higher chance for a conjugate to engage in 
multivalent binding. In the presence of an 
excess of conjugate, there is a higher 
chance for monovalent binding, which will 
disrupt complexes (see below).  
As the monovalent SLP228 peptide and the 
multivalent conjugate showed qualitative 
differences in their impact on protein 
complexes and, importantly, as HPMA-
SLP228 promoted complex formation, we 
set out to assess the impact of both mole-
cules on the formation of protein clusters 
inside cells. Constructs were introduced in-
to cells by microporation, (a 10 µL 
electroporation method, so a minimal 
amount of material is required). We have 
previously shown that electroporation af-
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Figure 3. Determination of intracellular conjugate concentrations following microporation. Jurkat 
T cells were microporated with 16.7 µM fluo-HPMA-SLP228 (i.e., 50 µM SLP228 peptides) or 
16.7 µM fluo-HPMA-control. A) Field-of-view of cells for which the intracellular concentration was 
determined by APD imaging. The cross-hair indicates the measurement location in one of three 
cells selected for intracellular FCS. Left: transmission image, right: fluorescein channel. (Scale bar: 
25 µm). B) Autocorrelation curves of subsequent FCS measurements of the above cell. C) The 
number of fluorescent particles in the detection volume for the FCS measurements. The values 
were fitted to a one-phase exponential-decay model as described previously [35] to extrapolate 
the intracellular concentration of the fluorophore at t = 0. D) Cell mask used to determine the ave- 
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fords an efficient import and homogenous 
cytoplasmic distribution of conjugates and 
free peptides [34, 35].  
 
Prior to testing the effect of the HPMA-
SLP228 conjugate on protein microcluster 
formation, we determined the average in-
tracellular concentrations of the 
conjugates achieved by electroporation, by 
using constructs with fluorescent labels 
(Supporting Figure S1B). Cells were ana-
lyzed with a combination of intracellular 
fluorescence correlation spectroscopy 
(FCS) and avalanche photodiode (APD) im-
aging. FCS derives information on molecule 
numbers of fluorescent particles from the 
amplitudes of the autocorrelation func-
tions. In APD detection there is a linear 
correlation between the number of 
fluorophores and the detected signal. The 
microporated cells were imaged (Figure 
3A) and three cells within the field-of-view 
were subjected to FCS measurements as 
described previously [35, 36]. Due to 
photobleaching, subsequent measure-
ments within a cell gave increasing 
amplitudes of the autocorrelation func-
tions (Figure 3B). As amplitude inversely 
relates to fluorophore number, it was pos-
sible to extrapolate the fluorophore num-
number at t = 0 by fitting the data mono-
exponentially (Figure 3C). The intracellular 
concentration of the three cells at t = 0 
was calculated from the detection volume, 
which was determined by using a 20 nM 
fluorescein standard. 
In parallel, the average intensities of the 
cells in the image were measured by using 
binary masks generated from the APD im-
age (Figure 3D). By averaging the 
fluorophore concentration/intensity ratios 
of the measured cells, we generated a fac-
tor that enabled us to estimate the 
intracellular fluorophore concentrations in 
all cells within a particular image (Figure 
3E). Both fluo-HPMA-SLP228 and fluo-
HPMA-control showed a positive linear 
correlation between the measured 
fluorophore concentrations and the inten-
sities in the APD images (Supporting Figure 
S4A). Interestingly, fluo-HPMA-control had 
a higher fluorophore concentration/cell in-
tensity ratio than did the fluo-HPMA-
SLP228 sample. However the counts per 
molecule (brightness per molecule) were 
approximately the same. The ratio differ-
ence can best be explained by an immobile 
fraction of HPMA-SLP228, which could not 
be detected by FCS. The difference in in-
tracellular fluorophore concentration 
between cells treated with different con-
structs was not affected by the 
fluorophore concentration/cell intensity 
difference (Supporting Figure S4B). 
rage fluorescein intensity for each individual cell within the image. Intensity-to-concentration coeffi-
cients were determined using the intracellular concentrations of the measured cells. E) These 
intensity-to-concentration coefficients were subsequently used to estimate the intracellular 
fluorophore concentration for each cell within the image. The graph shows the average intracellular 
concentration of fluorescein per cell (± SD). HPMA-SLP228: n = 36 cells (from 3 APD images), control-
HPMA: n = 56 cells (from 3 APD images). Panels A-D are taken from a fluo-HPMA-SLP228 sample. 
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Using this method, we estimated the aver-
age intracellular fluorescein concentration 
to be 582 nM per cell in fluo-HPMA-
control-treated samples and 177 nM in 
fluo-HPMA-SLP228-treated samples.  
 
To test whether the multivalent peptides 
could serve as synthetic scaffolds inside 
cells we incubated microporated Jurkat T 
cells on fibronectin-coated surfaces 
micropatterned with stimulating spots of 
αCD3 and αCD28 antibodies to mimic the 
immune synapse [37, 38] (Figure 4). For a 
stringent comparison of the different 
compounds, we coincubated HPMA-
SLP228-treated with HPMA-control-
treated cells on a single surface to avoid 
artifacts arising from sample-to-sample 
variation. We prelabeled one of the two 
groups with carboxyfluorescein 
succinimidyl ester (CFSE) to distinguish the 
different cells during analysis, as after fixa-
tion, permeabilization and immuno-
labeling, the fluorescent constructs could 
no longer be detected (results not shown). 
To correct for possible effects of the CFSE 
label, the experiments were conducted in 
duplicate; withreversing combinations of 
CFSE label and compound treatments.  
As previously observed [19, 23], GADS 
formed microclusters upon stimulation 
(Figure 4). The large majority of the cells 
interacted with single αCD3 + αCD28 spots 
and were positioned in such a manner that 
the spot was in the center of the contact. 
As expected, GADS clusters were mainly 
present on the spots, but they were also 
found on peripheral fibronectin.  
To elucidate the potential impact of the 
peptide and the conjugates on cluster for-
mation, the images were analyzed using 
quantitative image processing. To correct 
for a possible effect of CFSE, we pooled the 
data of two samples that differed only in 
respect to the group of cells that was 
treated with the CFSE label. The data was 
normalized per image as described previ-
ously [39]. Remarkably, whereas no 
difference in cluster density was observed 
between HPMA-SLP228 and HMPA-
control-treated cells on fibronectin, on the 
αCD3 + αCD28 spots the multivalent 
SLP228 conjugate caused cluster densities 
to be 22% higher (Figure 5A). Treatment 
with free SLP228 did not have a significant 
effect on GADS clustering (Figure 5B), 
which was in line with the 28% difference 
in cluster density on spots when HPMA- 
Figure 4. GADS clustering in conjugate and peptide-treated T cells. Jurkat T cells were labeled with 
CFSE or mock labeled and after overnight serum starvation microporated with 50 µM monovalent 
SLP228, 16.7 µM HPMA-SLP228 or 16.7 µM HPMA-control. Loaded cells and controls were subse-
quently coincubated on micropatterned surfaces of αCD3 + αCD28 spots overlaid with fibronectin. 
After fixation and permeabilization, cells were immunostained with αGADS. Left to right: CFSE, im-
munofluorescence, composite image of the stamped pattern (blue) and the immunolabel (grayscale) 
and transmission images. Some of the GADS microclusters are indicated with arrows. In the compo-
site image, the contrast and brightness for both channels were adjusted proportionally for clarity. 
CFSE channels were recorded with saturated signals to facilitate image processing. nl: no label. Scale 
bars: 15 µm. 
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SLP228 and free SLP228 were compared 
(Figure 5C).  
Besides the effect of the multivalent 
SLP228 construct on GADS cluster density, 
we also quantified cell spreading, surface 
preference [39], overall GADS signal inten-
sity and cluster-specific GADS signal inten-
sity (Supporting Figure S5). In the presence 
of the HPMA-SLP228 conjugate the overall 
and cluster-specific GADS signal on spots 
was higher in three out of five cases, in 
comparison to HPMA-control. For the oth-
er parameters no conjugate-specific 
effects were observed, thus demonstrating 
that the impact of the scaffold was limited 
to cluster formation. 
 
When inside cells, the HPMA-SLP228 con-
struct reproduced the effect seen on 
microarrays; no inhibition of cluster for-
mation was observed for the monovalent 
peptide. This lack of an effect may also be 
attributable to the fact that this peptide is 
rapidly degraded inside the cell [35]. Be-
sides creating multivalency, coupling to the 
HPMA scaffold also affords proteolytic sta-
bilization [34]. 
The results with the HPMA-SLP228 conju-
gate prove that multivalent presentation 
of interaction domains can modulate com-
plex formation in early T cell signaling. 
Futhermore, peptide microarrays provide a  
 
Figure 5. The effect of HPMA-SLP228 on GADS cluster densities. The GADS cluster densities for cells 
treated with different constructs and on different surfaces were quantified and normalized on a per-
image basis. Normalization was done towards the mean cluster density of the four conditions within 
an image. The values of both CFSE labeling orientations of the side-by-side comparison of two con-
structs were pooled to eliminate possible artifacts arising from the CFSE label. The graphs depict 
stimulus and peptide-construct dependence of the GADS cluster densities (mean ± SEM). A) GADS 
cluster densities of cells treated with HPMA-SLP228 in comparison to cells treated with HPMA-
control on αCD3 + αCD28 spots and fibronectin (n = 16 images, in total containing 737 HPMA-
SLP228 cells and 668 HPMA-control cells). B) GADS cluster densities of cells treated with monovalent 
(free) SLP228 in comparison to cells treated with HPMA-control on αCD3 + αCD28 spots and 
fibronectin (n = 16 images, in total containing 891 free SLP228 cells and 710 HPMA-control cells). C) 
GADS cluster densities of cells treated with HPMA-SLP228 in comparison to cells treated with free 
SLP228 on αCD3 + αCD28 spots and fibronectin (n = 16 images, in total containing 803 HPMA-
SLP228 cells and 792 free SLP228 cells). Corrected model p values (mod) were determined by two-
way factorial ANOVAs. In cases in which no significant interaction factor was found (int), a model in 
which no interaction term was included was used to determine the significance of the stimulus 
(stim) and the constructs (constr) on GADS cluster density. (Quantification of other signaling proper-
ties can be found in Supporting Figure S5.)  
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powerful and straightforward means to 
characterize conjugates for the induction 
of complex formation. As shown by the 
peptide microarray experiments, multiva-
lent conjugates can exhibit non-linear 
dose-response functions, with promotion 
of complex formation only observed within 
a certain concentration range (Figure 6A). 
At higher concentrations, additional conju-
gates inhibit the binding of multiple target 
proteins to a single construct (Figure 6B). 
Similarly, the number of moieties per scaf-
fold can modify the effect of multivalency. 
By increasing the number of binding sites 
per backbone, the avidity and the cross-
linking potential of a construct can in-
crease without increasing the overall 
concentration of moieties. Increasing the 
valency of a conjugate has been shown to 
increase effectiveness in the context of 
plasma membrane receptors and multiva-
lent ligands [40-42]. Given the complexity 
of the experiments, we limited ourselves 
to a polymer carrying (on average) three  
peptides per backbone. We hypothesized 
that this number is sufficient for promot-
ing interactions. 
Inside the cell the HPMA-SLP228-induced 
increase in GADS clusters can be explained 
by direct recruitment of GADS to the con-
jugate (Figure 6C). However, to promote 
the recruitment of other signaling pro-
teins, further complex formation is 
required. The microarray experiments 
showed an increase in GADS accumulation 
on phosphorylated LAT peptides upon 
treatment with HPMA-SLP228. One mech-
anism by which HPMA-SLP228 could 
stimulate complex formation is by cross-
linking LAT proteins through GADS, similar-
ly to the way SOS1 has been shown to do 
so through GRB2 [20].  
The multivalent presentation of interaction 
motifs originating from different signaling 
 
 
Figure 6. Model for the mode-of-action of multivalent HPMA-SLP228. A) At lower concentrations 
the multivalent conjugate increases GADS accumulation on peptide microarrays through engage-
ment of several proteins. B) This does not occur at higher concentrations. C) Inside living cells, 
HPMA-SLP228 promotes the formation of GADS complexes and microclusters directly (left). In addi-
tion, GADS proteins linked by a single conjugate might bridge neighboring scaffold proteins such as 
LAT (right). 
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proteins might enable the introduction of 
signaling shortcuts by establishing novel 
connections [43]. Ideally, the synthesis of 
such conjugates should employ strategies 
for a sequential, non-stochastic coupling of 
functional moieties [44]. For cellular entry, 
ligation of a cell-penetrating peptide (CPP) 
can be employed, as has been used suc-
cessfully for the delivery of apoptosis-
inducing HPMA constructs [30, 34]. CPPs 
linked to another SLP76 peptide (SLP184) 
have been used to disrupt the interaction 
between SLP76 and ITK in living cells and 
thereby inhibit ITK phosphorylation and 
Th2-specific cytokine production [45]. 
Gruimond et al. [46] subsequently showed 
that this peptide can reduce inflammation 
of the lungs in a murine model of allergic 
asthma. These studies illustrate the poten-
tial of bioactive peptides in the preclinical 
setting. The modular assembly of stable 
synthetic scaffolds in the form of multiva-
lent signaling peptides can be a valuable 
tool in the future development of clinical 
agents. 
 
 
Experimental Procedures 
 
Peptides and HPMA constructs 
The peptides LATpY132, LATpY191, SLP179 
and SLP228 (corresponding to known in-
teraction motifs of T cell signaling proteins) 
were purchased from EMC Micro-
collections (Tübingen, Germany) as pep-
tide amides (Supporting Figure S1). For 
coupling to HPMA an N-terminal cysteine 
residue was included. The preactivated N-
(2-hydroxypropyl)methacrylamide copol-
ymer N-methacryloyglycylglycine p-
nitrophenyl ester was acquired from Poly-
mer Laboratories (Church Stretton, UK), 
had an average molecular mass of 28.5 
kDa (Mw/Mn: 1.32) and a total nitrophenol 
Table 1. Titration of protein-protein interactions in the LAT-signalosome 
with interfering peptides
[a]
 
peptide LAT-PLCγ1 SLP76-PLCγ1 SLP76-GADS 
LATpY132 0.5 µM
[b,c]
 0.5 µM no effect 
SLP179 no effect 20-30 µM no effect 
SLP228 no effect 5-10 µM 5 µM 
LATpY191 10 µM
[b]
 nd no effect 
DMF control no effect no effect no effect 
 
a
The IC50 values of peptides for protein-protein interactions in the LAT signalosome as determined by 
FCCS (in part published in refs. [26, 47]). no effect: For up to 30 µM of the respective peptide, no sys-
tematic titration-dependent decrease of the cross-correlation amplitude was observed. DMF was 
employed at 1% (v/v) in the lysate, corresponding to the DMF concentration at 30 µM peptide. nd: 
not determined. Examples of the titration curves from which the values were obtained can be found 
in Supporting Figure S2. 
b
Published previously in ref. [26]. 
c
Published previously in ref. [47]. nd: not 
determined. 
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content of 8.28 mol% (approximately 12.5 
reactive groups per molecule). Following 
transesterification of the p-nitrophenyl es-
ter into a benzyl thioester, the peptides 
were conjugated by native chemical liga-
tion as described before [30]. On average 
approximately three SLP228 peptides per 
backbone were present (based on the ex-
cess of peptide in the coupling reaction). 
For visualization, a cys(carboxyfluorescein) 
moiety was introduced. HPMA-control was 
made by deactivating the benzyl thioester 
polymer in an aqueous environment. For 
the FCS experiments, this was preceded by 
the coupling of a cysteine C-terminally la-
beled with carboxyfluorescein (Supporting 
Figure S1B). 
 
Cell culture, pervanadate stimulation and 
preparation of cell lysates 
Jurkat E6.1 T cells (TIB-152; ATCC, Wesel, 
Germany) were cultured in RPMI 1640 
with stable glutamine, NaHCO3 (2.0 g/L 
PAN-Biotech, Aidenbach, Germany) and 
heat-inactivated fetal bovine serum (10%, 
FBS, PAN-Biotech). Cultures were grown to 
approximately 7 ∙ 10
5
 cells/mL at 37 °C 
with CO2 (5%) under humidified conditions 
and passed by dilution every 2 – 3 d.  
For stimulation of phosphotyrosine-
dependent complex formation in Jurkat 
cells, the broad-range phosphatase inhibi-
tor sodium pervanadate was generated in 
a freshly prepared mixture of equal vol-
umes of Na3VO4 (10 mM) and H2O2 (10 
mM) in HBS buffer (HEPES (10 mM, pH7.4), 
NaCl (135 mM), KCl (5 mM), MgCl2 (1 mM), 
CaCl2 (1.8 mM)). The solution was incu-
bated at room temperature for 15 min and 
used immediately after tenfold dilution. 
For activation, cells suspended in 
HBS/BSA/glucose (HBS with BSA (0.1% 
(w/v) and glucose (5mM)) were incubated 
with pervanadate for 20 min at 37 °C.  
Cell lysates were prepared by suspending 
cells in lysis buffer (Tris (20 mM, pH 7.5), 
Triton X-100 (1%), EDTA (1 mM), NaCl (150 
mM), n-octyl-β-D-glucopyranoside (50 
mM, Fluka/Sigma-Aldrich, München, Ger-
many), Na3VO4 (1 mM), Complete Protease 
Inhibitor Cocktail (Roche Applied Science, 
Mannheim, Germany)). After lysis on ice 
for 60 min, the crude lysates were clarified 
by centrifugation (20,000 g, 15 min). n-
octyl-β-D-glucopyranoside ensures the ef-
ficient extraction of transmembrane 
proteins such as LAT from lipid rafts.  
 
FCCS peptide competition experiments in 
cell lysates 
For peptide competition experiments, cell 
lysates (10
6
 cells per 20 µL) were mixed 
with peptides at the indicated final con-
centrations. FCCS measurements and 
analyses and IC50 determinations were per-
formed as described previously [26, 47] 
using a ConfoCor2 dual channel fluores-
cence correlation microscope (Carl Zeiss, 
Jena, Germany) equipped with a C-
Apochromat water immersion lens (40 × 
1.2 N.A.). Fluorophores were excited an 
argon ion laser (488 nm) and a helium 
neon laser (633 nm) and fluorescence de-
tected through a 500 - 550 nm band-pass 
filter and a 650 nm long-pass filter. The 
fluorescence signals of both channels were 
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separated using a 610 nm dichroic mirror. 
Ten measurements (15 s each) were re-
corded for each experimental condition. 
Autocorrelation functions were fitted using 
the FCS software of the ConfoCor2. Fit 
functions for cross-correlation functions 
accounted for one diffusing species. The 
antibodies used to label the endogenous 
proteins involved in interactions were 
αLAT (mouse IgG1, clone 11.B12; Upstate, 
Hamburg, Germany), αSLP76 (mouse 
IgG2a, clone 2B2.98; US Biological, 
Swampscott, MA), αPLCγ1 (rabbit poly-
clonal; Santa Cruz Biotechnology, 
Heidelberg, Germany) and αGADS (rabbit 
polyclonal, Merck Millipore, Amsterdam, 
The Netherlands). The secondary antibod-
ies were Alexa488- and Alexa633-
conjugated goat-α-mouse IgG and goat-α-
rabbit IgG (Molecular Probes, Leiden, The 
Netherlands). 
 
Generation of peptide microarrays 
The peptides (Supporting Table S1; EMC 
Microcollections) corresponded to known 
interaction motifs of proteins involved in T 
cell signaling, extended by a cysteine resi-
due at the N-terminus and with C-terminal 
amidation. The cysteine residue was in-
cluded to provide the sulfhydryl group as a 
further functionality for immobilization on 
epoxy-preactivated microarray substrates. 
Peptides were dissolved (3 mM) in N,N-
dimethylformamide (DMF). For immobili-
zation, peptide solutions were diluted 
(1:30) in phosphate buffer (100 mM, pH 8) 
containing Triton X-100 (0.006% v/v). 
Slides preactivated with N-hydroxy-
succinimide esters (Nexterion Slide H, 
Schott Nexterion/Peq-Lab, Erlangen, Ger-
many) were used as substrates for 
immobilization. Peptide microarrays were 
spotted using a Nano-Plotter NP2.0 
(GeSIM, Großerkmannshof, Germany), 
which employs piezo-driven pipetting tips 
for the dispensing of peptide solutions. 
Each microarray consisted of 16 subarrays 
comprising doublets of each peptide (1.2 
nL peptide spots; center-to-center spacing 
500 µm). Spotting was conducted at 15 °C 
with an air humidity of 65% to ensure slow 
drying and thus sufficient immobilization 
to the substrate. 
 
In vitro incubation of synthetic scaffolds 
with cell lysates on peptide microarrays 
After cell lysis, SLP228 peptide (0.5 or 2 
µM) or the HPMA-(SLP228)3 scaffold (0.167 
or 0.67 µM) was added to the lysate. The 
respective concentration of free HPMA 
backbone was used as a control. 
Incubation of the 16 subarrays with differ-
ent samples was achieved by fixing a 16-
well clip-on frame (Grace Bioloabs 
ProPlate Multiarray System, Molecular 
Probes/Life Technologies) onto the micro-
array slide. Microarrays were incubated 
with lysates (50 µL, 106 cells per subarray) 
for 1 h at 4 °C and then washed three 
times with washing buffer (PBS with BSA 
(0.05% w/v) and Tween-20 (0.05 % w/v)). 
For the detection of bound protein by indi-
rect immunofluorescence, microarrays 
were incubated with rabbit polyclonal 
αGADS antibody (2 µg/mL) diluted in 
washing buffer for 15 min at room tem-
Chapter 5 
 
154  
 
perature and washed three times with 
washing buffer. The microarrays were then 
incubated with a goat-α-rabbit Alexa-Fluor 
633-conjugated secondary antibody (1 
µg/mL) for 10 min at room temperature, 
followed by a final washing step with 
washing buffer. For the primary antibody, 
a negative control was carried out by 
immunostaining one subarray without pri-
or incubation with lysate. Finally, 
microarrays were dried with a stream of 
nitrogen and scanned (ProScanArray, 
PerkinElmer Life Sciences, Waltham, MA). 
Processing of the signals was as described 
previously using ArrayPro Analyzer (Media 
Cybernetics, Rockville, MD, USA) [28].  
Signals on microarrays were obtained by 
subtraction of the median of background 
signal intensities from the mean of signal 
intensities on a peptide spot. For local 
background values, signal intensities with-
in a local ring surrounding the respective 
peptide spot were used. For comparison of 
signal intensities, normalization was per-
formed in order to correct for differences 
in signal intensities between single micro-
array experiments. The signal intensity for 
each peptide was divided by the sum of all 
signal intensities of the respective microar-
ray. Finally, the obtained values were 
multiplied by 1000. 
 
Microporation 
Cells were washed with HBS once and re-
suspended in Resuspension Buffer R from 
the Neon Transfection System 10 mL Kit 
(Life Technologies, Bleiswijk, The Nether-
lands) to 2∙10
7
 cells/mL. (Fluo-)HPMA-
SLP228 or (Fluo-)HPMA-control was added 
(16.7 µM) shortly before microporation 
(three pulses of 10 ms, 1325 V, 10 µL tips) 
with the Neon Transfection System (Life 
Technologies). After microporation, the 
cells were allowed to recover in serum-
free RPMI (500 µL) for 1–6 h at 37 °C de-
pending on the experiment. For FCS 
measurements, medium without phenol 
red was used. 
 
Intracellular FCS and image-wide concen-
tration determination 
Jurkat E6.1 cells were serum-starved over-
night, and then microporated as described 
above. After recovery, the cells were 
washed twice and resuspended in serum-
free RPMI (no phenol red), then the cell 
suspension (200 µL) was transferred into a 
well of an eight-well Nunc chambered 
coverglass (Thermo Scientific). APD imag-
ing was performed with a TCS SP5 confocal 
laser scanning microscope equipped with 
an HCX PL APO 63 × 1.2 N.A. water-
immersion lens (Leica, Mannheim, Germa-
ny). An argon-ion laser (488 nm) was used 
for excitation and fluorescence (500-550 
nm) was recorded at a lateral sampling 
rate of 481 nm (512 ∙ 512 pixels). For each 
imaged field, three cells were chosen for 
intracellular FCS. For each cell, nine meas-
urements (10 s, 3 s intermissions) were 
performed with the FCS unit of the TCS 
SP5. The respective field was then imaged 
again to confirm that the cell had not mi-
grated away from the detection volume. 
Autocorrelation functions were calculated 
with ISS Vista software, version 3.6 RC (ISS, 
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Champaign, IL) and these functions were 
fitted to a triplet Gaussian model contain-
ing one diffusing component and a triplet 
term with GlobalsWE software (Laboratory 
for Fluorescence Dynamics, University of 
California, CA). Structure parameters and 
intracellular fluorophore concentrations 
were determined as described before [35] 
by using a fluorescein standard (20 nM) 
and Prism (Version 4.00; GraphPad Soft-
ware). The calculated detection volume 
was 0.24 fL. Cells that did not yield reliable 
subsequent measurements were not used 
for further analysis.  
The fluorophore concentrations within 
other cells in the images were estimated 
by relating the respective average cellular 
fluorescence intensities to those of the 
cells in which concentrations were meas-
ured by FCS. The process was as follows. A 
cell mask was generated from the image 
from the fluorescein channel with Fiji [48]. 
Using this mask, the average intensity of 
each cell within the image was deter-
mined. For cells for which the fluorescein 
concentration was determined by FCS, the 
ratios of fluorescein concentrations over 
cell intensities were taken and averaged. 
This average ratio was subsequently used 
to estimate the concentration of the con-
struct in the other cells within that image.  
 
Microcontact printing 
Silicon master templates, polydimethyl-
siloxane (PDMS) stamps and micro-
patterned stimulating surfaces on micros-
copy slides were generated as described 
previously [39] with the following adapta-
tions. Stamps patterned with 5 µm spots 
were coated with a solution of αCD3 (12.5 
µg/mL; mouse monoclonal IgG2a, clone 
OKT3), αCD28 (12.5 µg/mL; mouse mono-
clonal IgG2a, clone 9.3), unspecific murine 
IgG2a (75 µg/mL; clone UPC 10; Sigma-
Aldrich) and goat-α-guinea pig Alexa-Fluor 
647 (7 µg/mL; Life Technologies) in PBS. 
The latter was added, not to interact with 
biological molecules, but to serve as a fluo-
rescent marker to identify the stamped 
areas of the microscopy slides. The αCD3 
and αCD28 antibodies were kindly provid-
ed by Prof. Dr. Gundram Jung (Dept. of 
Immunology, University of Tübingen, Ger-
many). An overlay of fibronectin (20 
µg/mL; Roche) in PBS was used to func-
tionalize the non-stamped areas of the 
microscopy slides. 
 
Cell stimulation and immunocytochemis-
try 
Jurkat E6.1 cells were labeled with 
carboxyfluorescein diacetate succinimidyl 
ester cell tracer (1 µM; Molecular Probes, 
Life Technologies) or mock labeled at 1∙10
6
 
cells/mL according to the supplier’s proto-
col and subsequently serum starved 
overnight. Cells were then microporated as 
described above. After recovery, samples 
with/without CFSE and microporated with 
different constructs were paired, pooled, 
resuspended in serum-free RPMI (100 µL) 
and seeded onto the stimulatory, stamped 
patterns. The cells were incubated (37°C, 
10 min) and subsequently fixed with para-
formaldehyde (3%; Merck Millipore) for 10 
minutes at 4 °C and 15 minutes at room 
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temperature. After fixation the samples 
were washed three times with PBS and 
permeabilized with saponin buffer (PBS 
containing saponin (0.1%) and BSA (0.1%)) 
for 15 min. The samples were then labeled 
with αGADS (2 µg/mL in saponin buffer) 
for 1 h, washed three times with saponin 
buffer for 5 min and incubated with Alexa-
Fluor-546-conjugated goat-α-rabbit (4 
µg/mL in saponin buffer; Life Technolo-
gies) for 1 h. Samples were washed three 
times (PBS, 5 min) and finally coverslips 
were mounted using Mowiol mounting 
medium (Merck Millipore). 
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Supporting Information  
 
 
Figure S1. The four different peptides used and their designations (A). Overview of the used con-
structs without (left) or with (right) fluorescent markers (B). Schematic representations of the 
structural formulae of the random HPMA copolymer constructs represent the average polymer of 
that type.  
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Figure S2. Cross-correlation amplitudes for the titration of interactions in the LAT-signalosome 
with interfering peptides in Jurkat cell lysates at 10
6
 cells/20 µL. A) Titration of the SLP76-PLCγ1 
interaction in lysates of pervanadate-treated Jurkat T cells with peptides LATpY132, SLP228 and 
SLP179. B) Titration of the SLP76-GADS interaction in lysates of resting (rest) and pervanadate-
treated (PV) Jurkat T cells with peptide SLP228. Dotted lines represent mean cross-correlation am-
plitudes in lysates without peptide addition for pervanadate-treated cells (PV), resting cells (rest) 
or lysis buffer instead of lysate (buffer). Mean values and standard deviations of 10 repeated 
measurements of a representative experiment. 
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Figure S3. Effect of monovalent SLP228 and HPMA-SLP228 on the binding of GADS to peptide mi-
croarrays – overview over all arrayed peptides. Lysates of both, resting and pervanadate-
stimulated (PV) Jurkat T cells were incubated on microarrays in the presence of either monovalent 
SLP228 or HPMA-SLP228. For HPMA-SLP228 the concentration refers to that of the ligated SLP228 
peptide, for the HPMA control to that of the backbone. Colored squares represent the ratio of signal 
intensities of peptide/conjugate-treated over untreated lysates and the coefficient of variation (CV). 
Whites squares mean no signal, crossed out squares represent a loss of signal upon treatment. Pep-
tides were arranged from top to bottom according to the relative signal intensities detected without 
peptide and pervanadate treatment. These results represent the mean values of 3 independent ex-
periments. Even though it is impossible to provide explanations for all individual peptides, these 
findings indicate that the multivalent conjugate promotes the formation of complexes, which in turn 
have the capacity to bind to the arrayed peptides. Importantly, these results demonstrate that the 
multivalent conjugate possesses properties that are qualitatively different from the one of the 
monovalent peptide. 
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Figure S4. Intracellular fluorescence and concentration of HPMA-conjugates. A) Correlation be-
tween intracellular fluorescein concentrations determined by FCS (Figure 3) and cell intensities in 
APD images. Top: Cells microporated with fluo-HPMA-SLP228. Bottom: Cells microporated with 
fluo-HPMA-control. B) The average intensities of fluorescein per cell as determined through APD 
imaging ± standard deviation. Fluo-HPMA-SLP228: n = 36 cells (from 3 APD images), fluo-HPMA-
control: n = 56 cells (from 3 APD images). 
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Figure S5. Impact of conjugates and free SLP228 peptides on cell spreading and GADS clusters 
and signals. Cell spreading (top row) and spot preference (second row) were normalized on a per 
image basis to the respective mean value of the two types of cells present in that image. To 
exculde possible CFSE effects, the values were pooled with values from samples in which the CFSE 
labeling orientations were reversed. The p-values at the top of the graphs represent two-sample T-
tests and the p-values within the bars of the spot-preference-score (second row) represent the sig-
nificant difference from test value 1 of these treatments as determined by one-sample T-tests. The 
overall fluorescent GADS signal (third row) and the cluster specific GADS signal (bottom row) were 
analyzed in the exact same manner as was the GADS cluster density as decribed in Figure 5. The 
graphs depict the stimulus and peptide construct dependence of the various properties as the 
mean ± SEM. For the comparison of HPMA-SLP228 and the control HPMA treated cells (left) n = 16 
images were analyzed, in total containing 737 HPMA-SLP228 cells and 668 control HPMA cells. For 
the comparison of free SLP228 and the control HPMA treated cells (middle) n = 16 images were 
analyzed, in total containing 891 free SLP228 cells and 710 control HPMA cells. For the comparison 
of HPMA-SLP228 and free SLP228 (right) treated cells n = 16 images were analyzed, in total con-
taining 803 HPMA-SLP228 cells and 792 free HPMA cells. 
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Table S1. Arrayed peptides in peptide microarray experiments.  
peptide
[a]
 sequence
[b]
 binding motif 
for domain 
(domain sub-
type) 
Source 
(UniProt 
ID) 
interacting  
partners 
(UniProt ID) 
WIP446 CEDEWESRFYFHPISDLPPP-
CONH2 [49] 
WH1 WIP 
446-464 
(O43516) 
WASP 
(P42768) 
LATpY191 CEASLDGSRE(pY)VNVSQEL-NH2 
[50, 51] 
SH2 (GRB2, 
SHP/PLC, SFK 
type) 
LAT  
181-198 
(O43561) 
VAV (P15498), 
GADS (O75791), 
GRB2 (P62993), 
PLCγ1 (P19174) 
GAB2pY614 CKSTGSVD(pY)LALDFQPS-NH2 
[52] 
SH2 Gab2 
607-621 
(Q9UQC2) 
SHP1 
(P29350) 
LATpY132 CEDEDDYHNPG(pY)LVVLPDSTP-
NH2 [50, 53] 
SH2 (SHP/PLC 
type) 
LAT 121-
141 
(O43561) 
PLCγ1 
(P19174) 
SigpY437 CGEEREIQ(pY)APLSFHKG-NH2 
[54] 
SH2 (SHP/PLC, 
SFK-type) 
SIGLEC-7 
430-445 
(Q9Y286) 
SHPTP1 (P29350), 
SHPTP2 (Q06124) 
Fyb pY595 CEDDQEV(pY)DDVAEQD-NH2 
[55] 
SH2 Fyb 
589-602 
(O15117) 
FYN (P06241), 
SLP76 
(Q13094) 
Fyb pY651 CLDMGDEV(pY)DDVDTSDF-
NH2 [55] 
SH2 Fyb 
644-659 
(O15117) 
SLP76 
(Q13094) 
FYB pY771 CNDGEI(pY)DDIADG [56] SH2 Fyb, 
767-777 
(O15117) 
c-Src 
(P12931) 
PLCγpY783 CEGRNPGF(pY)VEANPMPT-
NH2 [57] 
SH2 (SFK type) PLCγ1  
775-791 
(P19174) 
PLCγ1 intramolecu-
lar (P19174) 
ZAPpY319 CVYESP(pY)SDPEELKD-NH2 [58] SH2 (GRB2, 
SFK type) 
ZAP70  
314-327 
(P43403) 
LCK  
(P06239) 
LATpY226 CEVEEEGAPD(pY)ENLQELN-
NH2 [59] 
SH2 (GRB2, 
SFK-type) 
LAT 217-
233 
(O43561) 
GADS (O75791), 
GRB2 (P62993), 
VAV (P15498) 
SHP1pY564 CSKHKEDV(pY)ENLHTKNK-NH2 
[60] 
SH2 (GRB2 
type) 
SHP1  
557-572 
(P29350) 
LCK (P06239) 
CD28pY202 CTRKHYQP(pY)APPRDFAA  [61] SH2 CD28 
202-217 
(P10747) 
Grb2 
(P62993) 
Chapter 5 
 
166  
 
CD3ζpY72/83 C-Ahx-
NQL(pY)NELNLGRREE(pY)DVL-
NH2 [62] 
Tandem-SH2 
(ITAM) 
CD3ζ 
ITAM1 69-
86 
(P24161) 
ZAP70 (P43403) 
SLP179 CSGKTPQQPPVPPQRPMAAL-
NH2 [63] 
SH3 (type II) SLP76  
179-197 
(Q13094) 
PLCγ1 (P19174) 
SLP182 CTPQQPPVPPQRPMAALPPP-
NH2 [63] 
SH3 (type II) SLP76 
182-200 
(Q13094) 
PLCγ1 (P19174) 
PAK6 CLDIQDKPPAPPMRNT-NH2 [64] SH3 (type II + 
atyp.) 
PAK1 6-20 
(Q13153) 
NCK (P16333) 
GAB2-509 CQPPPVNRNLKPDRKAKPTPLD-
NH2 [65] 
SH3 (atyp.) Gab2 
509-539 
(Q9UQC2) 
Grb2 
(P62993) 
SLP228 CAKLPAPSIDRSTKPPLDRS-
CONH2 [66] 
SH3 (atyp.) SLP76  
228-246 
(Q13094) 
GADS (O75791) 
UBP8-403 CNVPQIDRTKKPAVKLPEE-NH2  
[67] 
SH3 (atyp.) UBP8 
403-420 
(P40818) 
Hbp 
(O60381) 
CD2-292 CGHSHRPPPPGHRVQ-NH2 [68] SH3 CD2 
292-305 
(P06729) 
Fyn 
(P06241) 
 
[a] Peptide designations are derived from the protein containing the peptide sequence; for 
phospho-tyrosine (pY) peptides the number designates the position of the pY residue within the pro-
tein, for other peptides the number designates the first amino acid in the peptide. [b] For all 
peptides, an additional Cysteine was added at the N-terminus. 
 
 
Macro S1. Fluorescence associated with spots of αCD3 and αCD28 was extracted with a 
self-written macro (Fiji). The macro segments the stimulating surface in spots and overlay, 
separates CFSE labeled and unlabeled cells and defines signaling clusters. The macro is 
available free of charge via the internet at 
http://onlinelibrary.wiley.com/doi/10.1002/cbic.201402622/abstract as a .txt file. Guide-
lines to determine threshold values are included in the macro. 
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Introduction 
Protein microclusters of receptors and in-
tracellular signaling proteins are the first 
detectable signs of activation in T cells en-
countering their antigen and play a role in 
the organization of the IS [1]. The TCR and 
other receptors involved in the activation 
and/or modulation of the T cell response 
were shown to form microclusters, fol-
lowed by intracellular scaffold and adaptor 
proteins such as LAT and GRB2 and effec-
tor proteins such as PLCγ1. Many studies 
have quantitatively addressed the number 
of proteins within a microcluster [2-4], 
their colocalization and phosphorylation 
[5, 6], their migration over time [7-10] and 
conditions, proteins and domains required 
for their formation [4, 6, 9, 11-15].  
 
The importance of the involvement of lipid 
rafts in microcluster formation is still being 
debated [16-18], but protein microclusters 
are considered as vital for T cell activation 
following pMHC recognition. Microclusters 
of the TCR, for example, have recently 
been implicated to be mandatory for signal 
transduction, as T cells in vitro needed to 
encounter clusters of at least four pMHCs 
for a calcium response to occur [19].  
Thus far, however, little is known about 
how different stimuli influence the number 
and composition of protein microclusters. 
In order to address this question, methods 
are required to simultaneously expose T 
cells to different types of stimuli and per-
form a quantitative analysis of cluster 
formation (chapter two). Furthermore, 
with respect to the molecular mechanisms 
underlying clustering of membrane proxi-
mal proteins, it remains to be shown to 
what extent cluster formation is driven by 
remodeling of the cytoskeleton, by pro-
tein-lipid interactions and by protein-
protein interaction networks.  
Synthetic peptides corresponding to 
known interaction motifs of signaling pro-
teins represent a promising means to 
modulate protein-protein interactions in 
cellular signal transduction and can eluci-
date the functional significance and 
interdependence of specific interactions 
[20-24]. However, often such peptides are 
not intrinsically cell permeable and for 
their efficient introduction into cells they 
either have to be ligated to a CPP [25] (and 
chapter four) or imported through other 
means. Furthermore, once cytoplasmic, it 
is important that these peptides remain 
stable long enough to perform their in-
tended effect by avoiding proteolysis. For 
the targeted design of functional peptides 
it is therefore important to gain insight in-
to the effects of peptide composition on 
their intracellular pharmacokinetics.  
Peptides designed to modulate cellular 
signaling have one of two effects: they in-
hibit enzymatic activity or disrupt protein-
protein interactions (chapter one). In con-
trast, the establishment of new inter-
actions in signaling pathways could also be 
a valuable tool in signal transduction re-
search. Linking peptides to a linear 
backbone to generate a multivalent ligand 
has previously been shown to increase 
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peptide activity in cells [26]. Constructs of 
multiple, covalently linked, signaling pep-
tides might facilitate the generation of 
new protein-protein interactions and 
thereby enable the creation of novel sig-
naling pathways.  
The overall aim of this thesis was to in-
crease knowledge on how protein-protein 
interactions and costimulation underlie 
signaling complex and protein microcluster 
formation in T cell signal transduction by 
providing novel methods to address these 
issues. For this purpose in chapter two a 
method was introduced that enabled the 
comparison of protein microcluster densi-
ties and phosphorylation levels in two cell 
types, on two different stimuli in a single 
sample. Using this method it was demon-
strated that the costimulatory receptor 
CD28 and SHP2 affect phosphotyrosine 
microclusters in qualitative and quantita-
tive distinct manners.  
In chapter three we explored electro-
poration as a means to introduce peptides 
into the cytoplasm of cells and showed 
that even though the delivery efficiency 
was largely independent of the physico-
chemical characteristics of peptides of 
similar size, the stability of these peptides 
varied greatly. The effects of a crosslinked 
CPP on import and membrane stability was 
tested in chapter four. Efficient delivery 
vehicles are key to investigate intracellular 
effects of peptides that have shown activi-
ty against isolated proteins. Interestingly, 
instead of strongly increased cell penetra-
tion, the multivalent presentation of R9 
resulted in a heparan sulfate-independent 
increase of membrane disturbance and 
toxicity demonstrating that for multivalent 
conjugates multivalency of the CPP is a 
critical parameter.  
Finally, in chapter five the effect of 
multivalency was investigated in the set-
ting of protein complex formation in 
cellular signaling. Peptides representing an 
SH3 domain-binding region of SLP76 were 
coupled to a linear HPMA backbone. This 
conjugate enhanced peptide stability and 
created a minimal synthetic scaffold pro-
tein that increased connectivity in protein 
interaction networks and stimulated the 
formation of GADS microclusters. 
 
Microcluster formation on micro-
patterned surfaces 
The immobile nature of stimuli on the 
micropatterned surfaces makes them an 
excellent tool to quantitatively compare 
the effect of different stimuli on protein 
clustering (chapter two). Micropatterned 
surfaces can be considered an extension of 
antibody-coated coverslips used in early 
studies by Bunnell et al. [5, 13]. The 
micropatterned stimuli fill a unique niche 
within the field of the analysis of 
microcluster formation. The technique 
provides a valuable, internal control to 
whether cells actively respond to a stimu-
lus. This is useful even when the focus of 
the research is not on a comparison of 
stimuli because cluster-like structures may 
also be observed in the absence of stimu-
lation [27]. In addition, the manner in 
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which the micropatterned surfaces have 
been used here allows for many cells to be 
studied simultaneously, thereby increasing 
statistical power and eliminating observer 
bias in the selection of cells. The spotted 
array used in chapter five has the addi-
tional benefit of cells orienting themselves 
in an orderly fashion across the surface, 
making them less likely to form aggre-
gates, which in turn facilitates the 
identification of cell edges in quantitative 
image processing.  
As shown in the analysis of CD28 
costimulation and SHP2 deficiency, the 
possibility of incubating two different cell 
lines in a single sample provides a reliable 
means for finding small differences be-
tween cell lines or treatments (chapter 
two). This last feature can also be easily 
implemented in other techniques such as 
supported planar bilayers or any technique 
with samples in which only small variations 
between conditions might occur. Increas-
ing imaging resolution of the contact area 
could be considered for future implemen-
tations of the technique. The use of TIRF 
[28] or super-resolution microscopy tech-
niques [27, 29] will likely resolve more 
details about individual clusters, but would 
restrict the possibility of imaging multiple 
contacts simultaneously as this requires 
imaging of larger areas.  
There were three motivations to quantify 
data on a per image and not on a per cell 
basis in this thesis: 1) Enabeling the quanti-
fication of large numbers of cells 
simultaneously and of different cell types 
in parallel. 2) Completely eliminating ob-
server bias by selecting images based only 
on the quality of the stamped surface and 
cell number as observed without fluores-
cence. 3) Irregularly shaped cells and 
groups of touching cells prevented image 
analysis protocols from properly distin-
guishing cells of the same type.  
As a consequence, data concerning cluster 
densities, phosphorylation levels, spread-
ing etc. only indicate the averages found 
for particular conditions. This provided 
valuable information on what happens to 
cell populations as a whole, but infor-
mation on how these averages are 
established were not acquired. To what 
degree observed increases in cluster densi-
ties and phosphorylation levels (chapters 
two and five) are the result of an increase 
in a fraction of the cells or are due to a uni-
form difference throughout the population 
remains to be determined. However, it is 
generally known that T cells demonstrate 
considerable heterogeneity in their re-
sponses [30] (and chapter two) making it 
plausible that the differences observed are 
largely due to larger increases in a fraction 
of the population. Future work could de-
termine the ratio of cells that respond 
strongly to the CD28 costimulus and which 
appear relatively unaffected.  
Additionally, future improvements of the 
technique can be to increase the number 
of stimuli being compared. Comparing 
more than two stimuli is possible when 
multiple rounds of microcontact printing 
are performed [31]. Stamping spots with 
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increasing concentrations of TCR stimuli, 
for example, shows that LAT and 
phosphotyrosine cluster densities depend 
on the strength of the stimulus (Figure 1). 
Importantly, introducing extra stimuli does 
not require additional emission spectra 
and thus does not limit the use of fluores-
cence from other sources. By varying the 
fluorophore concentration on the different 
stamps one can discern the different stim-
uli during microscopy and image analysis, 
leaving room for multiple cell lines or addi-
tional immunofluorescent labels.  
 
 
CD28, SHP2 and their roles in protein 
microcluster formation 
Chapter two shows a clear role of CD28 in 
the formation and phosphorylation of pro-
tein microclusters. CD28 itself is known to 
assemble into clusters upon activation [32] 
and has two important tyrosine phosphor-
ylation sites in its cytoplasmic tail [33-35]. 
Part of the increase in phosphotyrosine 
cluster density will therefore likely be due 
to the direct phosphorylation and cluster-
ing of the coreceptor. However, a specific 
increase in tyrosine phosphorylated PLCγ1 
microclusters was also observed. CD28 is 
known to recruit ITK [36] and GADS [37] 
 
 
Figure 1. Multiple rounds of microcontact printing enable the parallel comparison of multiple 
stimuli. Stimulatory surfaces were prepared through three rounds of microcontact printing with 
polydimethylsiloxane stamps coated with: 1) 10 μg/ml αCD3, 30 μg/ml αCD28, 40 μg/ml unspecific 
murine IgG2a and 20 μg/ml goat-α-guinea pig Alexa Fluor 647, 2) 25 μg/ml αCD3, 30 μg/ml αCD28, 
35 μg/ml IgG2a and 10 μg/ml Alexa Fluor 647 3) 50 μg/ml αCD3, 30 μg/ml αCD28, 15 μg/ml IgG2a 
and 5 μg/ml Alexa Fluor 647. An overlay of 20 μg/ml fibronectin was used to functionalize the non-
stamped areas of the microscopy slides. Serum starved Jurkat T cells (1∙10
5
 cells) were incubated on 
these surfaces for 10 minutes, fixed with 3% paraformaldehyde and immunolabeled with Zenon 
Alexa Fluor 488 conjugated murine αphosphotyrosine and rabbit αLAT (secondary: Alexa Fluor 546). 
Scanning confocal microscopy images from top left to bottom right: transmission image, 
phosphotyrosine, LAT, stimuli (bright: 10% αCD3, intermediate: 25% αCD3, dim: 50% αCD3), compo-
site image of phosphotyrosine & LAT and composite image of phosphotyrosine, LAT and stimuli. 
Scale bar 25 μm. On the right the mean + SEM of the respective cluster densities are quantified (n= 6 
images in total counting 190 cells). 
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which is constitutively associated with 
SLP76 [38]. These three proteins are all in-
volved in the recruitment of PLCγ1 to the 
plasma membrane, the stabilization of its 
interaction with LAT and its phosphoryla-
tion [39-42]. Hence, the formation of 
phosphorylated PLCγ1 microclusters ob-
served in chapter two is likely caused by a 
stabilizing effect of CD28 on the LAT-PLCγ1 
signaling complex. 
The role of SHP2 in T cell signal transduc-
tion is intriguing. The phosphatase has 
been shown to be required for IL2 produc-
tion in T cells [43] and upregulates ERK 
phosphorylation through the formation of 
a complex with GRB2 and PI3K [43-45]. 
However, it has also been reported to in-
hibit T cell signaling through the inhibitory 
receptors CTLA4, PD1 and platelet endo-
thelial cell adhesion molecule 1 (PECAM1) 
[46-49]. In chapter two a small but signifi-
cant negative effect of SHP2 on the 
general tyrosine phosphorylation levels of 
protein microclusters and PLCγ1 
microclusters in particular was observed. 
PLCγ1 has not been reported as a direct 
target of SHP2 and contains neither the 
immunoreceptor tyrosine-based inhibitory 
motif (ITIM) nor the immunoreceptor tyro-
sine-based switch motif (ITSM) that are 
considered consensus motifs for SHP2 [50, 
51]. It is therefore possible that the in-
creased phosphorylation of PLCγ1 upon 
SHP2 knock down was an indirect effect of 
signaling processes involving SHP2 that 
have not yet been fully elucidated.  
Since the SHP2 knock down cells showed a 
decrease in IL2 production, in this setting 
the role of this phosphatase in the MAPK 
signaling pathway apparently outweighed 
its negative effect as a PTP on early T cell 
signal transduction. The precise mecha-
nisms employed by SHP2 in the regulation 
of T cell activation will need to be deter-
mined to resolve which effects of SHP2 can 
be considered redundant with respect to 
the activity of other enzymes. 
 
The multivalent presentation of CPPs 
The multivalent presentation of molecules 
is an effective way of increasing the activi-
ty of ligands with rather low affinity for 
their targets through avidity [52]. In the 
case of CPPs multivalency has been shown 
to improve membrane permeation and the 
delivery of cargo molecules over 100 fold 
without increasing toxicity [53, 54]. In the-
se cases, however, globular molecular 
designs were chosen for coupling of CPPs. 
Coupling to a linear scaffold, as done in 
this thesis, strongly increased the mem-
brane-disruptive potential and toxicity of 
the constructs (Chapter four). 
These findings demonstrate that the 
presentation of oligoarginines on a linear, 
flexible backbone affects cell penetration 
and toxicity of these CPPs in a different 
manner as a globular or branched presen-
tation. A possible explanation of these 
differences is that in the flexible design the 
conjugate may engage a larger membrane 
area. Remarkably, also for individual argi-
nine-rich peptides, the rigidity of the 
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backbone influences cell penetration. In-
creasing the distance between arginine 
residues or increasing the spacing of 
guanidinium groups through cyclization of 
decaarginine peptides enhanced the direct 
transport across the membrane of CPPs 
[55, 56]. Coupling of nonaarginines to 
poly(isocyano peptide) polymers, which 
provide a more rigid scaffold, will reveal to 
which degree backbone rigidity plays a role 
in activity [57]. 
A comparative study of different multiva-
lent peptide presentations coupled to 
varying scaffolds could also address the 
potential of such compounds in transport-
ing larger cargos across the plasma 
membrane. So far, interanalization of large 
cargoes was restricted to endocytosis [58, 
59]. Chapter four shows that in HeLa cells 
Dex-(R9)5 is at least in part internalized 
through nucleation zones. This could be 
because even though the dextran back-
bone is large it is also thin. The molecule 
could possibly pass through narrow open-
ings in the membrane that are used by the 
R9 peptides themselves, openings for 
which globular constructs would be too 
large.  With a proper balance of toxicity 
and import activity, such constructs may 
provide useful in the cytoplasmic import of 
functional polymers as described in Chap-
ter five. 
 
 
 
The role of multivalent protein-protein in-
teractions in signaling complexes and 
microclusters 
Park et al. [60] had previously shown that 
in a yeast system the function of the scaf-
fold protein STE5 relied mostly on the 
tethering of several kinases and little on 
conformational constraints that it might 
impose. Loss of MAPK signaling due to the 
mutation of interaction motifs in STE5 
could be restored by introducing PDZ do-
main mediated interactions at different 
sites in the scaffold protein and its inter-
acting kinases. With the HPMA-SLP228 
scaffold the relevance of multivalent pro-
tein-protein interactions in microcluster 
formation was addressed with a minimal 
synthetic design (chapter five). The scaf-
fold enhanced the formation of protein 
complexes on peptide microarrays and in-
creased microcluster densities on 
micropatterned surfaces. This validated 
the importance of multivalent protein-
protein interactions as a driving force be-
hind microcluster formation [4, 13-15, 61] 
and the lack of a requirement for specific 
conformational constraints. In addition, 
the increased GADS clustering in T cells 
stimulated on micropatterned surfaces is a 
very promising first demonstration that 
multivalent binders based on native signal-
ing domains can be used to modulate 
cluster formation in signaling pathways in-
side cells. Next, the effect of such an 
intervention on down-stream signaling 
events such as the calcium flux needs to be 
established. Furthermore, it will be inter-
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esting to investigate whether aspects of 
the T cell response such as cytokine re-
lease can be augmented in this manner.  
One possibility to further enhance 
proteolytic stability is to replace the pep-
tides on the HPMA backbone with their 
retro-inverso counterparts (chapter three). 
In some instances, biological activity is 
preserved after retro inversion [62]. Alter-
natively, protease resistance can be 
increased by the design of other 
peptidomimetics such as β-peptides or 
peptoids [63, 64]. In addition, we showed 
in chapter three that the negative 
phosphotyrosine peptides were generally 
more resistant to proteolysis than the 
proline-rich peptides in our analyses. This 
is in line with a previous study that showed 
that through phosphorylation, peptides 
can be protected from degradation by cer-
tain endopeptidases [65]. Multivalent 
constructs containing phosphorylated sig-
naling domains could therefore also be 
inherently more stable in an intracellular 
environment. Certainly, phosphotyrosines 
in such conjugates have to be replaced by 
their hydrolysis resistant counterparts, as 
rapid hydrolysis by phosphatases is other-
wise to be expected.  
The modular nature of the HPMA con-
structs provides a straight-forward 
implementation of alternative functionali-
ties. Instead of using only one peptide as 
demonstrated in chapter five, mixtures of 
peptides representing two or more differ-
ent signaling domains could be ligated to a 
single backbone, generating a construct 
that can crosslink different proteins. The 
latter could potentially be used to rein-
force existing interactions, reconstitute the 
function of adaptor proteins or even intro-
duce new connections. Due to the 
complications arising from the non-linear 
dose dependence of the enhancement of 
complex formation for the mono-
functional, multivalent conjugates (i. e. 
enhancement of complex formation at in-
termediate concentrations, reduction of 
complex formation at higher concentra-
tions), such heterofunctionalization could 
be a requirement for obtaining biologically 
active conjugates. The potential of MAPK 
pathway rewiring has been shown genet-
ically in Saccharomyces cerevisiae. By using 
fusion proteins of two mutated scaffold 
proteins it was possible to divert the input 
for a mating response to a response for 
high-osmolarity [60]. 
The ligation of one or more CPPs to the 
construct for cellular import [66-68] is one 
option to mediate cellular entry without 
electroporation (chapter four). For the 
generation of constructs carrying different 
peptides, ideally the numbers and position 
of each peptide should be controlled. Se-
quential monomer addition techniques 
offer the best control of synthetic polymer 
structure [69]. Moreover, a combination of 
coupling strategies on block copolymers 
can be employed to generate a defined 
structural orientation. One example is the 
copper-free click reactions involving specif-
ic cycloadditions to polymers carrying both 
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azide, oxime and nitrone functional groups 
[70].  
The development of therapeutic strategies 
based on the modulation of cellular signal-
ing by targeting protein-protein interaction 
domains has great potential. However, 
many aspects of the intricate balance be-
tween activation and inhibition of T cell 
activation are still unresolved. Therefore, it 
is difficult to foresee the effects of inter-
ventions in the heavily interwoven 
signaling network. It is very well possible 
that the targets used in this work are so far 
upstream in the signaling cascade that in-
tervention at this level causes changes in 
too many different pathways, not in the 
least because several signaling proteins, 
such as SHP2 as described above, appear 
to be involved in both stimulatory and in-
hibitory pathways. Nonetheless, the 
perspective of having a modular system for 
the regulation of T cell signaling is exciting.  
 
Concluding remarks 
Much has been learned about nano- and 
microclusters of signaling proteins over the 
last decade. An intriguing question that 
remains, is whether all proteins in a cluster 
are interconnected through protein-
protein interactions or whether they are a 
collection of smaller signaling complexes 
that merely colocalize. Here, super-
resolution microscopy will provide new in-
sights. 
Evidence is now emerging that the cluster-
ing of the TCR is an absolute requirement 
for T cell activation. Whether these entities 
are nanoclusters or microclusters will par-
tially be a matter of semantics as clear 
definitions concerning the number of pro-
teins to constitute either type of structure 
have not been formulated. The question 
will now shift towards intracellular pro-
teins such as LAT, GADS and SLP76. The 
clustering of these downstream, non-
receptor signaling proteins could in turn be 
the effect of their colocalization at TCR ac-
tivation sites and not a direct requirement 
for signal transduction. To address the 
question of whether clustering of certain 
proteins is compulsory for or only a conse-
quence of signaling, new approaches will 
need to be conceived to avoid the dilem-
ma of cause and effect that is inherent to 
the subject. Synthetic scaffolds that stimu-
late clustering of signaling proteins and the 
quantitative analysis of cluster densities as 
described in this thesis could assist in the 
pursuit of the answer. 
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SUMMARY
The formation of protein microclusters at 
the interface between a T lymphocyte and 
an antigen-presenting cell (APC) is one of 
the first events in the initiation of T cell 
signaling. Over the last two decades re-
search has generated a large body of 
knowledge on the nature of these 
microclusters. The known mechanisms 
driving protein microcluster formation are 
remodeling of the cytoskeleton, protein-
lipid interactions and multivalent protein-
protein interactions. The extent to which 
each of these factors contributes to the 
overall process, however, remains a topic 
of debate. Furthermore little is known on 
the effects of different stimuli on 
microcluster numbers and composition. 
The research described in this thesis was 
conducted with the aim of increasing 
knowledge on how T cell costimulation and 
multivalent protein interactions influence 
signaling complex and protein microcluster 
formation and to provide novel methods 
to address these issues. 
Chapter one starts with a brief overview of 
the role of T lymphocytes in immunity and 
pathologies that originate from T cell de-
fects. Because of their importance in 
immunity T cells are a key target for thera-
py. Treatments that can restore or 
modulate T lymphocyte function in more 
specific ways than available today could 
greatly advance human healthcare. For 
this purpose it is important to understand 
T cell physiology and signal transduction. 
In spite of its key role in the initiation of 
signaling, microcluster formation remains 
a poorly understood phenomenon and 
strategies are lacking to therapeutically 
modulate protein cluster formation. The 
chapter outlines the signaling pathways 
that lead to helper T cell activation and the 
protein-protein interactions involved. Scaf-
fold and adaptor proteins play a central 
role in establishing protein complexes 
through multivalent protein interactions. 
The chapter continues with an introduc-
tion to microclusters and a discussion of 
the methods that have been used to study 
them. For various techniques to induce T 
cell stimulation, namely stimulatory anti-
body-coated coverslips, supported planar 
bilayers, living APCs and micropatterned 
surfaces as well as for several super-
resolution microscopy techniques to inves-
tigate microcluster formation advantages, 
drawbacks and key findings are summa-
rized. Finally, an overview on peptide-
based methods to modulate signal trans-
duction pathways is presented. A range of 
examples covering both T cell-specific and 
other signaling pathways shows that the 
strategies on these studies either involve 
the disruption of interactions between sig-
naling proteins or inhibition of enzymatic 
function. Synthetic scaffold proteins with 
multiple binding sites for target proteins 
have the potential to increase protein 
connectivity and form a new tool for cell 
signal transduction research. 
To study microclusters in a quantitative 
manner it is important to use methods 
that enable a reliable comparison between 
different conditions in an unbiased man-
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ner. While methods that have been used in 
other lines of research all have their mer-
its, cells treated with different stimuli were 
always analyzed separately and on a per 
cell basis. Such an approach leaves room 
for bias in the selection of cells for analy-
sis, and sample-to-sample variation will 
compromise a comparison of different 
conditions. Especially the latter can skew 
results and make it difficult to detect sub-
tle differences between conditions. 
Therefore, in chapter two a method is pre-
sented that allows for the simultaneous 
comparison of two cell lines and two stim-
uli in a single sample and compares fields 
of view containing of up to a few hundred 
cells per image, eliminating observer bias 
in the selection of cells. Microcontact 
printing was used to generate 
micropatterned surfaces featuring alter-
nating stripes of different stimuli. 
Subsequently, two different cell strains 
were coincubated on these surfaces, fixed 
and then immunolabeled. Image pro-
cessing protocols were developed to 
analyze confocal microscopy images con-
taining hundreds of cells, extracting data 
on the overall accumulation or phosphory-
lation of a protein in the whole-cell contact 
area or in clusters in particular. Moreover, 
data was obtained on cluster densities, av-
erage cluster numbers per cell, cell 
spreading and preference of a cell for a 
particular type of surface. Using this novel 
method cluster of differentiation 28 
(CD28) costimulation was shown to result 
in increased cell spreading and a higher 
number of phosphorylated microclusters 
per surface area. The latter was true when 
cells were stained with a general α-
phosphotyrosine antibody but also when 
specifically probed for phosphorylated 
phospholipase C γ1 (PLCγ1). T cells lacking 
SH2 domain-containing protein tyrosine 
phosphatase 2 (SHP2) did not differ from 
cells expressing wild type levels of the 
phosphatase when considering the density 
of phosphorylated clusters. However, the 
knock-down of SHP2 led to an increase in 
the phosphorylation levels of individual 
clusters by 7%. This result indicated that as 
a phosphatase, SHP2 is non-redundant de-
spite the fact that the overall enzymatic 
activity of phosphatases in T cells is much 
larger than that of kinases. Microcluster 
numbers and densities in the knock-down 
cells remained the same, indicating that 
SHP2 does not prevent the formation of 
phosphorylated microclusters but attenu-
ates their phosphorylation level once 
formed. Interestingly this did not have a 
positive effect on downstream signaling. In 
fact, interleukin 2 (IL2) production in SHP2 
knock-down cells was reduced, implying 
that SHP2 plays a role on multiple levels in 
T cell signaling. The latter effect is likely 
due to its involvement on mitogen-
activated protein kinase (MAPK) signaling. 
To use peptides as a means to influence 
protein complex and microcluster for-
mation in T cell signaling, it is important to 
understand the behavior of such peptides 
inside cells. Chapter three assesses intra-
cellular peptide stability in relation to 
structural characteristics. A set of fluores-
cein-labeled peptides representing binding 
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motifs of various SRC homology 2 (SH2) 
and SH3 domains, each approximately 20 
amino acids in length, was imported into 
cells by electroporation and the cellular 
fluorescence was followed over time. Fluo-
rescence of the strongly negatively 
charged phosphotyrosine peptides was re-
tained longer within cells than fluor-
escence of the proline-rich peptides carry-
ing a neutral to slightly positive net charge. 
In cells electroporated with retro-inverso 
enantiomers of the peptides, fluorescence 
was retained significantly longer. In addi-
tion, fluorescence correlation spectroscopy 
(FCS) measurements of peptides incubated 
in cell lysates showed that with longer in-
cubation periods an increasing fraction of 
fluorescent particles had a higher diffusion 
constant, indicating that the labeled pep-
tides were decreasing in size. Only a very 
small fraction of the retro-inverso analogs 
showed a diffusion increase even after the 
addition of proteinase K. Also, inside living 
cells FCS measured lower diffusion con-
stants for retro-inverso D-peptides. Taken 
together these results suggested that pro-
teolysis was the main reason for the loss of 
fluorescence from cells and that resistance 
against proteolysis is strongly dependent 
on the structural characteristics of a pep-
tide. 
Another approach for protecting peptides 
from degradation is their coupling to a 
polymer backbone. In addition, coupling 
multiple copies of a ligand to a polymer 
creates avidity and therefore increases ac-
tivity. Chapter four investigates the effect 
of coupling several copies of the cell-
penetrating peptide (CPP) nonaarginine 
(R9) to a dextran backbone on activity to-
wards various cellular models. 
Multivalency in this molecular arrange-
ment strongly increased membrane 
perturbing activity and, as a consequence, 
toxicity. Incubation with erythrocytes that 
lack endocytosis did not lead to acute tox-
icity. Instead, we observed a pronounced 
membrane staining, cellular deformation, 
the aggregation of cells and phosphatidyl-
serine exposure. This led to the conclusion 
that the severe toxicity was due to an ac-
tive reaction by nucleated cells to 
multivalent R9 construct, such as endocy-
tosis. 
In chapter five peptides were coupled to a 
polymer backbone for a signal transduc-
tion study. A multivalent presentation of a 
proline-rich peptide was used to define the 
minimal structural requirements for a scaf-
folding protein. The selected peptide, 
SLP228, represents the proline-rich region 
of SH2 domain-containing leukocyte pro-
tein of 76 kDa (SLP76) that constitutively 
binds the adaptor protein GRB2-related 
adaptor downstream of SHC (GADS). The 
conjugate HPMA-SLP228 consisted on av-
erage of three copies of this peptide 
attached to a hydroxypropyl methacryl-
amide (HPMA) backbone through native 
chemical ligation. The first indication that 
this construct acted as a synthetic scaffold 
in T cell signaling was obtained by peptide 
microarray experiments with cell lysates in 
which the construct promoted the re-
cruitment of GADS to certain peptides on 
the array. Following introduction into living 
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Jurkat cells by electroporation, the scaffold 
enhanced the formation of signaling com-
plexes in cells incubated on micro-
patterned surfaces comparable to those 
described in chapter two. Cells treated 
with the construct formed more GADS 
microclusters per surface area than cells 
that had been treated with monovalent 
SLP228 or a control HPMA backbone.  
Finally, in chapter six the experimental 
findings described in this thesis are placed 
into a broader context and directions for 
further research and the functional role of 
protein microclusters in T cell signal trans-
duction are discussed. Furthermore the 
methods developed in this work are evalu-
ated and suggestions on how they can be 
implemented in or combined with other 
research are provided. Additionally, an ex-
ample of further development of the 
microcontact printing protocol and image 
analysis is given that allows for the parallel 
comparison of more than two stimuli.  
In conclusion, the novel methods for the 
quantitative study of protein microclusters 
and synthetic scaffolds presented in this 
thesis offer new approaches for T cell sig-
naling research and in the future might aid 
in the development of therapeutic agents. 
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SAMENVATTING
De vorming van eiwit microclusters, daar 
waar een T cel en een antigen pre-
senterende cel (APC) een interactie met 
elkaar aangaan, is een van de eerste 
ontwikkelingen die duidt op het begin van 
T cel signaal transductie. De afgelopen 
twee decennia is er veel kennis vergaard 
aangaande de eigenschappen van micro-
clusters. De drijvende krachten achter 
microcluster vorming zijn herstructurering 
van het cytoskelet, multivalente eiwit-
eiwit interacties en interacties tussen 
eiwitten en lipiden. In welke mate ieder 
proces bijdraagt aan de vorming van 
microclusters blijft echter een onderwerp 
van discussie. Bovendien is er nog weinig 
bekend over de effecten van verschillende 
celstimuli op het aantal gevormde 
microclusters en hun samenstelling. Het 
doel van dit proefschrift was het 
uitbreiden van de kennis over de invloed 
van costimulatie en multivalente eiwit-
interacties op signaal complexen en eiwit 
microcluster vorming in T cellen en het 
verschaffen van nieuwe methoden om dit 
soort vragen te beantwoorden. 
Hoofdstuk één begint met een kort 
overzicht over de rol van T cellen in het 
immuun systeem en ziektebeelden die 
kunnen ontstaan wanneer T cellen niet 
juist funtioneren. Wegens hun belangrijke 
rol in immuniteit zijn T lymphocyten een 
interessant doelwit voor medicijnen. 
Behandelingen die T cel functies kunnen 
herstellen of modificeren op meer 
specifieke wijzen dan momenteel mogelijk, 
kunnen voor de gezondheidszorg van grote 
waarde zijn. Het is daarom belangrijk om 
de signaal transductie en fysiologie van T 
cellen goed te begrijpen. Ondanks de 
sleutelrol die het speelt bij het initiëren 
van T cel signaal transductie, blijft 
microcluster vorming een slecht begrepen 
fenomeen en de therapeutische mogelijk-
heden om eiwit clusters te beïnvloeden 
zijn beperkt. Het hoofdstuk beschrijft de 
signaal routes die leiden tot de activatie 
van T helpercellen en de betrokken eiwit-
eiwit interacties. Scaffold en adaptor 
eiwitten spelen een centrale rol in de 
vorming van eiwit complexen door middel 
van multivalente eiwit interacties. Er volgt 
een introductie van microclusters en 
verschillende methoden voor de inductie 
van T cel stimulatie om microclusters te 
bestuderen, worden bediscussieerd. De 
voordelen, nadelen en belangrijkste 
ontdekkingen van deze methoden, zijnde 
stimulerende antilichaam-gecoate-dek-
glaasjes, supported planar bilayers, 
levende APCs en oppervlaktes met 
micropatronen worden samengevat. Ook 
een aantal super-resolutie microscopie 
technieken worden besproken. Ten slotte 
wordt er een overzicht gegeven van op 
peptiden gebaseerde methoden om 
signaal transductie routes te beïnvloeden. 
Een reeks voorbeelden van T cel-specifieke 
maar ook andere signaleringsroutes laat 
zien dat in deze studies gebruik wordt 
gemaakt van strategieën die de interactie 
tussen twee signaal eiwitten verstoren of 
de enzymatische activiteit van bepaalde 
eiwitten remmen. Synthetische scaffold 
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eiwitten met meerdere bindingsplaatsen 
voor doeleiwitten hebben de potentie 
eiwit connectiviteit te versterken en 
vormen daarmee een nieuw instrument 
voor signaal transductie onderzoek. 
Om eiwit microclusters op een 
kwantitatieve manier te bestuderen is het 
belangrijk om methoden te gebruiken die 
een objectieve en betrouwbare 
vergelijking tussen verschillende condities 
mogelijk maken. De methoden gebruikt in 
ander onderzoek in dit veld hebben veel 
waardevolle kennis opgeleverd.  
Verschillende cellijnen werden in deze 
studies altijd afzonderlijk van elkaar en op 
een per cel basis geanalyseerd. Dit type 
aanpak laat ruimte voor subjectiviteit 
tijdens de selectie van cellen om te 
analyseren en variatie tussen monsters zal 
de vergelijking van verschillende condities 
bemoeilijken. Vooral dat laatste punt kan 
onderzoeksresultaten vertekenen en het 
moeilijk maken subtiele verschillen tussen 
condities te detecteren. Daarom wordt in 
hoofdstuk twee een methode ge-
presenteerd die gelijktijdig de vergelijking 
van twee cellijnen alsmede de vergelijking 
van twee stimuli in één monster mogelijk 
maakt. Vergelijkingen worden gedaan in 
een beeldveld met enkele honderden 
cellen waardoor ‘observer bias’ tijdens de 
selectie van cellen wordt uitgesloten. 
Oppervlaktes met micropatronen van 
strepen met afwisselende stimuli werden 
gemaakt door middel van microcontact 
printen. Twee verschillende cellijnen 
werden samen geïncubeerd op deze 
oppervlaktes, gefixeerd en vervolgens 
gelabeld met fluorescerende antilichamen. 
Beeldverwerkingsprotocollen werden ont-
wikkeld om confocale microscopie beelden 
met honderden cellen te kunnen 
analyseren, zodat data kon worden 
verzameld met betrekking tot de 
accumulatie of fosforylering van een eiwit 
in de gehele celcontactregio of specifiek in 
de clusters. Ook werd data verzameld over 
clusterdichtheid, gemiddeld aantal clusters 
per cel, cel spreiding en de voorkeur van 
een cel voor een bepaaldestimulus. Met 
deze nieuwe methode was het mogelijk 
om te laten zien dat stimulatie van de 
coreceptor cluster of differentiation 28 
(CD28) resulteerde in een toename in 
celspreiding en een hoger aantal 
gefosforyleerde eiwit microclusters per 
oppervlak. Deze hogere cluster dichtheid 
gold zowel wanneer werd gelabeld met 
een algemeen α-fosfotyrosine antilichaam 
als wanneer gefosforyleerd fosfolipase C 
γ1 (PLCγ1) specifiek werd onderzocht. Er 
was geen verschil in de dichtheid van 
gefosforyleerde clusters tussen SH2 
domain-containing protein tyrosine phos-
phatase 2 (SHP2) knock-down cellen en 
cellen die SHP2 op normale niveaus tot 
expressie brachten. De knock-down van 
SHP2 leidde echter wel tot een toename 
van de fosforylering van individuele 
clusters met 7%. Dit resultaat suggereert 
dat, ondanks de overmaat van activiteit 
van fosfatases ten opzichte van kinase 
activiteit in cellen, SHP2 als fosfatase een 
niet te compenseren rol speelt.  
Microcluster aantallen en dichtheden 
veranderden niet door de knock-down van 
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SHP2, hetgeen er op wijst dat SHP2 niet de 
vorming van nieuwe gefosforyleerde 
clusters remt, maar hun fosforylatie-
niveaus afzwakt nadat ze eenmaal 
gevormd zijn. Verderop in de signalerings-
cascade werd er echter geen versterkend 
effect waargenomen van de knock-down 
van SHP2. Deze cellen hadden zelfs een 
gereduceerde productie van interleukine 2 
(IL2), wat duidt op een rol voor SHP2 op 
verschillende niveaus in de T cel signaal 
transductie cascade. Dit laatste effect 
hangt waarschijnlijk samen met de 
betrokkenheid van SHP2 in mitogen-
activated protein kinase (MAPK) 
signalering. 
Om peptiden aan te kunnen wenden als 
middel om eiwitcomplex en microcluster 
vorming in T cel signaal transductie te 
beïnvloeden, is het belangrijk om de 
eigenschappen van zulke peptiden in 
cellen te begrijpen. In hoofdstuk drie werd 
het verband tussen de intracellulaire 
stabiliteit van peptiden en hun structurele 
eigenschappen onderzocht. Fluoresceïne-
gelabelde peptiden, elk ongeveer 20 
aminozuren lang, die bindingsmotieven 
van verscheidene SRC homology 2 (SH2) en 
SH3 domeinen representeren, werden 
door middel van electroporatie in cellen 
gebracht. Vervolgens werd de afname van 
de fluorescentie van deze peptiden 
gevolgd. Cellen die werden behandeld met 
sterk negatief geladen peptiden bleven 
langer fluorescent dan de cellen behandeld 
met proline-rijke peptiden met een 
neutrale tot licht positieve netto lading. 
Cellen die geëlectroporeerd werden met 
retro-inverso enantiomeren van de 
peptiden bleven ook significant langer 
fluorescent. Bovendien werd met behulp 
van fluorescence correlation spectroscopy 
(FCS) metingen van peptiden in cellysaten 
vastgesteld dat hoe langer de incubatietijd 
was, des te groter de fractie met een hoge 
diffusieconstante werd. Dit wijst op een 
afname van de lengte van de peptiden in 
cellysaat. De retro-inverso enantiomeren 
lieten in zeer beperkte mate een toename 
van diffusie zien in cellysaten, zelfs na de 
toevoeging van proteinase K. Ook in 
levende cellen werden door FCS lagere 
diffusie constanten vastgesteld voor retro-
inverso analogen. Samen suggereren deze 
resultaten dat proteolyse de voornaamste 
reden voor de afname van fluorescentie in 
cellen was en dat de structurele 
eigenschappen van peptiden sterk bepalen 
hoe gevoelig deze peptiden zijn voor 
afbraak. 
Het koppelen van peptiden aan een 
lineaire polymeer verleent ook een 
effectieve bescherming tegen afbraak door 
proteases. Door het bevestigen van 
meerdere kopieën van een ligand aan een 
polymeer wordt er een kans op herhaalde 
interactie met de bindingspartner 
gecreëerd. Hierdoor wordt ook de 
activiteit van een construct vergroot. 
Hoofdstuk vier onderzocht het effect van 
een multivalent construct van cel-
penetrerende peptiden (CPPs) op 
verschillende celtypen. Het construct 
bestond uit een ruggengraat van dextraan 
met daarop een aantal kopieën van het 
CPP nona-arginine (R9). De multivalente 
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presentatie van R9 zorgde voor een 
versterkte verstoring van het 
plasmamembraan en daarmee een hoge 
toxiciteit. De incubatie van erytrocyten 
met het construct leidde niet tot acute 
celsterfte maar tot een sterke membraan-
kleuring, cellulaire deformatie, het 
aggregeren van cellen en het verschijnen 
van fosfatidylserine in de buiten-
membraan. Aangezien erytrocyten 
verscheidene cellulaire verrichtingen, zoals 
endocytose, niet uitvoeren, leidde dit tot 
de conclusie dat de hevige toxiciteit het 
gevolg was van een actieve reactie van 
kernhoudende cellen op het multivalente 
R9 construct. 
In hoofdstuk vijf werden peptiden aan een 
lineair polymeer gekoppeld voor signaal 
transductie onderzoek. Er werd een 
multivalente presentatie van een proline-
rijk peptide gebruikt om de minimale 
structurele voorwaarden voor de 
functionaliteit van een scaffold eiwit te 
onderzoeken. Het geselecteerde peptide, 
SLP228, representeert het proline-rijke 
deel van SH2 domain-containing leukocyte 
protein of 76 kDa (SLP76) dat in vivo 
normaliter aan het adaptor eiwit GRB2-
related adaptor downstream of SHC 
(GADS) gebonden is. Het HPMA-SLP228 
construct bestond gemiddeld uit drie 
kopieën van het peptide gebonden aan 
een hydroxypropyl methacrylamide 
(HPMA) keten door native chemical 
ligation. De eerste indicatie dat dit 
construct zich gedroeg als een scaffold 
eiwit in T cellen kwam van peptide-
microarray experimenten. In cellysaten 
versterkte het construct de binding van 
GADS aan bepaalde peptiden op de array. 
Na de introductie in levende Jurkat cellen 
door middel van electroporatie, 
stimuleerde de synthetische scaffold de 
formatie van signaal complexen in cellen 
die werden geïncubeerd op oppervlakten 
met micropatronen, vergelijkbaar met die 
beschreven in hoofdstuk twee. Cellen die 
met HPMA-SLP228 werden behandeld 
genereerden meer GADS microclusters per 
vierkante micrometer dan cellen die 
werden behandeld met monovalent 
SLP228 of een HPMA controle keten. 
Ten slotte worden in hoofdstuk zes de 
experimentele bevindingen van dit 
proefschrift in een bredere context 
geplaatst en worden de functionele rol van 
eiwit microclusters in T cel signaal 
transductie en voorstellen voor toekomstig 
onderzoek besproken. Ook worden de 
methoden die zijn ontwikkeld met dit werk 
geëvalueerd en worden er suggesties 
gedaan over hoe ze kunnen worden 
geïmplementeerd in, of worden ge-
combineerd met ander onderzoek. Verder 
wordt er een voorbeeld gegeven van een 
microcontact print protocol dat de 
parallelle vergelijking van meer dan twee 
stimuli mogelijk maakt. 
Concluderend, de nieuwe methoden voor 
de kwantitatieve bestudering van eiwit 
microclusters en synthetische scaffolds die 
in dit proefschrift zijn gepresenteerd 
bieden een nieuwe benadering voor T cel 
signaal transductie onderzoek en zouden 
in de toekomst kunnen helpen bij de 
ontwikkeling van therapeutische middelen. 
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